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Helicobacter pylori has shown strong association with various gastroduodenal 
diseases. It has been reported that H. pylori infection is acquired during childhood and 
may persist for decades but its mode of transmission has yet to be established. 
H. pylori differentiates morphologically from spiral to coccoid form during 
prolonged incubation, yet exhibited similar DNA fingerprints throughout this conversion. 
By immunogold labelling transmission electron microscopy, using antibodies raised 
against the spiral (3 day old culture) and coccoid (150 day old culture) antigens, results 
showed that these antigens were localized on the surface of H. pylori.  Flow cytometry 
revealed that both antigens shared common immunogenic epitopes and possibly respective 
unique proteins that hitherto not isolated/ identified.    
Sera of 21 families comprising 72 members when examined by ELISA and 
western blotting using the 3 day old spiral antigen showed that seropositivity was more 
prevalent in the older family members.  Comparison of the western blot profiles showed 
highly similar protein patterns between seropositive family members residing in the same           
household. This study demonstrates the possibility of an intrafamilial vertical      
transmission and H. pylori infection could possibly begin at young age.   
In the follow-up serology study, seroprevalence against H. pylori spiral or coccoid 
antigens in the paediatric children with epigatric pain (n=489) was 2 fold higher than the 
asymptomatic school children (n=599).  Interestingly, there was a 4 fold increase in IgG 
levels to the coccoid antigen as compared to the spiral antigen among the symptomatic or 
control group.  The results imply that the coccoid form may have a role in H. pylori 
infection in the symptomatic young population. Western blot profiles of representative 
seropositive and seronegative sera against both forms of antigens further show that the 
 xviii
coccoid form of H. pylori is capable of eliciting a humoral immune response that is highly 
similar to that induced by the spiral form.  This finding raises a concerned question: Is 
there an under-reporting on the presence of H. pylori infection in this group of young 
patients? 
The 15 isolates from different paediatric patients with epigastric pain presented 
different genetic fingerprints by RAPD.  The PCR analysis of different virulence genes 
showed that the H. pylori strains in Singapore are different from the western countries.  
The prevalence of antibiotics resistance and the Lewis antigens expression are similar to 
the local adult population.   
As morphological conversion progressed, there was a reduction of protein content.  
Comparative differential analysis on 1D and 2D PAGE demonstrated that the coccoid 
form has retained “essential” proteins which had been identified as Translational 
elongation factor EF-TU, 26 kDa, non-heme containing ferritin (Pfr) and neutrophil 
activating protein (NapA) by mass spectrometry (MALDI-TOF).  cagA and vacA were 
shown to be conserved by PCR.  In addition, the expression of 26 kDa, ureA and Lewis 
antigens were maintained throughout the time course study. 
The significant increase in seroprevalence to the coccoid antigen as compared to 
the spiral antigen in the symptomatic children suggests that the infection possibly could 
have begun with the coccoid form.  Strong evidence on vertical transmission was shown in 
the intra-familial study.  The proteomic and genetic studies indicated that most genes were 
conserved during the morphological conversion.  There are signs of conserved property of 
the 2 forms. Present comparative epidemiological and proteomics studies have lend 
 xix
support to the notion that coccoid form is viable and likely to have a role in the 
















































































Helicobacter pylori infection is one of the most common chronic infections in 
human since the isolation of the pathogen by Warren and Marshall (1983) two decades 
ago.  This gram-negative gastric bacterium chronically inhabits the stomach of more than 
half of the world population (Parsonnet, 1999; Westblom et al., 1999) and is associated 
with the development of acute chronic gastritis, peptic ulcer disease, gastric 
adenocarcinoma and mucosal-associated lymphoid tissue (MALT) lymphoma (Correa & 
Miller, 1995; Kuipers et al., 1995; Mitchell, 1999).  Most of the infected individuals 
remain asymptomatic throughout their life whilst only about 10% of those infected 
develop peptic ulcer disease and fewer than 1% are likely to develop gastric carcinoma 




1. 1 H. pylori INFECTION BEGINS WITHIN FAMILIES 
Despite the extensive studies on H. pylori infection, the precise mechanism of 
transmission has not been established.  Infection occurs predominantly through household 
contact during childhood (Malaty et al., 2000) while studies by Elitsur et al. (1999) and 
Taneika et al. (2001) have demonstrated intrafamilial clustering of H. pylori infection.  
The studies on family aggregation of the infection provide a model for investigating 




1.2  H. pylori INFECTION IN PAEDIATRICS 
1.2.1 Prevalence during childhood 
 Reports have shown that childhood is a time of high risk for acquiring H. pylori 
infection (Lindkvist et al., 1996; De Giacomo et al., 2002).  Boey and co-workers (1999) 
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conducted an epidemiological study on the prevalence of H. pylori infection in 514 
asymptomatic children.  Of the 261 children in age group of 0.5-5 years old, 19 (7%) were 
found to be seropositive for H. pylori.  A recent report by Malaty et al. (2002) which 
studied the age acquisition of H. pylori infection from infancy to adulthood, demonstrated 
that the highest rates of acquisition of the infection was before the age of 10.  Although 
serious complications associated with the infection are rare in childhood, disease 
progression may in the long run lead to peptic ulcer disease or gastric carcinoma in a small 
proportion of those infected (Forman et al., 1991; Imrie et al., 2001).   
   
1.2.2 Association with recurrent abdominal pain (RAP) and epigastric pain 
RAP is defined as the occurrence of three or more episodes of abdominal pain of 
such severity as to interfere with a child’s normal activity over a 3 months period (Apley 
& Naish, 1958).  This phenomenon is one of the most common complaints in childhood 
and the prevalence of organic diseases responsible for the pain has ranged from less than 
10 % (Stone & Barbero, 1970) to more than 50 % (Ashorn et al., 1993).  Epigastric pain is 
one of the main presenting symptoms associated with abdominal pain (Uc & Chong, 
2002). While H. pylori infects the younger population, its association with the 
development of non-ulcer dyspepsia and pathogenesis of RAP has been less clear 
(Heldenberg et al., 1995; Walsh et al., 1997; Bode et al., 1998).  There are studies which 
showed an association between RAP and H. pylori infection in children (Chong et al., 
1995; Rutigliano et al., 1999; Frank et al., 2000) whereas there are others which 
demonstrated otherwise (Bode et al., 1998; Wewer et al., 1998; Macarthur, 1999).     
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1.2.3 Treatment and antimicrobial resistant H. pylori 
The standard regimen most widely used to eradicate H. pylori is the triple therapy, 
which consists of 2 antibiotics and bismuth (Logan et al., 1991; Graham et al., 1992) or a 
proton pump inhibitor (Bazzoli & Pozzato, 1997).  The antibiotics potentially useful in    
H. pylori eradication are clarithromycin, metronidazole, amoxicillin and tetracycline.  
Guidelines proposed by the Canadian Helicobacter Study Group for the management of 
paediatric H. pylori infection recommend diagnostic tests only in children who are most 
likely to benefit from treatment, such as those likely to have peptic ulcer disease (Sherman 
et al., 1999).  In a separate report from the European Paediatric Task Force, there was 
consensus that the physician should offer treatment for the infection if the child undergoes 
endoscopy and H. pylori is identified (Drumm et al., 2000). 
Failure to eradicate H. pylori due to antibiotic resistant-H. pylori has been a 
growing clinical problem.  The study by Kalach et al. (2001), which evaluated the 
antibiotic resistance in children before treatment of H. pylori infection reported the 
resistance to metronidazole to be as high as 43% and 21% were resistant to 
clarithromycin.  Similarly, the findings from the study of Kato et al. (2002), indicated that 
a high prevalence of clarithromycin resistant strains in Japanese children were associated 
with eradication failure.  In a 9-year study on Spanish children, Lopez-Brea et al. (2001) 
showed that the resistance to clarithromycin and metronidazole in H. pylori had increased 
over the years from 2.27% to 28.33% (for clarithromycin) and 7.14% to 43.9% (for 
metronidazole).     
In Singapore, the prevalence of antibiotic resistance in paediatric patients with       
H. pylori per se has not been evaluated.  However, previous work by our research group 
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has documented an increased prevalence of resistance to metronidazole in H. pylori 
positive patients from 20% in 1995 to 47% in 1998 (Hua et al., 2000a) and hovered at 
~50% by 2000 (unpublished data).   
 
1.2.4 Population diversity  of H. pylori 
Genomic diversity of H. pylori strains was displayed using methods such as     
PCR-restriction fragment length polymorphism (RFLP) and random amplified 
polymorphic DNA (RAPD)-PCR (Hua et al., 1998; Gzyl et al., 1999).  The H. pylori 
isolates from unrelated individuals have shown to exhibit different genetic fingerprints.  
Several bacterial factors notably cagA (cytotoxin-associated gene), vacA 
(vacuolating cytotoxin), iceA (induced by contact with epithelial cells) and babA2 (blood 
group antigen-binding adhesin) have been implicated in the pathogenicity of H. pylori and 
different genotypes have shown distinct geographical distribution and correlation with 
disease outcomes (van Doorn, 1998; 1999, Zheng et al., 2000).   The cagA positive iceA1 
vacA s1c-m1 genotype was more dominant in Japan and Korea (Yamaoka et al., 1999).  
However, in the United States, the predominant genotype was cagA positive iceA2 vacA 
s1b-m1 genotype.  A comparison study by Oleastro and co-workers (2003) on the 
prevalence of virulence genotypes, namely cagA, vacA and babA2 in H. pylori isolated 
from adult and children patients reported that H. pylori strains harbouring the more 
virulent genotypes, particularly the type I (vacA s1 and cagA positive) and triple positive 
(vacA s1, cagA and babA2 positive) strains were more prevalent in adults.  In another 
study based on the Mexican population, Gonzalez-Valencia et al. (2000) observed 
differences in strains isolated from adults and children in the same population.  Among the 
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adults in Mexico, they found principally cagA positive vacA s1b strains as compared to 




1.3 COCCOID FORM OF H. pylori 
H. pylori has been found to occur in two morphological forms: spiral and coccoid.  
The actively replicating spiral form transforms into the dormant coccoid form when 
exposure to stressful environmental conditions such as increased oxygen tension 
(Catrenich & Makin, 1991; Cellini et al., 1994a), acid stress (Mizoguchi et al., 1998), 
treatment with antimicrobial agents (Berry et al., 1995) as well as prolonged incubation 
(Hua & Ho, 1996).  The spiral form has been shown to be the infective form that is 
responsible for gastroduodenal diseases as there is no definitive role dedicated to the 
coccoid form to date.   
The coccoid form of H. pylori is not culturable in vitro and the study by         
Kuster et al. (1997) suggested that this form is the morphological manifestation of cellular 
degeneration and cell death.  In the study, the total amounts and integrity of the RNA and 
DNA were significantly reduced and absence of a membrane potential were observed.  
Similar conclusion was also drawn from a number of other studies (Narikawa et al., 1997; 
Monstein et al., 1998), showing non-random fragmentation of ribosomal RNA and 
degradation of nucleic acid as the culture aged.  On the contrary, other investigators had 
demonstrated that the coccoid form is viable but non-culturable (VBNC) as reports 
suggested that coccoid form maintained cell structures, metabolism and protein expression 
(Cellini et al., 1998; Monstein & Jonasson, 2001; Nilsson et al., 2002).   
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Experimental data had shown the survival of H. pylori coccoid form in water for 
months (West et al., 1990; Mai et al., 1991).  Moreover, animals infected with the coccoid 
form were reported to be able to colonize and produce gastric alterations (Cellini et al., 
1994b; Wang et al., 1997).  A recent study by Rabelo-Goncalves et al. (2002) describing 
the histopathological findings in BALB/c mice model, challenged with coccoid strain of 
H. pylori, showed induction of an acute inflammatory response in the stomach of 
reinfected mice. The coccoid form was also present on gastric mucosa of infected 
individuals (Chan et al., 1994).   
The mode of transmission of H. pylori infection has yet to be unravelled.  
However, the coccoid form, which is the potential survival of extragastric form, has been 
suspected to play a vital role in the transmission process.  This form was also implicated in 

























The objectives of this study are:  
 
Epidemiological studies 
1) To study the possible intrafamilial transmission of H. pylori.  
 
2) To examine the seroprevalence of H. pylori in local paediatric patients with 
epigastric pain and to compare the level of serum IgG against both the spiral 
and coccoid forms of H. pylori. 
 
3) To characterize the clinical isolates from symptomatic paediatric patients with 
respect to genetic diversity, antibiotic susceptibility, Lewis antigens expression 
and presence of the putative virulence determinants.  
 
 
Dimorphism of H. pylori 
1) To study the DNA fingerprint, analyse the virulence genes and Lewis antigens 
expression during morphological conversion from spiral to coccoid form. 
 
2) To compare the protein expression profiles during the morphological 
conversion from the spiral to coccoid form by proteome tools and to identify 






















































SUMMARYSURVEY OF LITERATU E
 
2.1 HISTORY   
 
 The first well known report of gastric Helicobacters has been credited to an Italian 
anatomist Giulio Bizzozero, as early as in 1893.  In hand drawn illustrations, Bizzozero 
documented the presence of “spirochetes” with approximately 10 wavelengths within the 
parietal cells and gastric glands in the stomachs of dogs.  However, the first record on the 
presence of spiral organisms in the human mucosa, adjacent to carcinomas was described 
by Krienitz (1906).  
  In 1939, Doenges showed 43% of human stomach autopsies harboured spiral 
organisms and a year later, Freedberg and Baron (1940) presented findings of 
“spirochetes” in about 40% of the resected gastric specimens. These findings were     
viewed with scepticism as most of the samples of spiral organisms were obtained           
post mortem and the possibility of contamination could not be disregarded.  Moreover, the 
hypothesis of contamination gained superiority in the early 1950s when Palmer performed 
a study on more than 1,000 gastric biopsies taken with a blind suction biopsy instrument 
and found no evidence of spirochetes.  This incorrect conclusion drawn during that period 
could be due to the rigid endoscopes available, which only allowed biopsies to be taken 
from the fundus and not from the antrum, where H. pylori is usually located. The 
possibility that the appropriate staining solutions were not used could not be ruled out.       
  The interest in this gastric spiral bacterium was re-awakened when Steer and 
Colin-Jones (1975) noted that numerous spiral bacteria were present in 80% of their 
gastric ulcer specimens. Unfortunately, attempts to culture the organism yielded only 
growth of Pseudomonas aeruginosa. This was later assumed to be the contaminants from 
the endoscope.    
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 A major breakthrough in locking the link between gastroduodenal diseases and the 
spiral bacteria was established when two Australian researchers Robin Warren and Barry 
Marshall (1983), after numerous unsuccessful attempts, managed to culture the 
Campylobacter-like organism (CLO) by chance.  Furthermore, Barry Marshall himself 
had fulfilled the Koch’s postulate, confirming an association of the bacteria and clinical 
disease by voluntarily ingesting a culture of H. pylori and was subsequently diagnosed 
with gastritis (Marshall et al., 1985a).     
   The brief history on the discovery of H. pylori as illustrated in Table 2.1 shows 
that H. pylori has existed all this while, but investigators were not able to detect the 
bacteria in biopsies or merely considered their findings a result of contamination. The 
discovery of the gastric pathogen, H. pylori, has indeed led to a revolution in our 




2.2 TAXONOMY AND MORPHOLOGY 
 
2.2.1 Taxonomy of H. pylori  
This novel gastric bacterium isolated resembled Campylobacter in several aspects, 
both morphologically and microbiologically.  Therefore, the primary isolate was first 
referred to as Campylobacter pyloridis (Marshall & Warren, 1984).  The specific epithet 
was later revised to C. pylori conforming to the correct Latin genitive of the noun pylorus 
(Marshall & Goodwin, 1987).  However, further characterization of the organism     
indicated that perhaps C. pylori was not a true Campylobacter.  The ultrastructure details 
showed multiple sheathed flagella at one pole of the bacterium, in contrast to the single 
bipolar unsheathed flagellum typical of Campylobacter species (Goodwin et al., 1985).   
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 TABLE 2.1  The story of the discovery of H. pylori 
The story of H. pylori 
Year References Report 
1893 Bizzozero 
 
Spiral organisms in dogs 
1896 Salomon 
 
Spiral organisms in dogs and cats 
1906 Krienitz First description in a human with gastric 
cancer 
 
1938 Doenges Spirochetes in stomach (autopsies) 
 
1940 Freedburg & Barron Spirochetes in stomach with ulcers or 
carcinoma 
 
1954 Palmer All bacteria in stomachs believed to be 
contaminants 
 
1975 Steer & Colin-Jones Bacteria in gastric ulcer patients 
identified as Pseudomonas aeruginosa 
 
1983 Warren & Marshall  First culture of H. pylori 










The protein patterns and cellular fatty acid composition of C. pylori also differed 
markedly from those of Campylobacter species (Pearson et al., 1984; Goodwin et al., 
1985).  Analysis of the 16S rRNA sequence provided more evidence to exclude C. pylori 
from the Campylobacter genus (Romaniuk et al., 1987).  Finally, Goodwin et al. (1989) 
proposed the new genus name Helicobacter and since then, C. pylori was renamed 
Helicobacter pylori, the first member of the new genus.  
 
2.2.2 Morphology and physiology of H. pylori  
H. pylori is a helical S shaped gram negative bacterium.  It is 2.5-5 µm in length, 
0.5-1 µm in width and possesses a tuft of 4 to 6 polar sheathed flagella (Goodwin et al., 
1985).  Each flagellum is 2.5 µm long and about 30 nm in thickness, with a membranous 
terminal bulb (Goodwin et al., 1989).  The characteristic corkscrew motility enables the 
bacterium to burrow into the mucin lining the epithelial mucosa of the stomach (Goodwin 
et al., 1985).  The flagella components consist of the hook protein (Flg E) and two 
flagellin proteins, FlaA and FlaB.  H. pylori with disrupted flgE were non-motile and 
lacked the filaments, although both flagellin proteins were produced (O'Toole et al., 
1994).  Both flagellin subunits were found to be essential for motility and colonization of 
the stomach (Josenhans et al., 1995).    
H. pylori prefers a microaerophilic environment with 5-10% carbon dioxide 
environment for in vitro culture.  A variety of solid media containing 5-10% horse/sheep 
blood were used to culture the bacteria (Hachem et al., 1995).  Under microaerophilic 
atmosphere, H. pylori colonies usually appeared after 3-5 days incubation at 37°C.  
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H. pylori presents 2 different morphologic manifestations: spiral and coccoid 
forms. The role of the spiral form has been shown to be strongly associated with 
gastroduodenal diseases (Cover & Blaser, 1992; Annibale et al., 2001).  However, the 
biological significance of the coccoid form, which is non-culturable in vitro, has yet to be 
determined (Hua & Ho, 1996; Zheng et al., 1999).  Some investigators postulated that the 
coccoid form may represent a persistent form in which H. pylori can exist in the 
environment as VBNC (Monstein & Jonasson, 2001; Nilsson et al., 2002) and could 
possibly play a role in the transmission cycle and treatment failure (Axon & Moayyedi, 




2.3 H.  pylori INFECTIONS AND CLINICAL CONSEQUENCES 
H. pylori is the known major human bacterial pathogen responsible for 
gastroduodenal diseases. Once acquired and colonized, it can persist for life in the 
stomach. Many of those infected in the population experience no apparent adverse   
clinical consequences. However, a small population of carriers develop acute chronic 
gastritis, peptic ulcer disease, gastric adenocarcinoma and mucosa-associated lymphoid 
tissue (MALT) lymphoma (Correa & Miller, 1995; Kuipers et al., 1995; Mitchell, 1999).   
 
2.3.1 Non-ulcer dyspepsia (NUD) 
NUD or functional dyspepsia is defined as persistent upper abdominal pain or 
discomfort in patients without detectable abnormalities in structural or biological 
examinations (Fisher & Parkman, 1998; Talley et al., 1999).  In subjects with dyspepsia, 
endoscopic studies have reported that 15-20% have peptic ulcer, 5-15% gastro-
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oesophageal reflux, <2% gastric cancer while majority (60%) have NUD.  It was observed 
that NUD occurs more frequently in younger patients (38% in patients younger than 25 
years old) compared with older patients (3%-7% in patients older than 60 years old) 
(Lockhart et al., 1985; Fobat et al., 1987).      
 
2.3.2 Peptic ulcer disease 
Epidemiological studies of H. pylori infection have provided evidence 
demonstrating the implication of H. pylori in the development of peptic ulcer.  The 
prevalence of H. pylori infection in duodenal ulcer patients is about 70-98.9% (Marshall et 
al., 1985b; Nomura et al., 1994; Hu et al., 1995). The causative relationship between      
H. pylori and peptic ulcer is reinforced when the organism was successfully eradicated in 
patients suffering from duodenal ulcer and the follow-up study over the next 4 years 
showed no duodenal ulcer recurred in H. pylori-negative patients (George et al., 1990).  
With the overwhelming research on the causal link between H. pylori infection and peptic 
ulcer disease, the Maastricht 2-2000 Consensus Report strongly recommended H. pylori 
eradication therapy for patients with gastric and duodenal ulcers (Malfertheiner et            
al., 2002).  
Besides H. pylori infection, the use of non-steroidal anti-inflammatory drugs 
(NSAIDs) including aspirin, has also been considered to be a major risk factor implicated 
in the development of peptic ulcer disease (Huang et al., 2002). In a study which 
evaluated the risk factors (H. pylori, NSAIDs and smoking) for peptic ulcer and related 
serious upper gastrointestinal (GI) events, the population-attributed risk associated with 
peptic ulcer is 48% for H. pylori and 24% for NSAIDs usage (Kurata & Nogawa, 1997).            
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Studies have also shown that occurrence of peptic ulcer have increased in H. pylori 
infected NSAIDs users (Kordecki et al., 1997; Voutilainen et al., 1998). In gastroduodenal 
mucosa, NSAIDs may augment acute inflammation caused by H. pylori where 
inflammation may then exacerbate the biochemical injury to these tissues caused by 
NSAIDs (McCarthy, 1991).  However, the link between the use of NSAIDs and H. pylori 
infection is still a subject of clinical investigations, since conflicting results as to whether 
eradication of H. pylori would reduce the risk of peptic ulcer disease have been 
controversial (Chan et al., 1997; Hawkey, 1999; Chan et al., 2002). With regard to 
bleeding peptic ulcers, the report by Okan et al. (2003) showed a significant inverse 
relationship between H. pylori infection and NSAIDs usage.  In their study population, the 
frequency of NSAIDs use in bleeding ulcers was shown to be high (79.2%).  In contrast, 
the prevalence of H. pylori infection was lower in patients with bleeding.  This negative 
interaction suggests a protective effect of H. pylori infection, lowering the risk of 
gastrointestinal bleeding in ulcer patients taking NSAIDs.   
       
2.3.3 Gastric cancer 
Research highlighting the association between gastric cancer and H. pylori has 
achieved plausible progress over the years. Substantial clinical and epidemiological 
evidence have shown that this gastric bacterium is a risk factor in the development of 
gastric cancer (Correa et al., 1990; Nomura et al., 1991; Huang et al., 2003; Wong et al., 
2004).  In 1993, the Eurogast Study Group reported data from 13 epidemiological studies 
which showed associations between H. pylori and cancer.  The following year, the World 
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Health Organisation International Agency for Research on Cancer (IARC) designated     
H. pylori as a Class I (definite) carcinogen.   
The association between H. pylori and cancer may be explained by 2 possible 
mechanisms: one is based on a carcinogenesis-promoting effect of the bacterium itself and 
the other is based on the establishment of a carcinogenic environment due to long-term 
infection.  This long lasting infection may induce atrophic gastritis, which is considered to 
be the initial step in the gastritis-metaplasia-carcinoma sequelae in the stomach.   
Phospholipase A2 of H. pylori was shown to cause epithelial cell membrane 
damage.  In addition, the vacuolating cytotoxin (VacA+) of H. pylori constitutes increased 
risk for the development of peptic ulcer and gastric cancer.  The reactive oxygen species 
(ROS) generated from the inflammation response by the host during an infection can also 
induce DNA damage with the accumulation of DNA mutations, thus leading to 
pathogenesis of gastric cancer (Obst et al., 2000).  
The study by Uemura et al. (2001) convincingly showed the link between H. pylori 
and gastric cancer.  It was a long term prospective study of 1246 H. pylori infected 
Japanese patients who had duodenal ulcers, gastric ulcers, gastric hyperplasia or non ulcer 
dyspepsia and 280 non-infected patients.  After a mean followed up at 7.8 years (range    
1-10.6 years), 2.9% of the infected while none of the uninfected patients developed gastric 
cancer.   
Recent experimental animal model studies, in particular the development of cancer 
in Mongolian gerbils infected with H. pylori have provided direct evidence of the positive 
correlation of the bacterium with gastric cancer.  Hirayama et al. (1996) reported that      
H. pylori could colonize the stomach of gerbils and induce gastritis 12 weeks after 
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inoculation.  Gastric ulceration was observed at 24 weeks and intestinal metaplasia at 24 
to 48 weeks after colonization.  These pathological changes closely resembled the human 
pathology of H. pylori infection.  Likewise, Shimizu and co-workers (2000) showed that 
eradication of H. pylori in H. pylori infected Mongolian gerbils reduced the incidence of 
adenocarcinoma. They commented that H. pylori eradication may be an effective way to 
prevent stomach cancer. 
 
 
2.4 EPIDEMIOLOGY AND TRANSMISSION 
2.4.1 Prevalence of H. pylori infection 
The ubiquitous nature of H. pylori demonstrates no gender preponderance 
(Mitchell et al., 1992; Goh et al., 1997).  The prevalence of H. pylori infection is not 
uniformly distributed as significant differences both within and between countries has 
been reported (Bazzoli et al., 2001; Goh & Paraskthi, 2001; Robertson et al., 2003).  The 
general trend shows that the overall prevalence of infection in developed countries is 
lower than that in developing countries (Malaty et al., 1996; Feldman et al., 1998).   High 
rates of infection have been attributed to low socio-economic status and high living 
densities (Moayyedi et al., 2002).  A cross sectional study which investigated the 
prevalence of H. pylori infection in Southern China showed an overall prevalence of 
44.2% with a significantly higher rate in high population density urban areas (52.4%) as 
compared to 38.6% in rural regions (Mitchell et al., 1992).  Previous epidemiological 
studies have also documented an association of ethnic differences and the prevalence of   
H. pylori infection.  Among adults in the United States, healthy Hispanic and black 
populations have seropositivity rates several folds higher than those of the non-Hispanic 
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white populations (Dehesa et al., 1991). Singapore, a multi-racial country, has 
demonstrated differences in seroprevalence of infection among various races, with the 
highest in the Indian ethnic group (Kang et al., 1997).  
  Natural acquisition of H. pylori infection occurs mainly in the early years of life 
(Boey et al., 1999; Malaty et al., 2002).  Tindberg et al. (2001) in a cross sectional study 
found that 16% of children aged 10-12 years were infected.  Similarly, Opekun et al. 
(2000) showed seroprevalence of H. pylori increased with age and was only 8.3% in very 
young children (6-11.9 months).  During the past decades, the rate of H. pylori infection 
has dropped dramatically.  Fujisawa et al. (1999) studied the changes in epidemiological 
pattern of H. pylori infection over the past 20 years in Japan.  Sera of 1015 test subjects 
were collected and assayed for IgG against H. pylori.  A decreasing pattern was evident 
with seroprevalence declining from 72.7% in 1974 to 39.3% in 1994.  A drop in the 
prevalence of H. pylori has also been documented in Korean children of age younger than 
10 years (Park et al., 2001).   
  
2.4.2 Probable sources and Routes of transmission 
Source of Infection 
 So far, human is the principle source of H. pylori, although several animals which 
were considered as potential reservoirs such as domestic cats (Handt et al., 1995) and 
rhesus monkeys (Handt et al., 1997) have been exonerated. In addition to isolation of      
H. pylori from the animals, the bacterium has also successfully infected many laboratory 
animals (Karita et al., 1991; Sturegard et al., 1998; Koga et al., 2003).  Increased risk of 
infection with exposure to sheep was reported by Goodman et al. (1996) and the recovery 
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of H. pylori from sheep milk and gastric tissue (Dore et al., 2001), suggests a possible 
zoonotic transmission.   
Studies have claimed the domestic housefly as a vector of H. pylori infection 
(Grubel et al., 1997; Vaira & Holton, 1998).  However, Osato et al. (1998) demonstrated 
that H. pylori was not recovered from houseflies fed with human faeces either naturally 
infected or spiked with H. pylori. These results refuted the claim of housefly as a 
potential vector for transmission or a reservoir for H. pylori infection. 
 Water has also been implicated as a source of H. pylori infection.  One of the first 
reports suggesting water as the source of infection is from Klein et al. (1991), which 
reported that children from homes using a municipal water supply were three times more 
likely to be infected than those whose homes had internal water sources.  H. pylori-
specific DNA was detected in environmental sources (Hulten et al., 1998; Horiuchi et al., 
2001) but attempts to isolate the bacteria from water samples have been unsuccessful.  The 
failure may relate to the morphology conversion of the spiral form to the dormant coccoid 
form under the adverse environmental conditions.  Furthermore, experimental data from 
West et al. (1990) had demonstrated that this coccoid form is able to survive in river water 
for more than 1 year and subsequently be cultured.    
 
Transmission 
 The mode of H. pylori transmission is still elusive and remains a subject of debate.  
However, the geographic and social patterns of H. pylori infection are consistent with 
human-to-human transmission via the faecal-oral or oral-oral route.  Leung et al. (1999) 
published the findings on the isolation of H. pylori from contaminated vomitus.  In the 
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study, 4 children presenting gastroenteritis associated vomiting were found to be 
seropositive for H. pylori.  In one of the infected children’s vomitus, H. pylori was 
isolated.  In addition, Krajden et al. (1989) and Cellini et al. (1995) also reported the 
isolation of H. pylori from dental plague.  Interestingly, comparison of the protein as well 
as the restriction endonuclease patterns of the isolates from the stomach biopsy and dental 
plaque displayed similar profiles (Cellini et al., 1995).  Attempts to culture H. pylori from 
faeces have been futile but in 1992, Thomas et al. cultivated the bacteria from faeces of 1 
infected adult and 9/23 children from a Gambian village.   
 Employing the sensitive PCR method, H. pylori DNA was detected in a number of 
studies (Shuber et al., 2002; Wisniewska et al., 2002; Sicinschi et al., 2003).  Detection of 
DNA in the faeces lends credence to the faecal-oral route of transmission but it is essential 
to note that the presence of DNA does not imply that viable H. pylori is present.   
 
Intrafamilial Transmission 
 Intrafamilial spread is implicated as a major route for acquisition of H. pylori 
infection.  Familial aggregation of the infection has been shown in many studies (Oderda 
et al., 1991; Dominici et al., 1999; Miyaji et al., 2000).  The study by Rothenbacher and 
co-workers (1999) assessed the role of parental infection status in the transmission of       
H. pylori infection in 1221 pre-school aged children. The results provided strong evidence 
for a transmission pathway via parents to children.          
 Most of the epidemiological studies relied on the use of serology and urea breath 
test to define intrafamilial clustering.  However, employing molecular techniques such as 
PCR based random amplified polymorphic DNA (RAPD) and restriction fragment length 
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polymorphism (RFLP) have further demonstrated the presence of closely related H. pylori 
strains among members of the same family thereby providing information about probable 
transmission of specific strain between individuals (van der Ende et al., 1996; Han et al., 
2000; Roma et al., 2003).  An investigation by Goodman and Correa (2000) on rural 
Colombian children aged 2-9 years old, revealed that H. pylori infection transmitted most 
readily among siblings who were close in age, and most frequently from older siblings to 




2.5 PATHOGENESIS OF H. pylori INFECTION 
2.5.1 Adherence and Colonisation 
 Being a bacterial pathogen, H. pylori has to establish itself in the stomach 
following transmission. Adherence to the gastric epithelium is a crucial step in 
colonisation, a precursor of pathogenesis of H. pylori.  All isolates expressed several 
putative colonization factors, including various adhesins, flagellar motility and urease 
(Eaton et al., 1992; Hocker & Hohenberger, 2003).  
 H. pylori infection is a chronic infection and is considered unlikely that such 
infection remains with the absence of adhesin-host cell interactions (Evans & Evans, 
2000).  Adhesins are bacterial proteins, glycoconjugates or lipids that are involved in the 
initial steps of H. pylori infection and are important virulence factors.  Presently, there is 
no consensus as to which H. pylori adhesins are most important in vivo.  However, the 
best characterized adhesin is the blood group antigen-binding adhesion (BabA) which 
binds to difucosylated Lewisb (Leb) blood group antigens found on the gastric epithelial 
cells (Ilver et al., 1998).  Besides being an important adhesin, the presence of gene allele 
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babA2 was shown to be associated with H. pylori pathogenesis (Prinz et al., 2001).  Other 
adhesins included heat shock protein Hsp 60, H. pylori lipopolysaccaride (LPS), mucin 
binding proteins and neutrophil-activating protein (Valkonen et al., 1994; Yamaguchi et 
al., 1997; Namavar et al., 1998). 
  H. pylori possesses 4-6 sheathed flagella and their presence appear to be essential 
in H. pylori infection.  An isogenic non-motile mutant in the flagellar secretion apparatus 
component filQ resulted in a 30% reduction in adherence to human gastric cancer AGS 
cells (American Type Culture Collection no.CRL-1739) (Foynes et al., 1999).  In the        
in vivo study by Eaton et al. (1992), the non-motile H. pylori survived for only 6 days in 
infected piglets while the motile variant survived for a longer period of time (21 days).  
The study inferred that motility is necessary for full colonisation of gnotobiotic piglets by 
H. pylori. 
 The environment of the human stomach is usually within the pH range of 1-3.5.  
H. pylori is able to colonize the gastric epithelium in acidic conditions with the production 
of urease which metabolized urea to generate a neutral microenvironment.  In the study by 
Eaton and Krakowka (1994), urease was shown to be essential for initial infection of 
normal mucosa in gnotobiotic piglets.  
  
2.5.2 Determinants associated with pathological damage of the gastric mucosa    
cag pathogenicity island and VacA cytotoxin 
 An important pathogenic factor is the cytotoxin associated gene (cagA).  The cagA 
gene was identified as the marker for the presence of the H. pylori cag pathogenicity 
island (cag PAI).  The immunopredominant protein encoded by this gene varies from    
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128 kDa to 140 kDa according to the number of copies of a 102 to 108 bp motif that is 
repeated with specific strains (Xiang et al., 1995).  Strains with the cagA gene were able to 
induce epithelial cells to secrete Interleukin 8 (IL-8) and cause mucosal inflammation 
(Orsini et al., 2000).  Several studies have then demonstrated a positive association of 
presence of cagA and peptic ulceration in adults (van Doorn et al., 1998; Arents et al., 
2001).  In contrast, studies from Asian countries such as Singapore, Japan, Korea and 
Hong Kong showed that cagA positive strains which were predominantly present were not 
associated with any specific clinical outcome (Yamaoka et al., 1999; Zheng et al., 2000; 
Wong et al., 2001).   
The vacA gene encodes a vacuolating toxin (~88 kDa) excreted by H. pylori that 
damaged a variety of mammalian cell lines in vitro and caused epithelial damage when the 
purified protein was administered intragastrically into mice (Leunk et al., 1988; Telford et 
al., 1994).  Allelic variation among H. pylori vacA occurs in the signal and middle region 
of the gene.  The signal region exists as an s1 or s2 allele while middle region occurs as an 
m1 or m2 allele.  H. pylori populations isolated from different geographical regions 
exhibit different distributions of vacA alleles (Yamaoka et al., 1999; Zheng et al., 2000).  
In North America and Western Europe, s1 vacA allele is associated with peptic ulcer 
disease (Atherton et al., 1997; van Doorn et al., 1998).  However, although s1 alleles 
predominate in Asia, no association of the vacA genotypes with any clinical manifestation 





Lewis antigens  
 The O-antigen of lipopolysaccharide (LPS) in most H. pylori strains expresses the 
Lewis blood group antigens (Le) which are similar to those of the host (Kobayashi et al., 
1993).  The ability of H. pylori to produce the Lewis antigens resembling those of the host 
appears to favour survival of the bacteria in the stomach by evading the immune response.  
In addition, this adaptation may also facilitate adherence of the bacteria to the gastric 
mucosa (Applemelk et al., 2000).  Another role of the presence of Lewis determinants is 
the possible involvement in pathogenicity.  It was proposed that during an infection,       
H. pylori LPS could induce anti-Le antibodies which bind the bacteria and also the     
gastric epithelial cells, subsequently leading to tissue injury (Applemelk et al., 1997).  
Interestingly, the study by Zheng et al. (2000) which examined 108 clinical isolates, 
demonstrated that although the presence of cagA, vacA, iceA genes were not associated 
with gastroduodenal diseases, the expression of 2 or more Le antigens was significantly 
higher in H. pylori isolated from patients with ulcers than from non-ulcer patients. A 
comparative study of expression of LeX and LeY in H. pylori isolated from children and 
adults showed that expression of LeY was higher in adults than in children (Munoz et al., 




2.6 DIAGNOSIS OF H. pylori INFECTION 
The detection of H. pylori infection is a primary requisite for diagnosis of 
gastroduodenal diseases related to this bacterium.   In the paediatric population, duodenal 
ulcer is strongly associated with H. pylori infection and the risk of development of gastric 
cancer is relatively high if the infection is acquired at a young age (Blaser et al., 1995a; 
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Huang et al., 1999).  In view of these critical issues, accurate diagnosis of H. pylori 
infection is a key step towards proper patient management. Two categories of diagnostic 
methods for H. pylori infection are defined: invasive and non-invasive.  
Several factors such as the need to evaluate the sensitivity, specificity, positive and 
negative predictive value of a given test must be taken into account when selecting for a 
test.  In addition, the age of patients being tested also has to be considered.  At present, no 
single test can be absolutely relied upon to detect H. pylori colonization but if feasible,     
a combination of two tests is recommended (Laheij et al., 2000). The European 
Helicobacter pylori Study Group (EHPSG) also recommend that two or more tests be 
performed as the gold standard in comparative studies (EHPSG, 1997).   
 
2.6.1 Invasive tests 
The invasive methods require gastric biopsy specimens obtained during 
gastroduodenoscopy.  Presently, invasive biopsy tests include staining of histological 
samples, biopsy urease test, culturing of biopsy specimens and polymerase chain reaction.  
 
Gastric biopsies 
 The most accurate method for detecting H. pylori in tissue is a combination of 
culture and histologic staining (Warthin Starry stain, Giemsa stains or hematoxylin & 
eosin stain) of the biopsy specimens obtained during endoscopy.  With histologic staining, 
a histopathologist can document H. pylori infection and at the same time assess the 
atrophic changes in the stomach.  However, the reliability of detecting H. pylori infection 
depends on factors such as the site, patching distribution of H. pylori, number and size of 
the biopsy specimens, as well as the stain used, not to mention the high level of expertise 
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in staining and visualizing the bacteria (El-Zimaity et al., 1995; Woo et al., 1996;            
El-Zimaity & Graham, 1999).   
 Despite the fact that culture will provide unequivocal evidence of the presence of 
H. pylori, successful recovery of the bacteria from biopsies will depend on transporting 
and processing of the samples, selection of media and culture conditions (Veenendaal et 
al., 1993; Van der Hulst et al., 1996, Piccolomini et al., 1997; Grove et al., 2001).  This 
method enables the growth of fresh clinical isolates which can be tested for antibiotics 
susceptibility which can be useful in treatment management.  The other salient advantage 
is to use the culture obtained for research, especially in molecular epidemiological study.  
In essence, obtaining the culture enables fingerprinting of the isolate and typing of the 
isolate with respect to the virulence genes.    
 
Molecular biology techniques  
 Polymerase chain reaction (PCR) is particularly useful for molecular epidemiology 
and for fingerprinting H. pylori isolates. This technique has been used to genotype         
H. pylori in paraffin-embedded gastric biopsy specimens (Scholte et al., 2002), which 
may be useful in the post-treatment period, to differentiate recurrence of infection from 
re-infection with another strain of H. pylori (Hildebrand et al., 2001).  
 Recently, molecular techniques such as real time PCR and fluorescent in situ 
hybridisation (FISH) were evaluated for use in detection of H. pylori in gastric biopsy 
samples.  The cagA and vacA genotypes were tested by melting curve using the real-time 
PCR and compared to the gastritis status and cell proliferation status (Ruzsovics et al., 
2001).  The study by Russmann et al. (2001) demonstrated that this bacterial pathogen 
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was detected in 63 biopsy specimens as compared to 67 cultured positive specimens by 
FISH with rRNA-targeted fluorescence-labeled oligonucleotide probes specific for          
H. pylori.   
 
2.6.2 Non-Invasive tests 
Non-invasive tests obviate the need for endoscopy which can inflict physical stress 
on the patient.  Moreover, invasive tests could yield possible false negative results due to 
the patchy distribution of the bacteria in the stomach (Pronovost et al., 1994).  Clinical 
tests like the Urea breath test and serology test are well-established screening procedures 
which help to reduce the cost and workload of invasive endoscopy (Laheij et al., 1998; 
Vaira et al., 1999a). Given the special niche of H. pylori, attempts are continuously made 
to improve the non-invasive diagnostic tests.  
 
Urea breath tests (UBT) 
 The UBT are easy, straightforward and accurate non-invasive tests for H. pylori 
infection.  The test is based on the principle that in the presence of H. pylori urease 
activity, CO2 is liberated from urea and produces ammonia to buffer its acidic 
environment.  Ingestion of C-labelled urea results in the excretion of labelled CO2 which 
can be detected in the expired breath.  13C and 14C UBT are semi-quantitative tests of 
active H. pylori infection (Debongnie et al., 1991; Chang et al., 2002).  
 13C-UBT, containing the nonradioactive isotope, has high diagnostic accuracy in 
children (Delvin et al., 1999).  However, this method has its drawbacks:  
1. It is difficult to perform in noncompliant children who are unwilling to ingest the    
13C-urea. 
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2. Age of children may make exhaled breath collection difficult.   
3. Mental or physical disturbances may present further difficulty.  
 This was illustrated in the study by Imrie et al. (2001) which showed that 
borderline or false positive results occurred more frequently in children younger than 2 
years compared with older children. 
 
Serological tests 
H. pylori elicits a local mucosal and a systemic antibody response. Serologic 
testing is based on the detection of anti-H. pylori IgG antibody in the patient’s serum 
(Blecker et al., 1995;  Wang et al., 2003). The simplicity and cost-effectiveness have 
enabled the serological tests to be widely employed for epidemiological research to assess 
the prevalence of H. pylori infection in various populations (Brown et al., 2002;        
Chong et al., 2003). The commonly employed serodiagnostic technique is the enzyme-
linked immunosorbent assay (ELISA). The sensitivity and specificity of ELISA is 
dependent on the nature of the bacterial antigen preparation. Therefore, considerable 
research effort has been placed in search of a suitable antigen (Ho & Marshall, 2000).  
Commercial tests, the Pyloriset and the Helico-G use an acid extract of H. pylori antigen.  
The HM-CAP (Evans et al., 1989) uses a mixture of high molecular weight H. pylori cell-
associated proteins, consisting mainly of urease and cell wall adhesin.      
The performance of serologic tests in diagnosis of treatment success is hampered 
by the lingering serological response after successful eradication therapy or spontaneous 
healing which will lead to false positive results.  Furthermore, studies have shown that the 
cut-off values for children and adults may differ.  Crabtree et al. (1991) showed that if the 
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adult cut-off value was used, 50% of the children with H. pylori gastritis would have been 
considered seronegative.  Similarly, Sunnerstram et al. (1999) also recommended a lower 
cut-off value for children than for adults.  It is clear that the choice of cut-off value is a 
mean of adapting the serological test to the patient population analysed.  Hence, when 
children are tested for H. pylori antibodies, it is important to choose a method which has 
already been validated in the paediatric population. 
Immunoblotting is highly sensitive and more specific than ELISA.  It provides a 
full serologic profile of the immunogenic proteins that can be obtained from an individual. 
This method can be used to complement ELISA, especially when ELISA results are 
doubtful (Raymond et al., 2000).   
 
Stool antigen test (HpSA) 
In 1998, the United States Food and Drug Administration (FDA) approved the use 
of a new enzyme immunoassay for the detection of H. pylori antigen in stool for diagnosis 
and eradication efficacy of H. pylori infection in adult population.  H. pylori stool antigen 
test (HpSA) has been devised to detect the presence of H. pylori antigen by an ELISA 
method using monoclonal/polyclonal antibodies (Vaira et al., 1999; Suzuki et al., 2002).   
Many studies have reported that HpSA test is useful for the initial diagnosis of     
H. pylori infection (Trevisani et al., 1999; Ohkura et al., 2000; Vakil et al., 2000). 
However, its application in monitoring the efficacy of eradication therapy has been 
controversial as the assay can detect dead or partially degraded bacteria long after the 
successful eradication, leading to false positive results (Kabir, 2001).  Nevertheless, a 
recent study by Tanaka et al. (2003) has shown that the HpSA test is a useful method for 
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initial diagnosis and after eradication therapy.  They reported a high sensitivity (98.3%) 
and specificity (95%) prior to treatment. The sensitivity and specificity at the end of 
eradication therapy were 90% and 97.7%, respectively.  
Accessibility and non-invasiveness have made this new test an invaluable 
diagnostic tool in the paediatric population.  Data concerning reliability of the test in 
children has yielded satisfactory results (Husson et al., 2000; van Doorn et al., 2001; 
Koletzko et al., 2003).  In the study by Ni et al. (2000), involving 53 children, the 
performance of HpSA was evaluated and compared with 6 other diagnostic tests (Culture, 
biopsy urease test, histology, PCR, UBT and serology).  The diagnostic accuracy of HpSA 
(sensitivity 92.6%, specificity 100%) was observed to be comparable to the other tests.  
This non-invasive test was also found to be a useful method for post-treatment 
eradication testing of infection in children (Gosciniak et al., 2003). In addition, the 
European Helicobacter pylori Study Group has recommended the stool antigen test and 
13C-UBT for diagnosis of the infection and eradication assessment in older children 
(Malfertheiner et al., 2002).   
 
Other non-invasive tests 
 Some studies have looked into the use of saliva and urine as possible non-invasive 
means to detect antibody to H. pylori infection (Miwa et al., 1999; Luzza et al., 2000; 
Yamamoto et al., 2000).  It was observed that the evaluation result for salivary assay was 
not satisfactory (Luzza et al., 2000).  However, the study by Yamamoto et al. (2000) had 
obtained a sensitivity of 92% and a specificity of 93.1% with the urine based ELISA kit.  
 29
 Culturing of H. pylori from a gastric string which was to be swallowed by the 
individual has also been considered as a substitute for endoscopy biopsy (Ferguson et al., 
1999; Samuels et al., 2000).  The study by Samuels et al. (2000), demonstrated that           
H. pylori was isolated from 32/33 patients from a swallowed string coupling with the use 
of selective bacterial culture media. The string test also showed potential use as the culture 
obtained can be used for molecular epidemiological studies and the routine determination 




2.7 GENOMIC AND PROTEOMIC STUDIES 
2.7.1 H. pylori genome 
 H. pylori has a relatively small genome (~ 1.65 Mb) and is only about 1/3 the size 
of the E. coli genome.  In comparison, the H. pylori genome was shown to possess 17% of 
species specific genes to the closely related organism Campylobacter jejuni, (Pennisi, 
1999).  Completed genomes of two unrelated H. pylori strains (26695 and J99) as well as 
the comparison of the two have been made available (Tomb et al., 1997; Alm & Trust., 
1999).   
 H. pylori 26695, sequenced by The Institute of Genome Research, was isolated in 
the mid 1980s in the United Kingdom from a patient suffering from gastritis.  In contrast, 
H. pylori J99, an isolate from a duodenal ulcer patient in USA was sequenced in a 
collaborative study between Astra Zeneca R&D Boston (formerly Astra Research Center 
Boston) and Genome Therapeutics Corporation. Both genomes are displayed online         
at the following URLs: http//www.tigr.org/tigr-scripts/CMR2/CMRHomePage.spl and 
http://scriabin.astrazeneca-boston.com/hpylori/, respectively.    
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 Comparison of the 2 genomes shows that H. pylori J99 is 24,036 bp shorter and 
contains 57 fewer predicted open reading frames than strain 26695.  In addition, the 
analysis between the genomes of the two strains have also identified that each strain 
contains a set of genes (~6-7%) that are unique to each strain.  Interestingly, almost one 
half of these genes were clustered in a single hypervariable region, namely the plasticity 
zone.  In both J99 and 26695 genomes, almost 60% of the open reading frames (ORFs) 
were attributed with predicted functions (Alm & Trust, 1999).  
 Comparison of the two completed sequenced genomes has provided important 
information regarding the genetic heterogeneity.  There are now evidence for some genetic 
loci such as cagA and vacA of the Western and Asian strains represented distinct lineages 




“Proteome” was a term first introduced in 1995 (Wasinger et al., 1995) to describe 
the protein complement of a genome.  Proteomics is an emerging field of research that is 
essential to the interpretation of data evolving from the genomic studies. The technique of 
two dimensional polyacrylamide gel electrophoresis (2D PAGE) is at the heart of the 
proteomics research. 2D PAGE uses immobilised pH gradients in the first dimension to 
separate proteins on the basis of their pI, followed by SDS-PAGE run which subsequently 
characterises the proteins further according to their molecular sizes. Consequently, this   
2D PAGE system can be loaded with a few milligrams of protein and separated with 
thousands of protein spots (Hanash, 2000; Gorg et al., 2000).  Proteomics can provide   
data on expression levels, subcellular location, post-translational modifications, protein 
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structure and domains. Furthermore, 2D PAGE also overcomes co-migrating proteins 
which appeared as a common band with 1D PAGE (Utt et al., 2002).   
The proteomics approaches have been used in the studies of H. pylori, attempting 
to link certain gel patterns to specific gastroduodenal pathologies (Enroth et al., 2000) and 
elucidate proteins of potential diagnostic and vaccine candidates (McAtee et al., 1998a, 
1998b).  With exhaustive proteomic characterization of H. pylori, Jungblut et al. (2000) 
and Bumann et al. (2001) had managed to resolve up to 1800 protein species using the 
high-resolution two-dimensional electrophoresis technique and identified more than       
200 proteins. The results of protein identification were placed in the dynamic 2D PAGE 
database which is made publicly available at http://www.mpiib-berlin.mpg.de/2D-PAGE.  
 
Comparative proteomics 
 In comparative proteomics, the proteins expressed by a given strain are 
quantitatively analyzed and compared to the proteome of another strain growing under 
similar conditions or same strain but grown in different conditions. For H. pylori to 
colonize and establish itself in the stomach mucosa, the bacteria must survive passage 
through the extreme acidity of the stomach to reach the mucous layer which is near neutral 
pH.  Therefore, to understand the regulation of acid and base stress response in H. pylori, 
Slonczewski et al. (2000) investigated the effect of pH stress on protein profiles of           
H. pylori and had identified several proteins which were dependent on growth pH.  
Another comparative study was published by McAtee et al. (2001).  In the study, the 
group examined the proteome of a metronidazole resistant strain (rdxA negative strain) 
upon exposure to sublethal doses of metronidazole.  They revealed a total of 42 protein 
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spots which appeared to be differentially expressed and identified two upregulated 
proteins as alkylhydroperoxide reductase and aconitase B.       
 
Immunoproteomics 
 Immunoproteomics is a useful approach for analysis of humoral responses, with 
the aim of screening and identifying immunogenic proteins which may contribute 
substantially to vaccine development and to the improvement of diagnostic techniques 
based on serology.  This technique consists of systematic proteome analysis (2D PAGE), 
followed by immunoblotting with patient’s sera. In H. pylori immunoproteome 
investigation, a number of studies revealed high variability of humoral recognition 
patterns among different patients and H. pylori isolates (Dunn et al., 1989; Kimmel et al., 
2000; Jungblut et al., 2000; Haas et al., 2002).   
 In a recent study (Bumann et al., 2002), mice were infected with H. pylori SS1     
(a mouse-adapted strain originally isolated from a patient with peptic ulcer disease) and 
the proteins were resolved by 2D PAGE. Subsequently, the proteins were blotted, 
incubated with mouse sera and the immunogenic proteins were identified by matrix-
assisted laser desorption ionization-Time of flight mass spectrometry (MALDI-TOF).  
When H. pylori immunoproteomes of the infected mice were compared to those 
proteomics data previously described as H. pylori antigens recognised by infected 
individual, a high agreement in the antigens recognized was observed.  Hence, the study 
commented that murine Helicobacter model may be a valid model to screen antigens for 
vaccine development.  
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Difference gel electrophoresis (DIGE) 
 The reproducibility of the conventional 2D PAGE can be improved using DIGE, a 
newly emerging technique for comparative proteomics study. Different samples are 
labelled with mass and charge matched by spectrally resolvable fluorescent dyes, Cy2, 
Cy3 and Cy5, the pooled samples are then separated on the same 2D gel. Identical     
proteins existing in both pools will migrate to the same spot in the 2D gel, minimising the 
gel to gel variation over conventional 2D PAGE.   
This technique has been applied to a model system study of the E. coli proteome 
after benzoic acid treatment (Yan et al., 2002).  Zhou et al. (2002) also employed this 
technique for identification of esophageal squamous cell cancer specific protein     
markers. They demonstrated that the DIGE technology has adequate sensitivity, high 




2.8 OTHER Helicobacter SPECIES 
 Since the identification of Helicobacter pylori in 1984, many novel helicobacters 
have been isolated from humans and animals.  A growing number of other Helicobacter 
species which is shown in Table 2.2 are increasingly recognised as important human 
pathogens, most of which are likely acquired via zoonosis (Hua et al., 1999b; Solnick, 
2003).   
In human, a helical bacterium different from H. pylori was first described in the 
gastric mucosa by Dent et al. in 1987, initially designated “Gastrospirillum hominis”, 
which reflected its occurrence in human (McNulty et al., 1989).  However, analysis of the 
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16S rRNA sequence showed that it is a Helicobacter species and has been provisionally 
named "Helicobacter heilmannii" (Solnick et al., 1993).   
In addition, H. cinaedi, H. fennelliae, H. pullorum and "H. rappini" have been 
isolated from cases of enteric disease, bacteremia and pneumonic illness.  H. cinaedi and 
H. fennelliae have been isolated from the stools of homosexual patients with proctitis and 
proctocolitis (Totten et al., 1985; Tee et al., 1996).   
H. hepaticus is found to be the aetiological agent of chronic hepatitis and 
associated with hepatocellular tumours in aged A/JCr mice (Fox et al., 1994).  Lin et al. 
(1995) have shown that the bile samples tested were positive for H. pylori DNA using the 
nested PCR method while Nilsson et al. (2000), showed that 12 of 37 serum samples from 
patients with chronic liver diseases had high antibody levels to H. hepaticus surface 
antigens even after adsorption with H. pylori. Thus, authors commented that some 
Helicobacter species might play a role in human liver diseases.   
Neither the true niches occupied by this novel Helicobacter species is yet known 
nor is its spectrum of associated diseases fully defined. However, with the new 
developments in molecular techniques and improved isolation methods, it will not only 
better define the role of the Helicobacter species in human diseases but will also reveal 
novel species which are not currently identified.  However, none of the Helicobacter 
species mentioned in Table 2.2 has been reported to be associated with infection in 





 Table 2.2  Other Helicobacter species isolated from humans  
                  (Adapted from Solnick, 2003) 
  









Solnick et al., 1993; Trebesius  
et al., 2001 
 
H. felis Gastroenteritis Stomach Lavelle et al., 1994 
H. cinaedi Colitis, cellulitis Faeces, blood Totten et al., 1985 
 
H. fennelliae Colitis Faeces, blood Quinn et al., 1984; Fennell et al., 
1984 
 
H. pullorum Gastroenteritis Faeces Stanley et al., 1994 
H. canadensis Gastroenteritis Faeces Fox et al., 2000 
H. winghamensis Gastroenteritis Faeces Melito et al., 2001 
“H. rappini” Colitis Faeces Romero et al., 1988 























































 3.1 BACTERIAL STRAINS AND CULTURE CONDITIONS  
 
 H. pylori strain, RH 54 which was a clinical isolate from a local patient with 
healed duodenal ulcer and the standard strain NCTC 11637 were used in this study. 
  
  
3.1.1 Fermenter cultures  
 H. pylori strain RH 54 was cultured in 10 ml brain heart infusion (BHI) broth 
containing brain heart infusion medium (Gibco) supplemented with 10% horse serum 
(Gibco) and 0.4% yeast extract (Oxoid) (Appendix A1.1) for 3 days at 37°C in a 
humidified CO2  incubator (Forma Scientific) supplied with 10% CO2.  The 3 day old 
culture was subsequently reinoculated into 300 ml BHI broth and incubated for a further 3 
days under similar culture conditions. 
 Following the incubation, cells were transferred to a 10L fermenter vessel (Bellco 
Biotechnology).  The culture was incubated for 3 days to induce the active spiral form and 
for a prolonged period of 150 days to obtain the coccoid form according to the method as 
described by Ho and Vijayakumari (1993). Bacterial cells were tested for catalase, 
oxidase, urease activities (Appendix A2.1) and Gram stained to confirm identity of the 
culture. These bacterial cells were then harvested and used for the ELISA antigens 
preparation according to Khin and Ho (1994). 
 For subsequent genomic and proteomic studies (Section 3.11), H. pylori RH 54 
and NCTC 11637 were kept for a longer incubation period of 184 days and 219 days, 




 3.1.2 Plate cultures 
 H. pylori strain, RH 54 was grown on chocolate blood agar plates (Appendix A1.2) 
and incubated for various time points (3, 5, 7, 14 & 30 days) at 37°C in a humidified CO2 
incubator supplied with 10% CO2.  The bacterial cultures were identified as H. pylori 
based on cell morphology by Gram staining (spiral shape for 3 day old culture & coccoid 
shape for prolonged cultures), positive catalase, oxidase and urease tests. Once confirmed, 




3.2 SPIRAL AND COCCOID ANTIGEN PREPARATIONS 
 
The antigens for serodiagnosis were prepared by a slight modification of the acid 
glycine extraction method as described by Khin and Ho (1994).  Cells were harvested 
from the fermenter by centrifugation at 10,000 x g for 30 minutes at 4°C.  The cell pellet 
was washed in sterile distilled water and the cell suspension was then centrifuged at 
10,000 x g for 30 minutes at 4ºC.  The supernatant obtained was discarded and wet weight 
of the pellet was determined.  Cells were treated with 0.2 M acid glycine buffer (pH 2.2) 
at a concentration of 0.1g of cells (wet weight) to 2.5 ml of the buffer.  The cell 
suspension was vortexed at room temperature for 30 minutes and centrifuged at 11,000 x g 
for 15 minutes at 4ºC, after which, cell debris was discarded.    
The supernatant retained was neutralised to a final pH of 7.0.  The neutralised 
supernatant was dialysed in dialysis tubing with MW exclusion limit at 12,000-14,000 
daltons.  The dialysis process was carried out overnight at 4°C against distilled water with 
gentle stirring.  The dialysate was centrifuged at 3,000 x g for 10 minutes at 4ºC to remove 
any precipitates. This acid glycine extracted cell surface proteins constituted the acid 
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 glycine extract (AGE) antigen which was employed in subsequent serologic testings.  The 
protein concentration of the antigen was determined using Bio-Rad Protein Assay, based 
on the Bradford dye-binding procedure (Compton & Jones, 1985). All antigen 




3.3 FAMILIAL CLUSTERS STUDY 
 
3.3.1 Study population 
 Twenty one families comprising 72 subjects, age 1-73 years old who participated 
in a national serological survey conducted by the Ministry of Environment formed the 
basis of the study.  The sera were kindly provided by the Ministry of Environment, 
Singapore.  There were 2 families that were seronegative and thus served as negative 
controls for subsequent western blotting analysis.  Of the remaining 19 families, all but 
one family had 2 or more members residing within the same household were seropositive 
for H. pylori.  No comparison could be made for this family with only 1 seropositive 
member. Of the remaining 18 families, 3 families had three-tier relationships                       
(grandparents, parents and children), 13 were of two-tiers (parents and children) and the 
remaining 2 families comprised only siblings. 
 
3.3.2 Detection of  antibody against  the spiral antigen 
 IgG antibodies against H. pylori were determined using an in-house ELISA with 
the acid glycine extracted (AGE) antigen according to the method as described by Khin & 
Ho (1994).  The spiral antigen was diluted to a final concentration of 5µg/ml with 
carbonate buffer (Appendix A3.1).  The AGE antigen at 1µg (200 µl) of protein was 
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 applied to each well in 96-well flat-bottomed microtiter plate (maxisorp, Nunc). Coated 
plates were incubated overnight at 4ºC.   
 After incubation, unbound antigen was removed and each well was refilled with 
0.3 ml of serum diluent (Appendix A3.3) which served as the blocking buffer.  Residual 
binding capacity of the plates was blocked at this step.  The plates were incubated at 4ºC 
for an additional 24 hours before use.     
 The plates were brought to room temperature prior to use.  The serum diluent was 
aspirated and wells were washed 3 times in wash buffer I (Appendix A3.4).  Each washing 
step was about 3 minutes.  After each rinse, residual liquid was removed by gently tapping 
the plates faced down onto several paper towels laying on the benchtop.   
 Cord blood sera which showed negative IgG antibodies against H. pylori, served as 
the negative control.  This negative control and each test serum were diluted 100 fold in 
serum diluent.  As for the positive control, it comprised pooled sera from patients who 
were histological positive for H. pylori and demonstrated strong IgG antibodies response 
against H. pylori.  The positive control was diluted serially from 1:100 to 1:1600.  Aliquot 
of 100 µl of each test serum and control sera were added to the coated wells.  Each test 
serum was tested in triplicate.  The plates were incubated at room temperature for 1½ 
hours to allow antigen-antibody binding.  Following incubation, the plates were washed 3 
times with wash buffer I.  Peroxidase-labelled rabbit anti-human IgG (Dako) was used as 
the conjugate.  It was diluted 1:25,000 with conjugate diluent (Appendix A3.5) and 100 µl 
of the diluted conjugate antibody was added into each well.  The plates were left to 
incubate for another 1½ hours at room temperature.  After incubation, plates were washed 
3 times with wash buffer I, followed by 2 times with wash buffer II (Appendix A3.6).  
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 Aliquot of 100 µl of substrate solution was added to each well and the plates were 
incubated in the dark for 15 minutes.  The substrate solution comprised 0.03g of             
O-phenylenediamine hydrochloride (Sigma) and 30 µl of hydrogen peroxide (Merck) 
dissolved in 37.5 ml of phosphate-citrate buffer (Appendix A3.7).  The enzymatic reaction 
was terminated with the addition of 2.5 M sulphuric acid.  The optical density (OD) at    
492 nm was determined in a microtitre plate reader (Labsystem Ascent).  The absorbance 






 The AGE proteins were concentrated using a speed vac concentrator (Heto Maxi 
dry lyo system).  The concentrated proteins were dissolved in sterile distilled water to 
obtain a concentration of 30 µg proteins.  The protein sample was mixed with 10 µl of 2X 
treatment buffer (Appendix A4.1) in an eppendorf tube and distilled water was added to 
make up a final volume of 20 µl.  The tube was placed in a boiling-water bath for 5 
minutes.  The sample was then placed briefly on ice until use.         
 
Homogeneous gel and electrophoretic run 
 A single percentage 12% separating gel and 4% stacking gel were prepared 
(Appendix A4.2-A4.8).  This discontinuous system consisting of 2 gels with an upper 
stacking gel of pH 6.9 and a lower separating gel held at pH 8-9.  The stacking gel 
concentrates the sample into thin bands which can accumulate at the interface between the 
2 gels prior to separation.  Using a pipettor with a long thin tip, 20 µl of sample was 
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 loaded into each well. Wells which were not in use were loaded with 1X treatment buffer 
containing no sample.  Electrophoresis was carried out using Bio-Rad Mini-Protean 3 Cell 
at 100 volts for 2 hours.  
 
Coomassie Brilliant Blue G-250 staining  
 Coomassie Brilliant Blue G-250 which binds non-specifically to the proteins was 
used for staining the gels.  This staining method, though less sensitive than silver staining 
(detection limit: 100 ng proteins) is widely use for its convenience.  The staining protocol 
is adopted from Doherty et al. (1998). 
 After the electrophoretic run, the SDS-PAGE gel was soaked in the fixing solution 
containing 50% methanol and 2% phosphoric acid (85%).  The gel was fixed overnight 
with gentle shaking.  The gel was then washed 3 times with distilled water with 30 
minutes incubation between each wash.  Following which, the gel was incubated in 
incubation solution (34% methanol, 2 % phosphoric acid and 17% ammonium sulphate) 
for an hour.  After 1 hour incubation, 660 mg of Coomassie Brilliant Blue G-250 was 
added to 1L of the incubation solution and further incubated with continuous shaking up 
to 3 days.  After the gel was sufficiently stained, it was briefly rinsed with 25% methanol 
to remove the Coomassie Brilliant Blue G-250 colloids.  The gel was then destained in 
distilled water.  Several changes of distilled water enabled the proteins to be detected as 
blue bands on a clear background.  Gel image was captured using the densitometer 710 




 Silver staining 
       Silver staining is a more sensitive method than the coomassie blue stain with a 
detection limit of 0.5ng of protein.   
 Staining of the gels was performed as described by Gharahdaghi et al. (1999).  
Briefly, gel was first soaked in fixing solution of 50% methanol and 5% acetic acid for at 
least 1 hour. After 3 changes of water at 20 minutes each, the gel was sensitized by 
incubating in 0.2% sodium thiosulphate (Fluka). This was followed by 2 quick washes of 
water for 1 minute each wash.  The gel was immersed in 0.1% silver nitrate (Sigma) for 20 
minutes.  After incubation, gel was thoroughly rinsed with water and developed in 0.04% 
formaldehyde (37%) in 2% sodium carbonate (Merck).  The reaction was terminated with 
5% acetic acid.  Image of gel was taken for subsequent analysis and storage using the 
densitometer GS 710 and Quantity One software (Bio-Rad). 
 
3.3.4 Western blotting 
 
 Following SDS-PAGE, the gel was equilibrated in the transfer buffer (Appendix 
A5.1) for 10-15 minutes.  The transblotting process was carried out using the semi-dry 
blotting apparatus (Bio-Rad).  A few pieces of 3 MM Whatman filter papers were soaked 
in transfer buffer and placed on the bottom (anode) electrode plate of the blotting unit 
(Figure 3.1).  The Immibilon polyvinylidene difluoride (PVDF) membrane was first 
prewetted in methanol for 20 seconds, followed by a quick rinse in distilled water.  The 
treated membrane was then equilibrated in the transfer buffer and placed onto the filter 
papers.  The whole cassette was completed with the equilibrated gel, few more pieces of 
wetted filter papers and the electrode plate (cathode) of the blotting device on top of the 
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 stack.  A pipette was used to gently roll over the sandwich to remove air bubbles which 
would interfere with the electroblotting.  A constant current of 150 mA (Model 200/2.0 
power supply, Bio-Rad) was applied for about an hour.   
 The efficiency of the transfer was accessed by the transfer of the prestained 
molecular weight marker onto the membrane or using a Ponceau S stain to visualize the 
protein patterns on the membrane after blotting.  The blot was then blocked for 1 hour 
with agitation on a belly dancer shaker (Stovall Life Sciences Inc) in 5% skim milk in 
PBS Tween-20 (blocking solution) (Appendix A5.2).  After blocking, the blot was washed 
with wash buffer (Appendix A5.3) to remove any unbound blocking agent. The membrane 
could be cut into several strips and placed into wells of a staining tray with diluted 
primary antibodies (patient’s sera diluted 1:200 in 1% BSA/PBS Tween-20).  The tray 
was covered and incubated overnight at room temperature with gentle shaking on the 
shaker. 
 After incubation, the strips were washed with wash buffer and incubated with 
secondary antibody (horse radish peroxidase labelled rabbit anti-human IgG) diluted         
1: 800 in 1% BSA/PBS Tween-20. The strips were incubated for 1½ hours.  Subsequently, 
detection was achieved using the substrate, 4-chloro-1-napthol (Sigma).  The substrate 
solution (Appendix A5.4) was prepared by dissolving 60 mg 4-chloro-1-napthol in 20 ml 
100% cold methanol.  This solution was then added to 100 ml of PBS buffer with 60 µl of 
30% hydrogen peroxide added prior to use.  Strips were incubated in this substrate 
solution in the dark till bands developed.  The reaction was stopped by rinsing with 
distilled water repeatedly. The strips were air-dried and imaged using a GS 710 
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 densitometer (Bio-Rad).  Image analysis was carried out using the Quantity One software 
(Bio-Rad).  
 
3.3.5 Statistical Analysis 
 Cohen’s kappa statistical analysis was used to assess the agreement among the 
seropositive members in each household.  According to Fleiss (1981), values greater than 
40% are indicative of moderate levels of agreement chance. Values exceeding 75%   
strong agreement above chance.  The protein weight of each band was calibrated and the 
degree of agreement was determined statistically by the statistical program SPSS      
version 10.  In this study, we adopt a kappa value of ≥ 40% to be indicative of similarity 















 FIG 3.1  Gel membrane assembly for semidry electrophoretic  






 3.4 STUDY ON PAEDIATRIC PATIENTS 
 
3.4.1 Cut-off value for ELISA 
Many reports have highlighted the need of an ELISA cut-off for paediatric patients 
with dyspeptic symptom (Crabtree et al., 1991; Sunnerstam et al., 1999; Kindermann et 
al., 2001).  
In this study, the cut-off value for ELISA was based on a pre-evaluated 
comparative study of 114 local paediatric patients comprising 15 culture/histology 
positive and 99 histology negative samples.  Receiver operating characteristic (ROC) 
analysis was performed to determine the ideal cut-off point for the serological test. 
 
3.4.2 Study population 
In this study, a total of 489 consecutive children (mean age of 8.5 ± 3.3 years) 
with epigastric pain formed the study population. They were out-patient referrals to the 
paediatric gastroenterology clinic at the National University Hospital, which is a tertiary 
referral centre in Singapore. All children had been having epigastric pain for at least 3 
months, and had consulted their own general practitioners or paediatricians prior to 
referral to the specialist gastroenterology clinic. The patient population consisted of 263 
girls and 226 boys.  All the symptomatic children did not receive any antibiotics within 4 
weeks of the study.  Blood sample was collected from each individual. Serum was 
separated from the blood, aliquoted and kept at -20ºC until use.  The control group 
comprised 599 school children (age 9 ± 0.5 years) in the eastern part of Singapore         
who participated in a seroepidemiological survey conducted by the Ministry of the 
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 Environment.  The sera for this control group were kindly provided by the Ministry.  
Informed consent was obtained from parents of the children.   
 
3.4.3 H. pylori antibody determination 
The presence of immunoglobulin antibodies (IgG) against spiral (3 day old culture) 
and coccoid (150 day old culture) forms of H. pylori in all the sera was determined using 
in-house ELISA with antigen prepared from H. pylori RH 54 clinical isolate (Khin & Ho, 
1994).  The procedure was as described in Section 3.3.2.  Samples were tested in 
triplicate. 
 
3.4.4 Western blot profiling of representative sera 
 Sera from 5 children who were positive for H. pylori infection by either histology 
or culture and 4 who were negative for the infection but experienced epigastric pain were 
randomly selected for western blot.  The procedures were as described in Section 3.3.4.  
In this study, both the spiral antigen (3 day old culture) and the coccoid antigen (150 days 
old culture) were employed.  Comparison of the antibody profiles was performed for the 
two groups and between the two antigens.   
 
3.4.5 Statistical evaluation 
Statistical analysis was performed using the statistical software SPSS version 10 
(Scientific Package for Social Sciences, Chicago, USA).  The χ2  test and Fisher’s exact 
test were used to compare the proportions between groups.  The level of significance was 
set at a P< 0.05. 
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 3.5 CHARACTERIZATION OF H. pylori ISOLATES FROM PAEDIATRIC 
PATIENTS WITH DYSPEPTIC SYMPTOMS 
 
3.5.1 Clinical strains from paediatric patients 
A total of 15 clinical H. pylori strains isolated from paediatric patients with 
epigastric pain were randomly selected from our culture stock for the characterization 
study. These isolates were reconfirmed as H. pylori by gram staining and biochemical 
tests.  
These strains were isolated from the gastric antral biopsies of paediatric patients 
with epigastric pain, referred for gastroduodenoscopy at the Endoscopy Centre in the 
National University Hospital. Informed consent was obtained from parents of the 
paediatric patients. 
 
3.5.2 Identification of H. pylori 
The isolates were grown on the chocolate blood agar plates for 3 days at 37°C in a 
humidified CO2 incubator.  H. pylori appeared as characteristic water droplet-like colony 
of 1-2 mm in diameter. 
 
3.5.2.1 Gram stain 
 Gram staining of the culture showed that H. pylori is a gram negative spiral shaped 






 3.5.2.2 Enzymatic tests 
Urease Test 
         A small inoculum of the bacterial isolate was added to the urea reagent (Appendix 
A2.1).  A positive reaction was indicated by the colour change of the reagent from yellow 
to bright pink within 24 hours. 
 
Catalase Test 
A colony of the bacterial isolate was smeared onto the glass slide and a drop of 3% 
hydrogen peroxide (Merck) added to the smear.  A positive result was characterized by the 
presence of effervescence.  
 
Oxidase Test 
 A strip of filter paper was dipped into 1% oxidase reagent, tetra-methyl-p-
phenylenediame dihydrochloride (Sigma).  With a sterile toothpick, bacterial colony was 
transferred onto the reagent soaked filter paper.  Typical H. pylori shows a positive purple 




3.6 DETECTION OF VIRULENCE GENES 
 
3.6.1 Extraction of genomic DNA 
 The phenol-chloroform extraction method (Hua et al., 1996)) was used to obtain 
DNA from the isolates.  Genomic DNA was prepared from freshly harvested 3 day old 
plate culture.  The bacterial cells were transferred to an Eppendorf tube with TE buffer   
(10 mM Tris-HCl and 1 mM EDTA, pH 8.0) (Appendix A6.1). The suspension was 
centrifuged at 8,000 x g for 10 minutes in a microfuge (Sovall Biofuge) and gently washed 
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 once with TE buffer.  The pellet was suspended with 800 µl TE buffer and 100 µl of 10 
mg/ml lysozyme (Sigma Chemical Co.) and incubated at 37°C for 30 minutes. The 
bacterial suspension was lysed with 100 µl of 10% sodium dodecyl sulphate for another 
30 minutes at 37°C.  This was followed by the addition of 5 µl of 10 mg/ml proteinase K 
(Boehringer Mannheim GmbH.) to the mixture and incubated at 56°C for 1 hour.  Nucleic 
acids were extracted twice with equal volume of phenol and once with equal volume of 
chloroform.  DNA was precipitated by addition of one volume of absolute ethanol and     
20 µl of 3M sodium acetate at -20°C overnight before centrifuging at 12,000 x g for         
10 minutes in a microfuge.  The DNA pellet was washed once in 70% ethanol.  Thereafter, 
it was vacuum dried with a speed vac concentrator (Heto Maxi dry lyo system) and 
resuspended with 200 µl of sterile distilled water.  The concentration and quality of each 
DNA sample was estimated by the ratio of absorbance at OD 260/280.  The DNA was 
kept at -20°C until use.                     
 
3.6.2 Identification of virulence genes using PCR 
 The presence or absence of various virulence genes (cagA, vacA, iceA alleles) was 
carried out using PCR with specific primers presented in Table 3.1 and Table 3.2.  Two 
sets of primers were used for each gene examined.  The PCR reaction was performed with 
a 50 µl volume which consisted of 50 ng of H. pylori  genomic DNA, 1X PCR buffer            
(10 mM Tris-HCl, 1.5 mM MgCl2, 50 mM KCl and 0.1% Triton X-100), 0.2 mM each 
deoxynucleotide, 50 pmole of each specific primer and 1U of DyNAzyme DNA 
polymerase (Finnzymes).  The amplification cycle was performed in a GeneAmp PCR 
system (Perkin-Elmer) thermocycler.  PCR conditions were an initial cycle of 94°C for     
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 5 minutes, 50°C for 1 minute, 72°C for 1 minute, followed by 40 cycles of 94°C for          
1 minute, 50°C (annealing temperature) for 1 minute and 72°C for 1 minute. Final 
extension was performed at 72°C for 5 minutes to ensure full extension of the PCR 
products.   
      PCR reaction for one of the babA gene alleles, babA2 was also performed using 
the specific primers as listed in Table 3.1.  The reaction mixture of a final volume of 50 µl 
comprised 40 ng genomic DNA, 1X PCR buffer, 0.2 mM each deoxynucleotide, 10 pmole 
of both forward and reverse primers and 1U of DyNAzyme DNA polymerase.  The PCR 
reaction was as described for the cagA, vacA and iceA genes.  However, annealing 
temperature was set at 52°C instead of 50°C.     
  
3.6.3 Agarose gel electrophoresis 
 The PCR amplification products were run on 1% horizontal agarose gel in TAE 
buffer (Appendix A6.2).  Each well was loaded with 10µg sample with 1X DNA gel 
loading buffer (Appendix A6.3).  The gels were stained with ethidium bromide               
and transilluminated with UV light to visualise the PCR products. The size of the 
amplification product was used to confirm the presence of the gene. The image was 




3.7 DNA FINGERPRINTING 
 
3.7.1 RAPD fingerprintings of various clinical strains 
 
 A universal oligonucleotide primer 773 (5’-AAGAGCCCGT-3’) as described by 
Akopyanz et al. (1992) was chosen for PCR-RAPD and the amplification condition was 
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 carried out at low stringency (Hua et al., 1998b).  Briefly, the reaction mixture consisted 
of 50 ng genomic DNA, 2 mM MgCl2, 20 pmol primer 773, 1X PCR buffer, 1U 
DyNAzyme DNA polymerase and 200 mM each deoxynucleotide in a final volume of     
25 µl.  PCR reaction was performed with a 5 minute preincubation at 94°C, followed by 
39 cycles of denaturation at 94°C for 1 minute, annealing at 36°C for 1 minute and 
extension at 72°C for 2 minutes.  PCR products were examined by electrophoresis on 1% 
agarose gels.  
 
3.7.2 RAPD profiles of clones 
 
To access whether multiple-strain colonization occurs in local paediatric patients, 5 
single colonies from each isolate were picked from the primary growth.  Five randomly 
selected isolates were used in this clonal study.  DNA was isolated from the individual 
clone by the phenol-chloroform extraction method.  RAPD profile of each clone was 
obtained by running the PCR reactions with the universal primers with conditions as 
described in section 3.7.1.  DNA fingerprints for the 5 different clones from individual 
isolate were obtained when the PCR products were run on a 1% agarose gel.  In addition, 




3.8 Lewis antigens expression of H. pylori Isolates 
3.8.1 Primary isolates 
 The expression of Lewis (Le) antigens was determined as described by Simoons-
Smit et al. (1996) using ELISA with whole H. pylori cells as the antigen.  H. pylori  
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                  Primer sequence 




  Ta 
(0C) 








































     
   Lage (1995) 
 TTGTTGCCGCTTTGCTCTC  
 
   
     
vacA GCTTCTCTTACCACCAATGC 1160 50     Xiang (1995) 
 
 TGTCAGGGTTGTTCACCATG    
 
     
iceA1 GTGTTTTTAACCAAAGTATC 246 50    van-Doorn (1998) 
 
 CTATAGCCAGTCTCTTTGCA    
 
     
iceA2 GTTGGGTATATCACAATTTAT 229/334 50  van-Doorn (1998) 
 
 TTGCCCTATTTTCTAGAGGT    
 
     
babA2 AATCCAAAAAGGAGAAAAAGTATGAAA 831 52  Gerhard (1999) 
 
 TGTTAGTGATTTCGGTGTAGGACA    
 




411 50  Peek et al. (1995) 
     
ureC AAGCTTTTAGGGGTGTTAGGGGTTT 294 50  Labigne et al.      
         (1991) 
 AAGCTTACTTTCTAACACTAACGC 
 








   
  Ta  (annealing temperature) 
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                  Primer sequence 




  Ta 
(0C) 






















































































 Atherton et al (1995) 
 CTGCTTGAATGCGCCAAAC 
 
   
     
m1 GGTCAAAATGCGGTCATGG 290 53  Atherton et al (1995) 
 
 CCATTGGTACCTGTAGAAAC    
 
     
m2 GGAGCCCCAGGAAACATTG 352 52  Atherton et al (1995) 
 
 CATAACTAGCGCCTTGCAC    
 
     
m1T GGCCACAATGCAGTCATGG 290 50  Wang et al  (1998) 
 
 CTCTTAGTGCCTAAAGAAACA    
 
     
m1Tm2 GGCCACAATGCAGTCATGG 300 54  Wang et al (1998) 
 
 CATAACTAGCGCCTTGCAC    
 
  Ta  (annealing temperature) 
* Y is C or T and R is A or G 
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 isolates grown for 3 days on chocolate blood agar plates were harvested in sterile 
phosphate buffered saline (PBS), pH 7.4.  Bacterial suspension of OD600 O.5 (~7.5 x 107) 
was prepared and 100 µl of the whole cell suspension was coated per well in a 96-well flat 
bottomed microtiter plate (polysorp, Nunc).  The coated plates were incubated overnight 
at room temperature.  The plates were washed 3x with PBS containing 0.05% Tween 80 
(PBST).  Murine monoclonal antibodies (Mabs) against Lex, Ley, Lea and Leb (Signet 
Laboratories) were used as primary antibodies.  An aliquot of 100 µl of Mabs (100 µg/ml) 
was added and incubated overnight at room temperature.  After incubation, the plates were 
washed with PBST. The secondary antibody, goat anti-mouse immunoglobulins 
conjugated with horse radish peroxidase (Dako) was diluted 1:1000 with PBST, 
supplemented with 0.5% goat serum (Dako).  An aliquot of 100 µl of the secondary 
antibodies was added to each well and incubated at 37°C for 2 hours with gentle shaking 
and washed.  After which, colour developed with the addition of 100 µl of developing 
solution containing 1 mg/ml ortho-phenylenediamine dihydrochloride (Sigma) in 
phosphate citrate buffer, pH 5.4 (0.1 M C6H8O7H2O and 0.2 M Na2HPO4H2O) and 0.5 µl 
of H2O2 (30% [vol/vol]) per ml.  The plates were then incubated in the dark for half an 
hour before the addition of 50 µl of 10% (vol/vol) H2SO4 to each well to stop the reaction.  
The colour change was measured at 492 nm with Labsystem Ascent microtitre plate reader 
(Finland).  The optical density values > 0.2 was considered positive reactions (Zheng et 
al., 2000). 
 The specificity of the Mabs was validated by their ability to recognise the 




 3.8.2 Aging cultures 
 
H. pylori RH 54 and NCTC 11637 were grown on chocolate blood agar plates and 
harvested over a period of 3-219 days at different time points.  The expression of Lewis 
antigens (Le) was determined using an ELISA as described in Section 3.8.1.  Each sample 




3.9 ANTIMICROBIAL SUSCEPTIBILITY TESTS 
 H. pylori clinical isolates were tested for susceptibility to the 4 commonly used 
antimicrobial agents in the treatment of H. pylori infection. These were tetracycline, 
amoxicillin, metronidazole and clarithromycin.  The susceptibility test was carried out 
using the disk diffusion and Epsilometer test (E-Test). 
 
3.9.1 Disk diffusion method 
 Isolates were grown on chocolate blood agar for 3 days, harvested and was 
suspended in 0.85% sterile saline.  An inoculum containing ~108 CFU/ml in sterile saline 
was spread with a cotton swab onto the surface of chocolate blood agar and left to dry on 
the bench for about 5 minutes.  The following antibiotic disks (Oxoid) were placed onto 
each agar plate: tetracycline (30µg), amoxicillin (10µg), metronidazole (5µg) and 
clarithromycin ((15µg).  All plates were then incubated in microaerophilic atmosphere 
(10% CO2) at 37°C for 3-4 days.  The zone of inhibition was measured (in mm).  The zone 




 3.9.2 Epsilometer test (E-test) 
E-test is a quantitative technique for determining the antimicrobial susceptibility of 
both non-fastidious Gram negative and Gram positive aerobic bacteria.  E-test strip (AB 
Biodisk) is a strip which one side of the strip is calibrated with an MIC reading scale in 
µg/ml.  Whilst the other side is the predefined exponential gradient of antibiotic, dried, 
stabilized and is immobilized on the surface of the strip.  All antimicrobial agents were 
tested at concentration ranging from 0.016 to 256 µg/ml.  The agar plates were inoculated 
by confluent swabbing of the surface with the bacterial inoculum and left to dry on the 
bench at room temperature for 5 minutes.  The E-test strips were then applied onto the 
surface of each agar plate.  The plates were incubated at 37°C under microaerophilic 
conditions. After the 72 hours incubation period, the MIC (minimium inhibitory 
concentration) value was read as the intersection between the inhibition ellipse edge and 





3.10 ELECTRON MICROSCOPY AND FLOW CYTOMETRY 
 
3..0.1 Raising of antibodies against spiral and coccoid antigens 
 
Immunization to produce antibodies 
New Zealand white rabbits weighing ~1.2 kg were used in this immunization 
protocol.  Spiral antigen (RA 101) /coccoid antigen (BCD 23) of 250 µg was mixed with 
equal volume of complete freunds adjuvant (CFA; Sigma #F5881).  The CFA/antigen 
mixture was drawn into a 1 ml syringe. With a double-ended locking hub connector, the 
mixture was mixed till it formed an emulsion.  Prior to immunization, pre-immune blood 
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 sample was collected in a 15 ml centrifuge tube by bleeding the marginal veins of the 
rabbit.  The CFA antigen emulsion was injected into the rabbits subcutaneously.  The 
rabbits were bled 14 days after the priming immunization and blood samples were 
collected.  This was referred to as the immunised blood sample.  Subsequently, booster 
immunizations using incomplete freunds adjuvant (IFA; Sigma #F5506) (instead CFA) 
were administered 4 weeks after the priming immunization. Further booster 
immunizations were given at 2 week intervals.  Immunised blood was collected prior to 
each subsequent booster immunizations.  The blood samples collected were allowed to 
incubate at 37ºC for an hour and then 4ºC overnight until clot was formed. Serum was 
separated by centrifugation and the antibody titre was assayed by ELISA.  The serum was 
stored at -20ºC until use. 
 
Purification of antibodies 
 Protein A Sepharose CL-4B affinity column (Amersham biosciences) was used to 
isolate IgG from the serum.  IgG binds Protein A Sepharose CL-4B at neutral pH and 
physiological strength.  Thus, the serum was diluted with 50 mM Tris buffer, pH 7.0 and 
loaded into the column.  The IgG was eluted with 0.1 M glycine buffer, pH 3.0 and to 
preserve the acid labile IgG, 100 µl of 1 M Tris-HCl, pH 9.0 was added to neutralize the 






 TABLE 3.3  Zone diameter breakpoints for H. pylori (Disk Diffusion) 
  
 





Amoxicillin 10  < 17 Iovene et al  (1999) 
Clarithromycin 15   < 30        Midolo et al (1997) 
 Tetracycline 30   < 19        Midolo et al (1997)










Amoxicillin    ≥ 2        King  (2001)  
Clarithromycin  ≥ 2        King  (2001) 
 Tetracycline   ≥ 4                                    King  (2001)  
 Metronidazole   ≥ 8                   King  (2001) 
  
 
















 3.10.2 Immunogold labelling for Transmission Electron Microscopy (TEM) 
H. pylori strain RH 54 of different ages (3 day and 30 day old) were harvested and 
washed 3X with phosphate  buffered saline (PBS), pH 7.4 (Appendix A3.2) for 5-10 
minutes at each change. The cells were then fixed for 20 minutes in 4% paraformaldehyde 
+ 0.1% glutaraldehyde with 0.5% Triton-X in PBS.  This was followed by another 3 
washes with PBS.  Sample was incubated in 0.05 M glycine-PBS for 15 minutes before 3 
washes with PBS.  The fixed cells were blocked with 0.5% bovine serum albumin (BSA)-
PBS buffer.  Following that, cells were incubated overnight with the respective purified 
1:20 diluted spiral/coccoid antibodies at 4ºC. All antibody dilutions and subsequent 
washes were carried out using the BSA-PBS buffer.  The cells were washed 3X with 
BSA-PBS buffer and bound antibodies were localized by incubating the cells for 2 hours 
at room temperature with 1:20 diluted 10nm gold-conjugated protein A (Sigma).  This was 
followed by 2 changes of PBS with 0.5% BSA and another 2 washes with PBS without 
BSA.  The immunogold labelled cells were post-fixed with 2% glutaraldehyde in PBS at 
room temperature for 2 hours.  After which the cells were rinsed 3X with BSA-PBS buffer 
and left overnight at 4ºC.  The next step was to post-fix the cells with 2% osmium 
tetroxide (OsO4) in PBS for about an hour.  After 3 washes in BSA-PBS buffer, the cells 
were dehydrated in an ascending ethanol series (50%, 75% and 95%) at room temperature  
for 15 minutes at each change. This was followed by 3 changes of absolute ethanol for 20 
minutes each. Subsequently, cells were infiltrated with mixtures of ethanol and embedding 
media, Low Viscosity Epoxy Resin (LVER) by passing through 3 changes of the mixtures 
of various proportions: 
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 1st change- 7 parts ethanol + 3 parts LVER for 30 minutes 
2nd change- 5 parts ethanol + 5 parts LVER for 30 minutes 
3rd change- 3 parts ethanol + 7 parts LVER overnight 
 
The fixed cells were incubated overnight in the last change of mixture (3 parts ethanol + 7 
parts LVER).  The following day, cells were then passed through 3 changes of freshly 
prepared LVER.  These cells were left in media for an hour in between each change.  
During the last change, cells were transferred to beem capsules for embedding and 
polymerisation at 65ºC for 16-18 hours.  Ultra-thin sections were cut using a microtome 
(Ultra-cut E, Leica) and contrasted with uranyl acetate and lead citrate. The sections were 
then viewed under the Philips 208S transmission electron microscope at the Electron 
Microscopy Unit, NUS. 
 
3.10.3 Flow cytometry analysis 
The specificity of the antibodies raised against spiral and coccoid antigens to the 
H. pylori cells at various time points was evaluated using the flow cytometry.  H. pylori 
culture of different ages ranging from 3-184 days were used.  At each time point, H. pylori 
culture was harvested.  Cell pellet was suspended in PBS to OD600 of 0.5.  After the OD 
adjustment, 1ml of the bacterial suspension diluted in PBS was centrifugation at 7,700 x g 
for 5 minutes.  The supernatant was decanted and pellet loosened by gentle vortexing after 
the addition of 100 µl of the respective antibodies (spiral/ coccoid) diluted in 0.2% BSA- 
PBS (w/v) to a final concentration of 1 µg/ml.  The mixture was incubated on ice for 30 
minutes.  Following incubation, the mixture was centrifuged at 7,700 x g for 5 minutes 
and the supernatant was discarded.  The pellet was then resuspended in 0.2% BSA-PBS 
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 and mixed with 100 µl of anti-rabbit IgG FITC (fluorescein isothiocyanate) conjugate 
(1:50 dilution).  The mixture was incubated in the dark on ice for another 30 minutes 
before it was centrifuged.  The pelleted bacteria labelled with FITC were resuspended in 
300 µl PBS in FACS tubes.  Bacteria pellets without FITC resuspended in 300 µl PBS 
were used as negative control.  Flow cytometry analysis of stained cell suspension was 
performed on the flow cytometer, Coultier Elite ESP (Beckman Coultier).  A total of 
10,000 gated events were collected and analysis of the data was carried out by using the 




3.11 GENOMICS AND PROTEOMICS STUDIES 
 
3.11.1 RAPD profiles of RH 54 and NCTC 11637 at various time intervals  
At each time point (3, 5, 7, 14, 30 days), H. pylori cells were harvested and washed 
with sterile PBS.  For induction of the coccoid form of H. pylori, prolong culture of both 
strains were prepared by growing the cultures in the fementer vessels as described in 
Section 3.1.1.  Strain RH 54 was grown for a period of 184 days while NCTC 11637 was 
grown for 219 days.  Bacterial cells were harvested and genomic DNA was extracted 
using phenol-chloroform method (Hua et al, 1996).  The DNA profiles for each time point 
were generated by PCR-RAPD using the single short oligonucleotide primer 773                   
(5’-AAGAGCCCGT-3’).  The PCR products (10 µl) were analyzed by electrophoresis on 







 3.11.2 Putative virulence genes in aging cultures  
The DNA of the ageing cultures (a period of 3 days to 184/219 days) was  
extracted.  PCR amplification of the various virulence genes were performed using the 
primers listed in Table 3.1 and with respective conditions as described in Section 3.6.2.     
 
3.11.3 Gene expression in aging cultures 
Total RNA Preparation  
 Total RNA at the various time intervals was prepared using a commercially 
available total RNA-extraction kit (RNeasy Mini, Qiagen).  Firstly, bacteria (~1 X 109) at 
various time intervals were harvested by centrifuging at 5,000 x g for 5 minutes at 4°C.  
The cell pellet was retained and subsequent extraction process was performed at 20-25°C.  
The cell pellet was resuspended in 100 µl of lysozyme containing TE buffer (400 µg/ml) 
and vortexed for 5 minutes. The extraction steps were carried out according to the protocol 
provided by the supplier. After isolation of the total RNA, it was treated with DNase I 
(Sigma) by incubation at 37°C, followed by inactivation of the reaction mixture at 95 ºC 
for 5 minutes.  In order to exclude any amplification bands resulted from residual DNA, 
an aliquot of the DNase mixture was subjected to PCR using primers for ureC gene. The 
prepared RNA was frozen at -80°C until use. 
 
 
Preparation of cDNA  
 The RNA (2 µg) was transcribed to cDNA using the random hexamers as primers 
(Table 3.1).  The mixture was incubated at 70ºC for 10 minutes and placed on ice for         
2 minutes.  The mixture was incubated with 1X reverse transcriptase buffer (Promega),     
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 1 mM deoxynucleotides and 40U of RNasin ribonuclease inhibitor (Promega) at 25ºC for 
5 minutes and then 10 U of Avian Myeloblastosis Virus Reverse Transcriptase (AMV RT) 
(Promega).  The sample was placed at 25ºC for 10 minutes and then at 37ºC for an hour.  
The reaction mixture was heat inactivated at 70ºC for 10 minutes before chilling on ice.   
  
 
Reverse transcription PCR (RT-PCR) amplification 
 
 RT-PCR assays were carried out using primer pairs targeting the various genes   
(26 kDa and ureA), shown in Table 3.1.  
 
3.11.4 Sample preparation for 2D gel electrophoresis  
 Two-dimensional (2D) gel electrophoresis is a powerful and widely used method 
for proteome analysis (Jung et al., 2000; Bumann et al., 2001; McAtee et al., 2001).  In 
this study, this technique was used to obtain and compare the protein profiles of the 




 Culture cells at various time points were harvested and lysed using the lysis buffer 
(~300–400 µl) (Appendix A7.1).  This was left on ice for 30 minutes. Endonuclease 
(Sigma) was added to the lysate and incubated on ice for 10 minutes.  After which, the 
lysate was spun at 12,000 x g for 5 minutes at 4ºC.  The supernatant was aliquoted and 
stored at -20ºC.  The protein concentration for each extract was measured using the      
Bio-Rad Protein assay and bovine serum albumin (BSA) was used as the standard.   
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 3.11.5 IEF and 2D PAGE  
The IPG strip (Amersham Biosciences) was rehydrated prior to IEF (Isoelectric 
focusing). Protein samples were analyzed on 18 cm IPG strip with pH interval of 3-10 
with a non-linear gradient (pH 3-10 NL) (Amersham Biosciences).  The protein sample 
was diluted with rehydration buffer (Appendix A7.2) to a final total volume of 350 µl with 
60 µg of protein.  The rehydration buffer together with protein sample was loaded onto the 
strip holder.  The strip was placed with the gel side down. To minimise evaporation and 
urea crystallization, IPG cover fluid was applied into the strip holder. Rehydration 
proceeded for 12 hours at a low voltage of 30 V (active rehydration) to facilitate the entry 
of the proteins.  IEF was conducted using the Ettan IPGhor system with setting: 200 V for 
200 Vhr, 500 V for 500 Vhr, 1000 V for 1000 Vhr, 8000 V for 62,000 Vhr for the 18cm 
strip used.   
 Prior to the run in second step, the strip was equilibrated with SDS buffer to 
transform the focused proteins into SDS-protein complexes which carries negative charges 
only.  Equilibration was performed twice on a shaker for 15 minutes each.  The first step 
was in 10 ml/strip of SDS equilibration buffer (Appendix A7.3) with 1% dithiotheitol 
(DTT).  After the first 15 minutes, the strip was equilibrated with the equilibration buffer 
supplemented with 2.5% iodoacetamide (IAA) for another 15 minutes.  Strip was then 
embedded on top of the 12 % SDS-PAGE gel using 0.5% (w/v) hot agarose embedding 
solution coloured with a trace amount of bromophenol blue. The protein marker was 
spotted onto the electrode pad and placed next to the strip.  The vertical gel was run with 
low current (8 mA/gel) for the first 30 minutes to reduce the endoosmosis effects, 
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 followed by increasing the speed of run to 25 mA/gel for ~5 hours or until the blue dye 
reached the bottom of the gel.    
 
3.11.6 Visualisation of gels 
 
After electrophoresis, the gel was removed from the gel cassette in preparation for 
staining.  Two detection methods (coomassie blue and silver stains) were employed and 
procedures are as described in Section 3.3.3.  As coomassie staining is a less sensitive 
stain in comparison to silver staining, the protein load was increased (> 500 µg/gel) when 
using coomassie stain.  The stained gel was scanned using the Densitometer 710 (Bio-
Rad) and protein profiles were compared and evaluated using the Bio-Rad image 
evaluation software, PD Quest. 
 
3.11.7 Difference gel electrophoresis (DIGE) 
 DIGE is a method which pre-labelling the protein samples with fluorescent dyes 
such as Cy2, Cy3 and Cy5 prior to 2D electrophoresis for differential expression analysis 
(Yan et al., 2002; Zhou et al., 2002) (Figure 3.2).  For this study, 3 and 30 day old RH 54 
cultures were compared and analysed.  The procedure was carried out according to the 
Ettan DIGE User manual (Amersham Biosciences). 
 
Preparation of cell lysate compatible with CyDye DIGE fluor labelling 
 Bacterial cells were harvested by centrifugation at 12 000 x g for 4 minutes at 4ºC.  
The pellet was resuspended in 1 ml of cell wash buffer (Appendix A8.1) in a microfuge 
tubes. Cells were washed and centrifuged at 12 000 x g for 4 minutes at 4ºC.  The pellet 
was again resuspended in wash buffer and the washing steps were repeated at least 3 
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 times.  The washed cell pellet was lysed with the cell lysis buffer (Appendix A8.2) and 
left on ice for 10 minutes.  After which, the cells were subjected to 15s bursts from an 
ultrasonic probe (Soniprep 150 sonicator).  Following 5 cycles of bursts interspersed with 
1 minute cooling periods in ice at the end of each cycle. The crude extract was centrifuged 
at 12 000 x g for 10 minutes at 4ºC to remove any unbroken cells and debris. Cell 
supernatant was then retained and the pH of the lysate was checked by spotting 3 µl onto a 
pH indicator strip.  The pH of the lysate would be adjusted to pH 8.0 with diluted sodium 
hydroxide (50 mM).  Protein was quantified using Bio-Rad Protein Assay.  
 
Preparation of CyDye DIGE fluors for protein labelling 
 The Cy2 and Cy3 were reconstituted in fresh 99.8% anhydrous 
dimethylformamide (DMF).  The CyDye DIGE fluors were taken from the freezer and left 
to warm at room temperature for 5 minutes.  A total of 25 µl DMF to 25 nmol of fluor.  
The mixture was mixed vigorously for 30 seconds and subsequently centrifuged for 30 
seconds at 12, 000 x g using a microfuge.  This was the stock fluor solution of 1nmol/µl.  
The fluors were stored in the dark and at -20ºC.  This stock was diluted to working 
solution before use with the samples.   
 A 50 µg of protein was labelled with 400 pmol of fluor.  The fluor and protein 
sample were thoroughly mixed by vortexing and were left on ice for 30 minutes in the 
dark.  The reaction was stopped by the addition of 1 µl of 10 mM lysine. This solution was 
left on ice in the dark for 10 minutes.  Labelling of the protein was completed and the 
labelled sample was stored at -70ºC in the dark for 3 months. 
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 Rehydrating the gel strips with protein samples 
 Equal amount of 50 µg each of Cy3 labelled spiral protein and Cy5 labelled 
coccoid protein were mixed with equal volume of the 2X sample buffer (Appendix A8.3).  
The total volume of labelled protein was made up to the volume (350 µl) required for      
18 cm Immobiline strip using the rehydration buffer.  IEF and subsequent 2D PAGE were 
carried out as described in Section 3.11.4.  The 2D gel images were captured using the 
Typhoon 9200 (Amersham Biosciences). The Cy3 gel images were collected at an 
excitation wavelength of 540 nm and an emission wavelength at 590 nm whereas the Cy5 
labelled gels were scanned at an excitation wavelength of 620 nm and an emission 
wavelength of 680 nm.  The resulted images were viewed using the Fluorsep software 
(Amersham Biosciences). 
 
3.11.8 Spots excision and identification by Mass Spectrometry 
 
Protein spots of interest from 2D gels stained with Cy-dyes, coomassie blue and 
silver stain were selected for identification by mass spectrometry. Comparison of protein 
expression profiles of the spiral and coccoid forms, protein spots of interest were excised 
from the gels manually with a clean spatula.  Individual excised spots were placed in clean 
eppendorf tubes and kept at -80ºC prior to enzymatic digestion.   
 Silver stained proteins were destained with chemical reducers as described by 
Gharahdaghi et al. (1999) before trypsin digestion.  Briefly, the silver stained gel spots 
were rinsed twice with water, followed by washing the spots in water for 10 minutes by 
vortexing.  The reactive substances of the chemical reducers are potassium ferricyanide 
and sodium thiosulphate.  These chemicals destained the gel spots by removing the silver.  
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 Stock solutions of the chemical reducer and 16 mg/ml of sodium thiosulphate were freshly 
prepared.  A 1:1 ratio of the two stock solutions were mixed and 50 µl of this mixture was 
added to the gel pieces.  The gel pieces were destained by gentle vortexing for 30 minutes 
at room temperature.  The brownish colouration of the gels disappeared and the gel pieces 
were rinsed twice with water to stop the reaction.  A quick spin was carried out after each 
wash.  After rinsing with water, 100 µl of 100 mM ammonium bicarbonate was added to 
cover the gel pieces for 20 minutes with gentle agitation.  Subsequently, the gels were cut 
into smaller pieces and washed with 50-100 µl of 50 mM ammonium bicarbonate in     
50% acetonitrile at room temperature for 15 minutes. After incubation, the liquid was 
discarded and the gel pieces were submerged with 3-4 gel volume of acetonitrile for 
another 15 minutes.  The tube containing the opaque white gels was centrifuged and 
supernatant discarded.  The gels were dried in a speed vac concentrator (Heto Maxi dry 
lyo system).  
 The dried gels were sent to Mass Spectrometry service centre where enzymatic 
digestion using the trypsin enzyme was carried out.  Peptide mass maps of tryptic digest 
peptides were generated using MALDI-TOF mass spectrometry and subsequent database 




















FIG 3.2  Flow chart of DIGE analysis of two protein samples.  





































 4.1 BACTERIAL CULTURE 
Figure 4.1 shows the growth of H. pylori on moist chocolate blood agar plate after 
incubation for 72 hours at 37 ºC in microaerophilic environment.  H. pylori colonies were 
small (0.5-2.0 mm), translucent and water droplet-like. 
 
4.1.1 Microscopy observation 
Figure 4.2 shows the 2 differentiated morphological forms of H. pylori observed 
under phase contrast microscopy. In young culture (3-day old), H. pylori appeared as 
curved rods, while on prolonged incubation, coccoids were observed. 
 
4.1.2 Gram staining and enzymatic tests 
H. pylori is a Gram negative gastric bacterium (Figure 4.3). The bacterium is 




4.2 H. pylori  IN FAMILIAL CLUSTER STUDY 
4.2.1 Seroprevalence of H. pylori   
In the familial cluster study, the distribution of sero-status of the 72 test subjects 
from 21 families was determined using our in-house ELISA assay.  Among which, 50/72 
(69.4%) were seropositive for H. pylori antibody IgG (Table 4.1).  Seropositivity was 
more prevalent in the older family members of the same household.  As shown in Figure 
4.4, the prevalence increased with age from 50% among those with age from 1-15 years 
























FIG 4.1  The typical appearance of H. pylori  colonies on a chocolate agar plate. 
 Colonies are small (0.5-2 mm in diameter), translucent and water droplet    
 like. 











FIG 4.2  Dimorphic features of H. pylori.  (1000 X) 
Phase contrast micrograph of a 4 day old culture, showing the different 






































FIG 4.3  Gram staining of H. pylori (1000 x). 













 families with at least one seropositive member, one or more of the younger members of 
the same family were also found to be seropositive.  On the contrary, Family 6 which was 
made up of only 3 family members, the ELISA results showed that the child was 
seronegative even though both parents were tested seropositive.  However, both husband 
and wife did not share similar antigenic profile. Besides this family, the young 
grandchildren in Family 10 were also tested seronegative when their grandparents were 
tested positive for H. pylori antibody.  The remaining 2 families, Family 18 and 21 had no 
seropositive individuals (Table 4.1), thus these families were chosen as the negative 
controls for subsequent western blotting analysis.   
 
4.2.2 Western blotting profiles 
The antibody profiles showed a diversified pattern with protein masses ranging 
from ~8 to 130 kDa (Figure 4.5).  It was observed that the older family members exhibited 
more reactive bands as compared to those younger members residing in the same 
household.   Analysis of the immunobot profiles showed the presence of a high molecular 
mass protein of 120-130 kDa in 49/50 of the seropositive samples (Figure 4.5).  
Comparisons of the seropositive and seronegative immunoblots revealed the presence of a 
common group of proteins of medium molecular masses (~40-60 kDa).   
 
4.2.3 Family cluster statistical analysis 
Computer assisted analysis of the protein bands was performed using the Quantity 
One software program (Bio-Rad) and the agreement between antibody profiles of 
seropositive samples in the same household was assessed statistically using  Cohen’s 
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 Table 4.1  Family cluster statistical analysis  
Family No. of 
 family 
members   
Seropositive  
members 
* Comparisons with 
agreement (%) 
Family relationship 
(for Cohen’s kappa statistical analysis)  
1 6 2             0/1 (0%) - 
2 5 4             1/6 (17%) Mother & son 
3 3 3             3/3 (100%) Father & sons; siblings 
4 2 2             1/1 (100%) Siblings 
5 3 2             1/1 (100%) Mother & son 
6 3 2             0/1 (0%) - 
7 4 4             6/6 (100%) Grandmother & grandsons; Mother & daughter;  
    mother & sons; siblings 
8 3 2             0/1 (0%) - 
9 5 4             3/6 (50%) Father & son; husband & wife; siblings 
10 4 2             1/1 (100%) Grandparents (refer to text) 
11 4 2             1/1 (100%) Mother & daughter 
12 3 1              - - 
13 2 2             0/1 (0%) - 
14 3 3             0/3 (0%) - 
15 4 3             1/3 (33%) Husband & wife 
16 5 5             3/10 (30%) Father & daughter; Father & son;  
    grandfather & granddaughter 
17 3 3             3/3 (100%) Mother & sons; siblings 
18 4 0             - - 
19 2 2             1/1 (100%) Father & son 
20 2 2             1/1 (100%) Mother & son 
21 2 0             - - 
Total       72  50   50 blots comparison  
                      
      * % Similarity =    No. of comparison with  ≥ 40% similarity  x 100





























(11) (13) (12) 
(9) (5) 
 
FIG 4.4  Seropositivity of H. pylori in different age groups.  
Prevalence increased with age from 50% in those ages 1-15 to 100% in those 
age 61-73.  Number in parenthesis denotes the seropositive samples in the   
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FIG 4.5   Immunoblot pattern obtained with sera from household members. 
  Seropositive samples: Lanes 1, 3, 4-8, 10 and 13; Seronegative samples: 
Lanes 2, 9, 11, 12.  Arrow shows band of ~120 kDa present in seropositive 






 kappa analysis. The protein bands from the immunoblot were calibrated and comparisons 
of the blots between household members residing in the same family are illustrated in 
Table 4.1.  
A total of 50 intra-familial blot comparisons were carried out for 18 families.  No 
comparison could be made for the remaining 3 families. This is because no seropositive 
member was detected in members of 2 families (Families 18 and 21) while there was only 
one seropositive individual in Family 12.  The percentage similarity as calculated 
according to Cohen’s kappa analysis is shown in Table 4.1.  Family 17 is used to illustrate 
the analysis.  Of the 3 family members in this family who took part in the survey, all were 
tested seropositive (Mother and two sons).  Meanwhile, a total of 3 comparisons were 
carried out; comparisons between Mother & son 1, Mother & son 2 and between siblings. 
From these 3 sets of comparison, it was noted all comparisons showed degree of similarity          
≥ 40% (3/3). The relationships of those blots that demonstrated similarity were that of 
mother & sons and siblings as stated under the Family relationship column in Table 4.1.   
 Results from the present study showed that 5 families exhibited no similarity (0%) 
in the blot profiles compared. These are families 1, 6, 8, 13 and 14.  The rest of the 13 
families demonstrated a certain degree (17-100%) of agreement in protein patterns among 
individual household members.   
 Comparison of the 26 blots demonstrating similarity in blot profiles. Of these, 15 
showed similarities in blot patterns between parents and children, 5 between siblings, 3 
between grandparents and grandchildren and 3 between spouses.   
  It was noted that seronegative samples from Family 18 also showed 
immunoreactive bands (47-64 kDa).  Therefore, comparisons of the positive samples 
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 within each family after deducting those non-specific bands that were present in            
seronegative family 18 were also performed. It was then found that the results did not 




4.3 H. pylori  IN CHILDREN WITH EPIGASTRIC PAIN 
4.3.1 Paediatrics cut-off point for ELISA  
  As there is no existing ELISA test kit specific for paediatrics, it is pertinent 
to have our in-house ELISA tested with a cut off value.  The cut-off value for ELISA was 
based on a pre-evaluated comparative study of 114 local paediatric patients.  Of these 
patients, 15 were culture and/or histology positive whilst the remaining 99 were negative 
for H. pylori infection by histology.  Figure 4.6 illustrates the distribution of the IgG titre 
(OD values) for these two groups of children. The sensitivity and specificity of the 
serology assessments using various cut-off values are shown in Figure 4.7.  
One of the ways to express the relationship between the sensitivity and specificity 
of the diagnostic test is to construct a Receiver-operator characteristic (ROC) curve (Kist 
et al, 1999; Kato et al 2003).  Figure 4.7 depicts the ROC curve where the plot is based on 
sensitivity against 1-specificity.  From this curve, the cut-off value of Mean+2sd (standard 
deviation) was deemed the most appropriate. With this cut-off value, the sensitivity and 
specificity were 100% and 97%, respectively.   
  Our ELISA data processing is based on a consistent set of positive control 
sample comprising the pooled sera of H. pylori infected patients with high IgG titre.  
Three sets of these sera were serially 2-fold diluted from 100X (P100) to 3200X (P3200).  
The ELISA for the control samples were carried out on separate plates on different 
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 occasions so as to minimize any experimental errors. The chosen value of Mean+2sd 
(0.883) based on the ROC curve, fell within the absorbance of P400 and P800 (Table 4.2).  
The test results obtained were tabulated as such: 
 
    ODsample > OD p400 : positive 
OD p400 > ODsample > OD p800 : grey zone  
    OD sample < ODp800 : Negative 
 
 As the coccoid form is known to be viable but non-culturable (VBNC), the 
histology/culture results were based on observation/culturing of the spiral form.  In view 
of this, the cut-off value for the spiral antigen was used in both ELISA test for spiral and 
coccoid antigens. 
 
4.3.2 Seroprevalence of the two differentiated antigens  
The serology results showed that 65 of 489 (13.3%) of the children with epigastric 
were found to have increased levels of IgG against the spiral form of H. pylori.  In 
contrast, 273/489 (55.8%) were seropositive against the antigen prepared from the coccoid 
form (Figure 4.8).  Of the 65 samples that were seropositive for the spiral-form antigen 
(spiral antigen), 36 were girls and 29 were boys.  Interestingly, a proportional distribution 
of the seropositivity was also observed in 149 girls and 124 boys against the coccoid-form 
antigen (coccoid antigen).  However, the distributions by gender for the groups 

































FIG 4.6   ELISA analysis of anti-H. pylori IgG in paediatric patients. 
Distribution of IgG response (OD values) in H. pylori positive and 
negative children.  
   
 
.           
  
Table 4.2 Setting the cut-off limit for paediatric patients  
Absorbance readings for each plate      (OD)    
Positive Control
  1 2 3 Ave  (Dilutions) 
  
  
P100  1.277 1.455 1.547 1.426  
P200  1.174 1.339 1.343 1.285  
P400  0.929 1.013 1.021 0.987  
P800  0.735 0.788 0.828 0.784  
0.883
P1600  0.554 0.585 0.594 0.578  
P3200  0.414 0.397 0.423 0.411  




















Mean + 2sd Mean + 1.5sd Mean + sd 
Mean + 2.5sd 
Mean + 3sd 
 
Cut-off Sensitivity Specificity  
Mean + sd 1 0.848 
Mean + 1.5sd 1 0.929 
Mean +2sd 1 0.97 
Mean +2.5sd 0.933 1 
Mean +3sd 0.933 1 
 
FIG 4.7  Receiver-operator characteristic (ROC) curve of calculated assay sensitivity  
 and specificity at different cut-off levels.   

















 As shown in Table 4.3, among the 65 children who had raised levels of IgG antibodies 
against the spiral antigen, 58 were also found to have antibodies against the coccoid form 
of H. pylori.  The remaining 7 samples seropositive for the spiral antigen were however 
found to have no significantly increased levels of IgG antibodies against the coccoid 
antigen. The serological results also showed that a total of 215 children tested 
seronegative for the spiral antigen were found to be seropositive for antibodies against the 
coccoid antigen.  A total of 209 of 489 (42.7%) children in this study showed no 
antibodies against either form. 
 Of the 599 asymptomatic school children who represented the negative control in 
this study, 7% (42/599) had elevated levels of IgG antibodies against the spiral antigen 
and 26.5% (159/599) had antibodies against the coccoid antigen (Figure 4.8). 
 
 
4.3.3 Use of coccoid antigen in serologic testing 
To validate the use of the coccoid antigen as the antigen of choice for ELISA, the 
sensitivity and specificity of the assay were calculated using spiral antigen as the 
reference standard for comparison (Table 4.3).  The choice of using the spiral antigen as 
the reference standard for comparison is because the spiral form is routinely used for the 
serodiagnosis of H. pylori infection. Furthermore, endoscopically confirmed H. pylori 
infection is also based on this actively dividing spiral form.  
When spiral antigen was used as the standard for comparison, the calculated 
sensitivity was 89.2% (58 of 65 children) and specificity was 49.3% (209 of 424 
children), with a negative predictive value of 96.8% (209 of 216 children) and a positive 



































FIG 4.8  Comparison of seropositivity between school children and children with  
epigastric pain. 
   A total of 489 children with epigastric pain and 599 school children formed the    







TABLE 4.3  Seroprevalence of the two differentiated antigens of H. pylori 
      
  Coccoid-form antigen 
Spiral-form antigen Seropositive Seronegative 
Seropositive  58 7 
Seronegative   215 209 
 
* Following calculations were based on using the spiral-form antigen as standard for comparison. 
Sensitivity: 58/65 = 89.2% 
Specificity: 209/424 = 49.3% 
Positive predictive value: 58/273 = 21.2% 




 4.3.4 Correlation of histology with seropositivity for coccoid antigen 
Of 273 children with positive ELISA for the coccoid antigen, 120 underwent 
endoscopy.  Interestingly, the histology findings showed that majority of these children 
(85/120) had evidence of inflammation (mild chronic gastritis). In addition, the presence 
of coccoid cells was detected in one patient.  The remaining 35 patients demonstrated no 
significant histopathology their gastric antral mucosa. 
 
4.3.5 Seroprevalence of paediatric  patients of different ethnic origins 
The children who participated in this study were of various ethnic backgrounds: 
Chinese, Malays, Indians and other ethnic groups.  There were 360 Chinese, 43 Malays, 
46 Indians and 40 of other races.  The prevalence of seropositivity among the different 
races and age groups is illustrated in Table 4.4.  Although there was no statistically 
significant difference in prevalence among the 4 ethnic groups (P>0.05), children of the 
Indian race were observed to have the highest rate of seropositivity (21.7%) for antibodies 
against the spiral antigen.  Malay children appeared to have a slightly higher prevalence 
(14%) as compared to the Chinese children (12.5%) and children of other races (10%). 
The seroprevalence of H. pylori in various age groups is shown in Table 4.4.  The study 
shows a gradual increase in the rate of acquisition of H. pylori infection with age.  
Children aged 5 years old and younger had a prevalence of seropositivity of 7.1% with 
prevalence increasing to 21.4% for those aged 11 years and older.  The serology results for 
antibodies against the coccoid form (Table 4.5) showed that 54.2%, 60.5%, 60.9% and 
60% Chinese, Malays, Indians and children of other races were seropositive, respectively.  
It was noted that 188/358 (52.5%) children of aged 10 and younger, were seropositive for 
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 the coccoid-form antigen, whereas 85/131 (64.9%) of children aged 10 years and older 
were seropositive for coccoid antigen (Table 4.5).   
 
4.3.6 SDS PAGE of spiral and coccoid antigens 
Differential protein profiles of the acid glycine extracted (AGE) spiral (3 day old 
culture) and coccoid (150 days old culture) proteins are represented in Figure 4.9.  
Proteins were separated by 1-DE using 12% SDS-PAGE gel, subsequently stained by 
Coomassie G-250. 
Comparison of the profiles showed that surface proteins of the two morphological 
forms were highly conserved.  Nevertheless, a reduction of protein bands was observed in 
the coccoid culture.  Both forms expressed major proteins with masses of 88, 69, 43, 24, 
20, 17 and 16 kDa (Figure 4.9).  The amount of proteins of 43, 24 and 16 kDa were 
significantly reduced in the coccoid cells.  Two proteins of masses 33 and 13 kDa were 
expressed predominantly in the spiral cells. A protein of low molecular weight (MW),     
20 kDa was up-regulated in the aged culture.   
 
4.3.7 Immunoblot analysis of  humoral immune response in children with 
epigastric pain 
 
Western blots were used to detect H. pylori specific immunoreactive bands in 5 
culture/histology positive and 4 culture negative samples. The positive samples were 
seropositive for spiral and coccoid antigens while the culture negative samples were 
seronegative for both antigens by ELISA.   
 As shown in Figure 4.10, variability in number and intensity of bands were 
observed in individual sample against the two differentiated antigens.  In general, the total 
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 number of bands detected was higher for H. pylori culture positive than the culture 
negative samples.  The immunoreactive bands for the positive samples, ranged from 15 to 
24 for the spiral antigen and 10 to 16 for the coccoid antigen.  In comparison, the number 
of immunoreactive bands for the culture negative samples ranged from 7 to 11 bands for 
spiral antigen and 6 to 9 bands for the coccoid antigen.  The cross reactive proteins 
detected in both the H. pylori positive and negative samples were mainly the medium 
molecular weight proteins of 45-67 kDa. When the immunoblot profiles were compared, 
several common H. pylori specific immunoreactive proteins were detected (Figure 4.10 
1b): A (144 kDa); B (102 kDa); C (94 kDa), D (81 kDa ), E (72 kDa), F (42 kDa); G (36 
kDa) and H (32 kDa).  Similarly, a number of low MW bands were also detected in the H. 
pylori positive samples (13-17 kDa).  Figure 4.10 2b, reveals that the 2 morphological 
forms shared common immunoreactive bands of 144 kDa (Band A), 81 kDa (Band D) and 
42 kDa (Band F) though the intensity of these bands were much reduced.  Interestingly, a 

















                               








Total     
(n=489) 
0-5 5/78      (6.4%) 
1/6      
(16.7%) 
1/7    
(14.3%) 
0/7                
(0%) 
7/98         
(7.1%) 
6-10 19/188 (10.1%) 
2/22     
(9.1%) 
5/26   
(19.2%) 




11-15 21/94     (22.3%) 
3/15      
(20%) 
4/13   
(30.7%) 




Total 45/360     (12.5%) 
6/43     
(14.0%) 
10/46     
(21.7%) 
4/40               
(10.0%) 
65/489     
(13.3%) 
 







TABLE 4.5  Seropositivity to H. pylori coccoid form antigen in children with  epigastric   
 pain 
 
                               








Total     
(n=489) 
0-5 43/78      (55.1%) 
3/6      
(50%) 
4/7    
(57.1%) 
4/7                
(57.1%) 
54/98        
(55.1%) 
6-10 91/188 (48.4%) 
11/22     
(50%) 
17/26   
(65.4%) 




11-15 61/94     (64.9%) 
12/15      
(80%) 
7/13   
(53.8%) 




Total 195/360     (54.2%) 
26/43     
(60.5%) 
28/46     
(60.9%) 
24/40              
(60.0%) 
273/489     
(55.8%) 
 






                                     
















                                 
FIG 4.9  Protein profiles of the spiral (S) and coccoid (C) AGE antigens.  
Proteins separated by 1-DE, followed by coomassie blue staining. 
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FIG 4.10  Western blot patterns of sera from 9 dyspeptic patients.  
1a & 2a are immunoblot patterns against the spiral-form and coccoid-form 
antigens, respectively, while 1b & 2b are the diagramatic representations of 
the blots, respectively.  Lanes 1-5 show the patterns blotted with sera of   
H. pylori culture positive patients. Lanes 6-9 show the patterns blotted with 
sera from patients who were H. pylori culture negative. Identification of 
several immunoreactive bands:  A (144 kDa); B (102 kDa); C (94 kDa), D 
(81 kDa), E (72 kDa), F (42 kDa); G (36 kDa); H (32 kDa), highlighted in 
dark green. In 2b, bands highlighted in black (298 kDa) is seen present in 
positive samples against the coccoid antigen. 
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 4.4  CLINICAL STRAINS FROM PAEDIATRIC PATIENTS 
The 15 H. pylori isolates were shown to be spiral form (Figure 4.3A) from a 3 day 
old culture grown on the chocolate blood agar plates (Appendix A1.2 or A1.3) or 
embedded in the gastric antral biopsies (Figure 4.11).  The organism was positive for 
urease, catalase and oxidase tests. 











                                                                                       
                                                                        











FIG 4.11  Gram stain of a H. pylori positive biopsy smear. 
 Large number of H. pylori in gastric biopsy stained in pink.  
       Arrows indicate the Gram negative spirals.  
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1 299 Duodenal ulcer 
2 310 Duodenal ulcer  
3 393 Gastritis 
4 504 Gastritis 
5 522 Gastritis 
6 578 Gastric ulcer 
7 741 Non-ulcer dyspepsia 
  8* 1260 Duodenal ulcer 
  9* 1272 Healed duodenal ulcer 
10 1276 Non-ulcer dyspepsia 
11 1295 Esophagitis 
12 1320 Gastritis 
13 1351 Gastritis 
14 1352 Gastritis 
15 1416 Duodenitis 
      
      * isolated from same patient 
   
                                                                               
4.4.1 RAPD PATTERNS 
4.4.1.1 Genomic fingerprinting of clinical strains  
RAPD profiles generated using the 10bp primer 773 was found to be useful in 
strains discrimination.  Figure 4.12 illustrates the RAPD-DNA fingerprints obtained with 
the 15 clinical isolates from the symptomatic children.  Each isolate presented a total of 4 
to 7 bands of MW ranging from 0.4 kbp to 3.0 kbp. It was observed that each patient 
harboured a distinct H. pylori isolate even though commonly conserved bands were seen 
in some isolates.  As shown in Figure 4.12, strains 8 and 9 displayed similar DNA 




 4.4.1.2 Genomic fingerprinting of clones  
In order to assess whether there is multiple-strain colonization in local population, 
5 single colonies (single colony strains) were randomly isolated from each of the 5 
different clinical cultures.  In all, chromosomal DNA of 25 single colonies were extracted 
and typed. The 5 clones of each respective culture exhibited identical DNA fingerprinting 
patterns.  Figure 4.13 illustrates the representative profiles from 2 of the 5 clinical strains. 
Similarity in DNA profiles between clones suggests that the patients harboured 




4.4.2 PREVALENCE OF VIRULENCE GENES 
The presence or absence of the virulence genes in the 15 H. pylori isolates was 
analysed by PCR (Figure 4.14) with the specific primers (Table 3.1 & 3.2). 
 
4.4.2.1 H. pylori genotypes in paediatric patients 
The cagA and cagE genes were detected in all 15 isolates (Table 4.7).  The iceA 
genotyping revealed that 12 of 15 isolates (80%) were positive for iceA1 while iceA2 was 
found in the remaining 3 strains.  Interestingly, these 3 isolates were isolated from patients 
who had gastritis.  The babA2 gene was detected in 12/15 (80%) isolates.  
The allelic variation of vacA gene was studied (Table 4.8).  The vacA s1 allele was 
present in all strains tested.  The s1c was observed to be the most common s alleles with 
13 strains possessing the gene.  Three strains were detected with s1a alleles.  The s2 allele 










                  















FIG 4.13  Representative RAPD patterns of various clones of 2 clinical isolates.  
 Clones of each isolate (A: Strain 2; B: Strain 4) displayed similar 





MW   1      2      3     4      5      6      7      8     9    10    11    12   13    14     15 
  
FIG 4.12  Arbitrarily primed PCR (RAPD) fingerprint patterns of H. pylori   
  isolates.  
The PCR profiles of 15 clinical isolates generated using primer 773. Unique 
fingerprints were observed for each isolate except isolates 8 and 9. Isolate 9 
was isolated from patient 8 on a revisit.   MW shows the DNA size marker 
(GeneRulerTM 100bp DNA Ladder Plus). 
B  A 
  MW   1       2      3      4      5  MW   1       2      3      4      5 
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 Type m2 was detected in 7 strains while m1T was found in 4 strains.  As for the 
remaining 4 isolates, 2 were found to be of m1 genotype, whilst the other 2 strains were 
assigned for m1Tm2 genotype (Table 4.8).  Interestingly, 2 strains (Strains 10 and 12) 
were found to have mixture of alleles for the s regions (Table 4.8). Considering the 
combination of vacA s and m types, 6 mosaic combinations were found (Table 4.9) with 
genotype s1c/m2 being the most frequently observed in paediatric patients with a 
frequency of 37.5% (6/16).  
  Overall, the common genotype of strains isolated from local young patients 
is observed to be cagA+, vacA s1c/m2 iceA1 and babA2+.  The only s2/m2 strain was 
isolated from a patient with NUD and the genotype was detected to be cagA+, vacA 
s1c/s2/m2, iceA2 and babA2 -.                
 
4.4.2.2 Virulence genotypes of clones from single colony   
Twenty-five single colony samples from 5 clinical isolates were typed for various 
virulence genes.  The PCR results showed that all single-colonies obtained from an isolate 
displayed similar genotype.  Figure 4.15 depicts the virulence genotypes of the 5 clones 











       
 
 













        

































FIG 4.14   PCR products of various genes. 
       A 1% agarose gel A stained with ethidium bromide illustrating the PCR products  
for A: cagA; B: cagE; C: iceA1; D: iceA2 and E: babA2. MW shows the DNA size 










 Table 4.7  Genotypes of the 15 clinical isolates 
  Genotype status 
Strain 
No. cagA cagE iceA1 iceA2 babA2 
      
1 + + + - + 
2 + + + - - 
3 + + - + + 
4 + + + - + 
5 + + + - + 
6 + + + - + 
7 + + + - - 
8 + + + - + 
9 + + + - + 
10 + + - + - 
11 + + + - + 
12 + + + - + 
13 + + - + + 
14 + + + - + 
15 + + + - + 
      




Table 4.8   H. pylori vacA genotypes 
  
  vacA alleles 
Strain 
No. m1 m1Tm2 m1T m2 s1a s1c s1b s2 
1 - - + - - + - - 
2 - - - + - + - - 
3 + - - - + - - - 
4 - - + - - + - - 
5 - - - + - + - - 
6 - - + - - + - - 
7 - - - + - + - - 
8 - + - - - + - - 
9 - + - - - + - - 
10 - - - + - + - + 
11 - - + - - + - - 
12 - - - + + + - - 
13 - - - + - + - - 
14 + - - - + - - - 
15 - - - + - + - - 
 (+) refers to amplification of the respective m and s regions by PCR 
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s1a/m1  2 
s1a s1c/m2  1 
s1c/m2  7 
s1c/m1T  4 
s1c s2/m2  1 
s1c/m1tm2  2 
Table 4.9   Relationships between m-region and signal sequence typing of  
 vacA for 15 H. pylori isolates 
 
4.4.3 ANTIMICROBIAL SUSCEPTIBILITY STUDY 
In this study, the primary resistance of the 15 H. pylori isolates to amoxicillin, 
clarithromycin, metronidazole and tetracycline were tested using antibiotics sensitivity 
tests.  These are frequently used antibiotics in combination with proton pump inhibitors or 
bismuth salts for the treatment of H. pylori infection. The antimicrobial susceptibility 
testing was first performed using the disk diffusion method (Figure 4.16A).  The diameter 
of zone of growth inhibition was recorded and the cut-off for each antibiotic was referred 
to Table 3.3.   
  All 15 isolates were sensitive to amoxicillin and tetracycline by disk diffusion 
test.  It was observed that 4/15 (26.7%) and 10/15 (66.7%) of the isolates were resistant to 
clarithromycin and metronidazole, respectively by disk diffusion test. The clarithromycin 
and metronidazole susceptibility testing was further evaluated using the E-test (Figure 
4.16B).  Two isolates (13.3%) was shown to be resistant to clarithromycin with an MIC of 
8mg/L (cut-off for Clr® is at 2 mg/L).  Resistance to metronidazole was observed in 8/15 
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 (53.3%) strains using E-test.  Of the 8 metronidazole resistant isolates, 1 exhibited  MIC 
of 32 mg/L and remaining 7 had higher MICs (>256 mg/L) (cut-off for Mtr® is at 8 mg/L).   
A higher resistant rate was observed using the disk diffusion method as compared to using 
the E-test.  Nonetheless, strains tested resistant by E-test were also noted to be resistant by 
disk diffusion method.                         
 The antimicrobial susceptibility of the two strains (Strains 8 & 9) isolated from 
same individual on 2 different occasions showed that the strain isolated during the second  
visit exhibited combined resistance to clarithromycin (8 mg/L) and metronidazole       
(>256 mg/L).  This is the only strain observed in the present study that demonstrated 
















































FIG. 4.15  PCR products of various genes of H. pylori  strain 9 
A 1% agarose gel showing the PCR products of A: cagA; B: vacA; C: iceA1; D: 
iceA2 and E: babA2. Strain 9 is positive for cagA, vacA, iceA1 and babA2.  MW 
shows the DNA size marker (GeneRulerTM 100bp DNA Ladder Plus). 
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FIG 4.16   Antimicrobial susceptibility tests. 
 A: Disk diffusion method (arrow indicates the zone of inhibition)
 B: E-Test (arrow indicates the point of inhibition of growth)     
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 4.4.4 EXPRESSION OF LEWIS ANTIGENS  
 
4.4.4.1 In primary H. pylori  isolates 
Le antigen typing on 15 H. pylori isolates using ELISA showed that all the isolates 
expressed Lex while 13/15 (86.7%) isolates expressed Ley.  Only 1 isolate was found to 
express the Lea and 3/15 (20%) were shown to carry the Leb antigen.  Present study 
showed that the type II carbohydrate antigens, Lex and Ley are more commonly expressed 
by the H. pylori isolates than the type I antigens, Lea and Leb.  In addition, 14/15 isolates 
were observed to express ≥2 Le antigens.  All isolates had both Lex and Ley except 1 strain 
which expressed Lex and Lea instead.   
The H. pylori strains (8 & 9) isolated from the same patient during different visits 
demonstrated not only similar genotype but also expressed homogeneous Le antigens 
phenotype.   Both isolates expressed Lex, Ley and Leb.   
 
4.4.4.2 In aged H. pylori cultures 
 
Le antigens expression by H. pylori during morphological conversion was studied 
using the standard strain (NCTC 11637) and a local clinical isolate (RH 54).  RH 54 was 
grown from a period of 3 to 184 days while NCTC 11637 was grown for a slightly longer 
period of 219 days.   
The Le antigens expression was based on the OD values as a measure of the 
amount of antigens expressed by the individual strain.  Values >0.2 OD were considered 
positive (Zheng et al, 2000). Tables 4.10 and 4.11 illustrate the mean OD values of the 2 
H. pylori strains tested.  Both strains were observed to express different levels of Le 
antigens (Mean OD for RH 54 > Mean OD of NCTC 11637).  The results showed that    
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 RH 54 expressed Lex and Ley while NCTC 11637 expressed only Ley.  Neither of the 
strains expressed Lea.  Expression of Leb by RH 54 was observed in 5-30 days old 
cultures.  
   When Le antigens expression at various time points were compared, 2 OD peaks 
were observed, at 5th and 30th day of the growth profiles (Figure 4.17).  The general trend 
of Le antigens expression increased from the 3rd to 5th day of growth.  After which a 
decline in the Le antigens level continue until the 14th day of growth.  Interestingly, an 
increase in Le antigen level renewed from 14th to the 30th day.  Subsequently, as the 
culture aged further (184/219 days), the antigens expression dropped to a level comparable 
to that of the 3 day old culture. This interesting pattern of Le expression during the 




4.5  IMMUNOELECTRON MICROSCOPY AND FLOW CYTOMETRIC 
ANALYSIS OF THE LOCALIZATION OF H. pylori ANTIGENS DURING 
DIFFERENT MORPHOLOGICAL STAGES 
 
 Transmission Electron Microscopy (TEM) was used to examine the antigen-
antibody interaction with immunogold labelled rabbit anti-H. pylori antibodies against 
both morphological forms of H. pylori .   
  The electron micrographs (Figure 4.18A & B) show that immunogold particles of 
10nm were seen to localize on the cell surface of 3 day old H. pylori regardless of the 
types of antibodies (anti-spiral antibodies & anti-coccoid antibodies) used. Similar 
observation was noted for the coccoid cells against the anti-spiral and anti-coccoid 




Table 4.10  Lewis antigens expression ( Average OD value) in aging culture of       











Table 4.11  Lewis antigens expression (Average OD value) in aging culture of H. pylori   





                                                                                              
 





                                                                           
 
 
                                                                
Strain RH 54
Le Ag
3 5 7 14 30 184
Le x 0.357 1.489 1.263 1.043 1.882 0.273
Le y 2.680 5.221 5.188 4.498 4.981 2.525
Le a 0.105 0.100 0.129 0.086 0.104 0.105




3 5 7 14 30 219
Le x 0.069 0.060 0.065 0.053 0.074 0.074
Le y 0.487 0.932 0.883 0.601 0.664 0.207
Le a 0.070 0.060 0.063 0.079 0.076 0.046
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FIG  4.17  Graphical representations of the Le antigens expression during morphological  
 conversion.  
Two peaks, at 5th and 30th day of culture were observed.  As the culture aged 
further, the Le antigens expression level dropped to that comparable to the 3-day 
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  Based on the finding that the antigens were localized on the cell surface of              
H. pylori, flow cytometry was engaged to further examine the antigen-antibodies 
interaction.  In Figure 4.19, the flow cytometry analysis illustrates the binding affinity of 
the purified antibodies to H. pylori spiral and coccoid cells.  The anti-spiral IgG has a 
higher affinity for the 3-day old cells as compared to the 35 and 184-day cells, which 
comprised mainly the coccoid cells (Figure 4.19A & B). Similarly, the anti-coccoid IgG 
was incubated with both spiral (3-day old culture) and coccoid cells (35 and 184-day old 
culture).  Interestingly, there is a shift of the coccoid cell profiles (35 to 184-day old 
culture) to the right as observed in graphs C and D.  This observation illustrates a binding 




4.6 GENOME AND PROTEOME STUDIES 
 
4.6.1 Genomic fingerprinting of aging RH 54 and NCTC 11637 cultures 
As illustrated in Figure 4.12, RAPD fingerprints showed that the DNA patterns of 
the 2 strains were dissimilar.  However, DNA profiles of the spiral forms were highly 
homologous to their respective coccoid forms (Figure 4.20).  Both strains show slight 
variations in band density in aged culture of 184 days and 219 days.  Conversely, majority 
of the bands were conserved in aging cultures which comprised the coccoid cells.       
 
4.6.2 Presence and expression of various genes in aged cultures 
 The test strains at various time points were tested for the presence of the 26kDa, 
ureA, cagA and vacA genes.  Figure 4.21 illustrates the presence of PCR products of        
294 bp and 411 bp in all cultures even up to a long period of 184/219 days which  
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FIG  4.18  Electron micrographs showing binding of various antibodies to 3-day old  
 H. pylori cells using the immunogold labeling technique. 
 A: anti-spiral IgG + 10nm immunogold particles. B: anti-coccoid IgG + 10nm      







FIG 4.19  Flow cytometric analysis of antigen-antibody interaction. 
H. pylori  RH 54 cells of various timepoints (3-184 days) were used. A and B 
show the binding affinity profiles when the anti-spiral IgG was used.  C and D 
show the profiles when anti-coccoid IgG was used.  The X-axis measures the 
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 corresponded with the 26kDa and ureA genes, respectively.  Similarly, presence of 2 other 
virulence genes (cagA and vacA) was also observed in all cultures (Figure 4.22). 
   Besides detecting the presence of several important genes, the expression of 
26kDa and ureA genes in growing and aging phase cultures were studied. All RNA 
preparations were treated with DNase I and negative with PCR before performing          
RT-PCR.  The RT-PCR was positive using the 26kDa and ureA primers for the 2 strains at 
different time intervals (3, 7, 30 and 184/219 days) (Figure 4.23).  Results from RT-PCR 
showed that coccoid forms maintained the 26kDa and ureA genes expression throughout 
the incubation period. 
 
 
4.6.3 Proteomics analysis 
4.6.3.1 Identification of proteins in spiral and coccoid AGE preparations 
Eight protein bands (A-H) of the AGE preparations, separated by 1-DE were 
excised and identified by mass spectrometry.  Figure 4.24 depicts the mass and identity of 
the various proteins.  Proteins A and B were identified as serotransferrin precursor and 
serum albumin precursor, respectively originated from Equus caballus (Horse). These 
proteins are most likely the contaminants from horse serum/ blood incorporated in the 
medium for culturing H. pylori. 
 The remaining 6 proteins were identified as H. pylori proteins.  Protein band C of 
37.3 kDa which was reduced in the coccoid form was identified as a putative protein, with 
no apparent function updated.  Three proteins which were also present in the coccoid 
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FIG 4.20  RAPD profiles of H. pylori cells (RH 54 & NCTC 11637) at various time 
points. 
Lanes 1 through 6 contain cells harvested at various time points                  
(3-219 days). The genomic DNA was conserved during morphological 
conversion as the DNA profiles of the ageing cultures (coccoid forms) were 
almost similar to that of the 3-day old cultures (spiral forms).  MW shows 
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  FIG 4.21  PCR analysis of housekeeping genes in H. pylori (RH 54 & NCTC 11637) 
of different time points. 
Lanes 1 through 6 contain cells harvested at various time points. For Strain 
RH 54, Lane 1: 3 day; Lane 2: 5 days; Lane 3: 7 days; Lane 4: 14 days; Lane 
5: 30 days; Lane 6: 184 days.  For Strain NCTC 11637, Lane 1: 3 day; Lane 
2: 5 days; Lane 3: 7 days; Lane 4: 14 days; Lane 5: 30 days; Lane 6: 219 
days. MW shows the DNA marker (GeneRulerTM 100bp DNA Ladder Plus/λ 
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FIG 4.22  PCR analysis of  virulence genes in H. pylori (RH 54 & NCTC 11637) at 
different time points. 
Lanes 1 through 6 contain cells harvested at various time points.  Strain RH 54, 
Lane 1: 3 day; Lane 2: 5 days; Lane 3: 7 days; Lane 4: 14 days; Lane 5: 30 
days; Lane 6: 184 days.  Strain NCTC 11637, Lane 1: 3 day; Lane 2: 5 days; 
Lane 3: 7 days; Lane 4: 14 days; Lane 5: 30 days; Lane 6: 219 days. MW 
shows the  DNA marker (GeneRulerTM 100bp DNA Ladder Plus/ λ DNA 
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FIG 4.23  RT-PCR analysis of 26 kDa and ure A gene expression. 
 Agarose gel (1%) electrophoresis of the PCR product of the respective genes  
showing the detection of mRNA from RH 54 (1a &1b) and NCTC 11637 (2a 
& 2b). Lanes 1-4 (1a & 1b) represent samples from 3-day, 7-day, 30-day and 
184-day cultures, respectively.  Lanes 1-4 (2a & 2b) represent samples from 3-
day, 7-day, 30-day and 219-day cultures, respectively.  MW shows the DNA 
marker (GeneRulerTM 100bp DNA Ladder Plus).  
    








                                                 
 MW        S          C 
kDa
 
Band  Protein identity  MW (kDa) 
database 
Functions, if known 
A Serotransferrin precursor (horse) 78.1   
B Serum albumin precursor (horse) 68.6   
C Putative 37.3 Conserved with no known 
function 
D Iron superoxide dismutase 24.5 Destroys radicals which are 
normally produced within cells & 
are toxic to the biological systems 
E 26 kDa (alkyl hydroxide reductase) 20.2 Reducing a variety of 
hydroperoxide substrates; 
essential for growth of bacteria 
F Non-heme iron containing ferritin 
Pfr 
19.4 Iron storage protein 
G Neutrophil activating protein 
NapA 
16.9 May perform analogous functions 
in iron detoxification & storage 
H Thioredoxin 11.9 Participate in various redox 
reactions 
                                              




















 protein (Band G) and thioredoxin (Band H).   As illustrated in Figure 4.24, the H. pylori 
protein E of apparent molecular mass about 20.2 kDa which was upregulated in the 
coccoid form was identified as the 26 kDa protein.  Band F was identified as the non-heme 
iron containing protein, Pfr.  The brief description of the functions of the identified 
proteins is recorded in Figure 4.24.   
 
 
4.6.3.2 Comparison of protein profiles in aging cultures - 1D-PAGE 
 The protein profiles of the aging cultures (RH 54 & NCTC 11637) are illustrated 
in Figure 4.25.  The present study demonstrated that the respective aged cultures (coccoid 
cells) exhibited highly similar protein pattern as the 3 day old culture (spiral cells) as seen 
in Figure 4.25.  However, the protein bands decreased both in numbers as well as in 
intensity (down-regulated) during morphological conversion from spiral to coccoid form 
(Figure 4.25).  
 
4.6.3.3 Comparison of protein maps  in aging cultures - 2D-PAGE  
Figure 4.26 shows the resolution of proteins from lysed cell pellets of H. pylori 
strain RH 54, at various time points by 2D-PAGE, using a non-linear isoelectric focusing 
gradient of pH 3-10 and a 12% polyacrylamide gel in second dimension. In all the gels, 
protein spots are spread over the whole pI range of 3-10 (Non-linear IPG) and the whole 
MW 10-150 kDa.  It was observed that more proteins were resolved at the basic range of 
the strip.  Comparisons of the gels showed that the protein profiles were relatively similar 
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FIG 4.25  Protein profiles of the aging cultures of RH 54 and NCTC 11637. 
Decreased in the number of protein bands was observed as the culture aged. 
Lane 1-5: 3, 5, 7, 14, 30 day old cultures, respectively.  Lane 6: 184 day old 
culture (RH54)/ 219 day old culture (NCTC 11637).   







 the protein spots was observed during the morphological conversion from the spiral form 
to the coccoid form.  In total ~676 spots were detected on the 3 day old H. pylori culture 
(spiral form) as compared to 485 proteins, 374 proteins in 30 and 184 day old cultures 
(coccoid forms), respectively.   
  The silver stained gels revealed prominent individual proteins (Figure 4.27).  It was 
also observed that the major proteins each appeared as a “train” of spots (isoforms) 
migrating at slightly variable pI values, a phenomenon commonly ascribes to diverse 
levels of post-translational modification (Packer et al., 1997).   
As the culture aged, horizontal streaks were notably observed in the 2D gels, 
especially in the 184 day old culture (Figure 4.26F).  This might be attributed to the 
contamination of horse serum proteins/horse blood supplemented to the growth medium or 
the debris of the growth medium itself.  The horizontal streaks were demonstrated to be 
similar to the gel pattern obtained from resolving proteins from the growth medium which 
comprised the brain heart infusion supplemented with 10% horse serum (Figure 4.28).  
From the stained gels, several protein spots were excised and trypsin digested 
followed by MALDI-TOF analysis (Figure 4.27). The identities of these spots are 
summarized in Table 4.12.  Comparative analysis showed that protein clusters (Figure 
4.27, box j) were reduced significantly in the coccoid cells.  Two isolated proteins which 
formed train of spots on the gels were identified as Urease B (Spot c) and 26 kDa protein 
(Spot h) and both proteins were down-regulated as compared to the profile obtained from 
the spiral cells (Figure 4.27 A). In contrast, there were proteins such as g (Translational 
elongation factor EF-Tu) and i (adhesin thiol peroxidase) which appeared up-regulated in 
the coccoid cells.  Several other proteins identified are VacA (Spot a), Heat shock  
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 FIG 4.26   2D gels of H. pylori RH 54 at various time points. 
  A: 3 day; B: 5 day; C: 7 day; D:14 day; E: 30 day; F: 184 day 
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Table 4.12  Identities for isolated protein spots from the 2D gels shown in Figure 4.27  
 
Protein spot Name  MW (kDa) pI 
a VacA 93.3 9.34 
b Heat shock protein 70 66.9 5.29 
c Urease B 61.7 5.64 
d Heat shock protein 58.2 5.49 
e Flagellin A 47.6 5.44 
f,g Translational elongation factor EF-Tu (tufB) 43.6 5.18 
h 26 kDa protein (tsaA) 20.2 5.98 


















FIG 4.28  2D gel profile of BHI supplemented with horse serum. 













 proteins (Spot b & d), flagellin A (Spot e) and translational elongation factor EF-Tu   
(Spot f).  These proteins were found to be conserved in the coccoid form.   
 Comparison of the differential gel profiles has enabled selection of several protein 
spots of interest for identification.  However, due to the detection limit of the coomassie 
blue staining, low abundance proteins would not be stained.  Hence, these spots were not 
able to be identified. The use of silver staining may alleviate the problem of detection 
limit. However, the amount of protein presence may not be sufficient for identification by 
mass spectrometry. 
 
4.6.3.4 2D Differential In-gel Electrophoresis (DIGE) 
Differential analysis of the spiral and the coccoid cells was also performed using 
DIGE, a new emerging technology for proteomic analysis.  The proteins from spiral (3 
day old culture) and coccoid (30 day old culture) were labelled with Cy3 and Cy5 dyes, 
respectively.  Figure 4.29 A-C illustrates the individual Cy3, Cy5 and the combined gel 
images.  Common proteins present in both morphological forms appeared yellow in the 
combined image, Figure 4.29C.  As this system enables multiplexing of separate protein 
mixtures on the same gel, it was visibly observed that there was a reduction of proteins in 
the coccoid cells as compared to the spiral cells.  In addition, few coccoid specific spots 
(appeared red) were observed.  However, several proteins were conserved in the coccoid 































FIG 4.29   DIGE gel images of spiral and coccoid cells of H. pylori RH 54. 
       A: Cy3 image of proteins from 3 day old culture (spiral cells);  B: Cy5 image of  
proteins from 30 day old culture (coccoid cells); C: combined protein profiles 
























 5.1 EPIDEMIOLOGY AND TRANSMISSION 
5.1.1 Family clusters study-Intrafamilial transmission? 
There have been reports addressing the high prevalence of H. pylori infection 
among family members with infected individuals (Oderda et al., 1991; Dominici et al., 
1999).  Malaty et al. (2000) reported a 4-fold increase in prevalence of H. pylori infection 
among children living with positive index mothers compared to children staying with 
negative index mothers.  Interestingly, in the present study of 21 families, at least one 
young member in each family was seropositive.  The possible reason can be attributed to 
that the children were living with parents and/or grandparents who were seropositive.  
This observation suggests the possibility of a vertical transmission. 
The current study also demonstrates that the rate of seropositivity increases with 
age; 50% among those with age from 1-15 years old to 100% in subjects aged 61-73 years 
old (Figure 4.4). This finding is consistent with an earlier report on a larger local 
population based study of 2,626 individuals (Committee on Epidemic Diseases, 1996). In 
that study, the rate of seropositivity increased gradually from 3% for children aged 4 years 
and younger to 71% seropositivity for those aged 65 years and older.  Likewise, the 
observation is seen in accordance with many reports from other countries (Everhart et al., 
2000; Malaty et al., 2003).     
 
 
Western blots analysis 
 For further evaluation on the intrafamilial acquisition of H. pylori, western blotting 
was performed to investigate the patterns of H. pylori antibodies among family members 
residing in the same household. 
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 Based on the analysis illustrated in Figure 4.5, the western blots profiles detected a 
range of proteins ranging from ~8 to 130 kDa.  In addition, the intensity of the 
immunoresponse to some antigens varied in each individual.  Similar observations were 
also reported in the study by Pineros et al. (2001) who showed that the antigenic 
components ranged from 30 to 120 kDa. This heterogeneity in the profiles may reflect the 
diversity at the genomic level (Hua et al., 1998) or the change of immune response to 
different immunodominant antigens during the course of H. pylori infection.    
Analysis of the various antibody profiles revealed the presence of the high 
molecular weight protein, ~120-130 kDa in 98% of the seropositive samples. The 
molecular weight of the protein points to the CagA protein as described by Covacci et al. 
(1993).  Though presence of cagA gene related well with peptic ulcer disease (PUD) in the 
western population, this gene has been reported to be present in 90% of the local 
population infected with gastroduodenal diseases studied by Zheng et al. (2000).  Zheng 
and colleagues (2000) emphasized that cagA is not associated with peptic ulcer disease 
when compared with patients having non-ulcer dyspepsia (NUD).  Even though, cagA 
does not serve as the virulence marker for PUD, combined results from current study and 
that of Zheng et al. (2000) illustrated the importance of this high molecular weight protein 
as a reliable marker for H. pylori infection/colonization.  In addition, Kuo et al. (2003) 
analyzed the sera for H. pylori specific antigens using the commercial kit, HelicoBlot 2.0 
(Genelabs Diagnostic, Singapore) and the data showed that the 116 kDa (CagA) protein 
presented the highest sensitivity. In the same kit, VacA with a MW of 89 kDa was also 
taken as an important marker for H. pylori infection. In the present study, the only 
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 seropositive sample which had no immunoreactive band of 120 kDa, was observed to 
possess a band of similar MW as VacA. 
As shown in Figure 4.5, the medium molecular weight proteins (40-60 kDa) were 
present in both the seropositive and seronegative samples, including seronegative Family 
18.  These medium size proteins which parallel subunits of urease, heat shock proteins and 
flagellins were reported to be responsible for cross-reactivity with antigens of other 
bacterial species (Andersen & Espersen, 1992; Nilsson et al., 1997).  Thus, these groups 
of proteins are not useful in discriminating H. pylori infection. 
 
Family Clustering 
 Numerous data have been collated to demonstrate familial clustering of H. pylori 
infection (Georgopoulos et al., 1996; Elitsu et al., 1999; Goodman & Correa, 2000).  The 
same strains of H. pylori have also been reported to be identified among families based on 
molecular techniques (Wang et al., 1993; Georgopoulos et al., 1996).  In a recent study by 
Dominici et al. (1999) on the general population, they reported that children with both 
parents who were seropositive had double the risk of being infected by H. pylori than 
those from families of which both parents were seronegative.  
In the present study, the antibody profiles of the 72 individuals from 21 families 
using the western blotting were compared.  Based on the Cohen’s kappa analysis, 13 
families showed certain degree (17%-100%) in agreement of protein patterns among 
individual household members. Furthermore, parent–child transfer seems to be more 
frequent.  This is shown in the analysis when there were more immunoreactive bands from 
the parents as compared to the children in the H. pylori seropositive families. 
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  Discrepancy in interpretation of the results occurred in 2 families.  It was noted 
that the younger members in Families 6 and 10 remained seronegative despite the 
seropositivity of the older family members.  Family 6 comprised a young couple and a    
1-year-old child.  The parents were seropositive but the child was seronegative. One 
plausible explanation could possibly be that there was no seroconversion at the time of 
this study.  As for Family 10, members were of grandparents and grandchildren 
relationship and results from the blot comparisons demonstrated that only 3 sets of blot 
patterns demonstrated similar protein profiles for this relationship (Table 4.1). Most 
studies reported that parent-child and siblings transmission (Rothenbacher et al., 1999; 
Miyaji et al., 2000; Goodman & Correa, 2000) may play key role in the spread of             
H. pylori infection.  In contrast, the study of grandparents-grandchild transfer in H. pylori 
infection has not been explored specifically.  Nevertheless, Nwokolo et al. (1992) showed 
that highly similar DNA fingerprints were observed from individuals of 3 generations 
(grandfather, son and grandson) in the study of a duodenal ulcer disease family.  The 
limited data of the grandparents-grandchild relationship with respect to H. pylori infection 
could likely be the assumption of a less close association between the two generations, 
possibly due to the wide age gap. 
 Despite the data from current study supporting a possible vertical familial transfer, 
there were 5 blot comparisons that showed no similar protein profiles among household 
members. These subjects could have acquired the infection from other sources besides the 
family members. Therefore, interfamilial transmission should not be ruled out as a 
probable mode of acquiring H.  pylori infection. 
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  Genotyping of the H. pylori isolates in families can provide precise information 
about transmission of specific strain between individuals (Owen & Xerry, 2003). 
However, no isolates were obtained in the present family cluster study as this study was 
based on a seroepidemiological survey and no endoscopy was performed. Nevertheless, 
analysis and results obtained from the present study demonstrate that ELISA and western 
blotting in combination can also be a useful approach in determining familial status in 
relation to H. pylori infection.  The serological analysis in our study is in agreement with 
the hypothesis of intrafamilial vertical transmission (Taneike et al., 2001; Owen & Xerry, 
2003).  
 In view of this hypothesis, early childhood may be a critical period for the 
acquisition of H. pylori infection.  However, how H. pylori is transmitted remains elusive 
as the infective spiral form transforms to the viable but non-culturable coccoid form 
(VBNC) under various environmental conditions (Nilsson et al., 2002).  This inevitably 
signifies that the coccoid form, which is the morphological form in the extragastric 
environment, may be a key factor in the transmission cycle of H. pylori. 
 The subsequent serological study was performed to investigate the probable role of 
the coccoid form encompassing local young symptomatic population.   
 
 
5.1.2 Prevalence of H. pylori  infection in children with epigastric pain  
Infection by H. pylori is likely to be acquired predominantly in childhood 
(Fiedorek et al., 1991; Boey et al., 1999).  A recent study on H. pylori status from infancy 
to adulthood concluded that most newly acquired infection occurred before age 10 
(Malaty et al., 2002).  Although H. pylori infects the younger population, its association 
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 with the development of upper gastrointestinal symptoms such as epigastric pain and 
pathogenesis of recurrent abdominal pain has been inconsistent (Macarthur et al., 1999; 
Frank et al., 2000).  Findings from a study by Reifen et al (1994) demonstrated that        
H. pylori infection in children is not associated with specific clinical symptomatology.  In 
contrast, 2 paediatric studies reported that the epigastric abdominal pain as a clinical 
presentation occurs more frequently among children with H. pylori infection as compared 
to those without bacterial colonization of the antrum of the stomach (Hardikar et al., 1991; 
Chong et al., 2003). Hence, this study was performed on children with epigastric pain.  
Children with general abdominal pain were not examined further because there was no 
clinical indication to justify performing endoscopy or draw blood from this group of 
patients.   
  It is also known that a low percentage of paediatric patients with epigastric pain 
are H. pylori positive.  This could possibly due to many factors.  One of which is that it is 
the norm for the histopathologists to look for the presence of the spiral form and not the 
coccoid form of H. pylori.  If coccoid form was VBNC and had a role in pathogenesis, 
there is a possibility that the coccoid form will induce host immune response.  Therefore, 
in this present study, we examined the immune response against the spiral-form antigen as 
well as the coccoid-form antigen in young patients suffering from epigastric pain.   
 
Comparison of seropositivity to spiral and coccoid form antigens 
 Results from current study show that 7.0% (42/599) of the school children cohort 
(control group) tested were found to have antibodies against the spiral-form antigen.  The 
finding on non-symptomatic school children (control group) agrees with an earlier study 
 127
 based on 2626 subjects in various age groups (6 months to older than 65 years), in which 
6.7% (48/717) of children younger than age 15 years tested seropositive (Committee on 
Epidemic Diseases, 1996).  However, of the 489 symptomatic children, 13.3% were 
seropositive with antibodies against H. pylori spiral antigen.  This is approximately two 
fold increase in seroprevalence of H. pylori infection in children with epigastric pain as 
compared to the control group using spiral antigen.  This rise is significant (P<0.001).  
Interestingly, the rate of seropositivity for antibodies against the coccoid form for the 
children having epigastric pain and children in the control group were 55.8% and 26.5%, 
respectively. This observation again depicting a 2-fold increase in the symptomatic 
patients.  
 The study shows a 2-fold difference in the rates of seropositivity for the two 
groups of subjects when either form of the antigen was used in the serological test.  
However, the differences in the proportions of children within each study group positive 
between the spiral form and the coccoid form were 4-fold (Table 5.1). 
 The symptomatic paediatric patients showed increased levels of IgG against both 
the spiral form and coccoid form of H. pylori.  The results showed a 4 fold increase in the 
rate of seropositivity for antibodies against the coccoid-form antigen (55.8%) compared to 
that for antibodies against spiral-form antigen (13.3%) (P<0.001).  However, a study by 
Hua et al. (1998a) reported that in the adult symptomatic population, the rates of 
seropositivity for antibodies against either form were found to be comparable, with 50.7% 
seropositive for antibodies against the spiral-form antigen and 49.6% against the coccoid–
form antigen.  More recently, a publication by Figueroa et al (2002) also revealed that the 
sera of 295 infected individuals were highly reactive to both spiral and coccoid forms by 
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 ELISA.  The contrast may be due to the possibility that the coccoid form is involved in the 
initial stage of H. pylori infectivity and that there is a relative increase in seropositivity for 
antibodies against the spiral form with age.  This may also explain why we detected a 4 
fold increase in the rate of seropositivity for the coccoid form as compared to that for the 
spiral form in asymptomatic children (Table 5.1) as well as children with epigastric pain. 
Furthermore, the observed increased prevalence of seropositivity to the coccoid form of      
H. pylori in children with epigastric pain could suggest a possible infective role of the 





TABLE 5.1  Comparison of seropositivity of the two differentiated forms between 
asymptomatic children (controls)  and children with epigastric pain 
 
 % Seropositivity 
Antigens Children with epigastric pain (n=489) 
Asymptomatic school children (Control) 
(n=599) 
Spiral form 13.3 a,c  7.0 a,d 
Coccoid form 55.8 b,c 26.5 b,d
 
 
a,b Two fold difference between groups when either form of antigens used in ELISA         




   The present study with children having epigastric pain showed that there is no 
preponderance of seroprevalence by gender. However, there was an increased 
seroprevalence with age where the highest seropositivity was among Indian children.  This 
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 is in agreement with the findings of Boey et al. (1999) on asymptomatic Malaysian 
children: seropositivity increased with age and most common among Indian children.  A 
study by Kang et al. (1997) demonstrated that racial differences in H. pylori 
seroprevalence were more pronounced in the adult population.  The study also showed 
that Indians had the highest prevalence of infection, followed by Chinese and Malays but 
the Indian subjects had a lower frequency of peptic ulcer than the Chinese subjects. 
  
 
Association between the spiral and coccoid forms of H. pylori  
It was also observed that the coccoid form is strongly associated with the spiral 
form in the infection process as reported by Chan et al. (1994).  In this study, it was shown 
that when IgG antibodies against the spiral form were present, antibodies against the 
coccoid form were always detected, except for 7 children who were tested seropositive for 
the spiral form but found to be seronegative for the coccoid form. This observation 
contributed to the reduced sensitivity (89.2%) of using coccoid antigens in serologic 
testing when spiral antigen was used as the standard for comparison. However, detailed 
analysis of the data showed that 6 of these individuals had borderline titre of IgG 
antibodies against the coccoid-form antigen.  The low specificity (49.3%) may mean that 
there are numerous false positive results.  This is expected because, as illustrated in Table 
4.5, more than 50% of the test subjects had antibodies against the coccoid form.  In view 
of this observation, the possibility of under-reporting of H. pylori infection in this 
population of young symptomatic subjects must be given due consideration as current 
tests are designed with reference to the spiral form and not the coccoid form.  
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  The coccoid form is non-culturable in vitro and its viability is still subjected to 
debate.  However, in a recent study by Nilsson et al. (2002), ATP was detectable for at 
least 25 days after the morphological conversion from spiral to coccoid form and that 
mRNA of several genes were present in aged culture.  This supports the notion that the 
coccoid form is probably viable.  In addition, a study by Vijayakumari et al. (1995) 
showed that coccoid form of H. pylori which adhered to the Kato III cells in vitro is 
similar to the observed interaction of the spiral form with the gastric epithelium in vivo.  
Furthermore, a study using electron microscopy with epithelial cells showed the presence 
of both spiral and coccoid forms in 3 of the 8 H. pylori positive children (Janas et al., 
1995).  It is therefore probable that the coccoid form, like the spiral form is viable and 
infective, even though it is non-culturable in vitro. 
 In the present study on young symptomatic children (mean age of 8.5 years) with 
epigastric pain using H. pylori coccoid antigen in the serologic testing, an increased 
seroprevalence to the coccoid form was noted.  It is postulated that the infection may well 
begin with the colonization of the coccoid form.  It is therefore not surprising that most of 
these symptomatic children were not diagnosed as H. pylori positive because usual 
histological examination and serologic tests used for diagnosis are based on the 
observation of spiral form. 
  Whether the coccoid form plays an infective role is not definitive at this stage as 
coccoid form is being reported as viable but non-culturable (Nilsson et al., 2002).  Our 
findings have provided another facet on the role of the coccoid form of H. pylori.  This 
study demonstrates that the effect of the coccoid form has on the immune response in 
infected individuals, especially children cannot be underestimated.  It therefore raises the 
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 question: Is there a possibility of under reporting of H. pylori infection in paediatric 
patients with epigastric pain?    
 
Western blotting – Immunoreactive bands 
 Immunoblots based on the antibody response to H. pylori antigens is a non-
invasive assay for diagnosing H. pylori infection.  Anderson and Espersen (1992) had 
studied the H. pylori infection using Western immunoblot technique and managed to 
identify several H. pylori specific proteins.  Recent studies have focused on evaluating the 
performance of the commercial kits which differentiates the reactivity to each of the 
multiple H. pylori antigens (Park et al., 2002; Kuo et al., 2003; Ogun et al., 2003).   
To date, serology studies and commercial kits are based on the antigenic proteins 
of the spiral form of H. pylori.  Hence, in this study, western blotting against the spiral 
forms as well as the coccoid forms was performed on selected sera to examine the 
immunogenic profiles.  The high MW antigen of 144 kDa, presumably the CagA protein 
(Covacci et al., 1993) was identified by immunoblotting among infected children (Figure 
4.10 1b). This observation was also seen in earlier study (Section 4.2) which recorded the 
presence of a high MW protein (~120 kDa) in 49/50 seropositive family household 
members.  The variability of the size of this protein (116-128 kDa) has been reported by 
various authors (Cover et al., 1990; Crabtree et al., 1992; Raymond et al., 2000).  As in 
agreement with the study by Covacci et al. (1993), this protein which showed up as a 
minor component in 1-DE (Figure 4.9) is highly immunogenic (Figure 4.10).   
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 Comparing the immunogenic profiles against antigens of the two forms showed 
that coccoid forms of H. pylori are capable of eliciting immune response that is highly 
similar to that induced by the spiral forms (Figure 4.10).   
It was observed from the blot profiles for both antigens that besides the high MW 
protein (CagA), immunoresponse towards the low MW antigens (13-42 kDa) were 
characterised predominantly in children with H. pylori infection as compared to those 
uninfected children (Figure 4.10).  Recent studies suggest that the low MW antigens may 
be associated with H. pylori infection (Bode et al., 2002; Kuo et al., 2003).  Likewise, an 
earlier study by Mitchell et al. (1996) reported that the initial immunoresponse was 




5.2 CLINICAL ISOLATES FROM PAEDIATRIC PATIENTS 
In this study, only 15 strains isolated from paediatric patients were used in the 
characterization study. The low recovery rate of H. pylori from biopsy samples could be 
due to several factors: 
(a) the patchy distribution of this bacterium on mucosal surface which could lead to 
 sampling error (Loffeld et al., 1991;  Nedenskov-Sorensen  et al., 1991). 
 
(b) delayed in transporting the biopsy samples to the laboratory for processing (Soltesz  
et al., 1992). 
 
(c) in the initial phase of the study, biopsies were not taken from the symptomatic 





 5.2.1 Genomic fingerprinting- Interpatient and intrapatient variation of H. pylori  
 
One of the characteristics of H. pylori is the large degree of genetic heterogeneity 
among the strains. Through the use of DNA fingerprinting methods, this genomic 
diversity has been engaged in epidemiologic analysis of the mechanism of H. pylori 
transmission (Georgopoulos et al., 1996; Miehlke et al., 1999).  Molecular analysis by 
rRNA gene restriction pattern (ribotyping) of H. pylori for 4 members of a Japanese 
family, performed by Taneike et al. (2001), illustrated a familial infection.  In the study, 
the ribotyping pattern of the son who was reinfected after eradication therapy was similar 
to that of the mother’s who did not undergo treatment.  
Current study analysed 15 clinical strains isolated from 14 symptomatic children 
by DNA fingerprinting using RAPD. Of these 15 strains, 2 were isolated from a same 
patient during re-visit. The DNA fingerprints were shown to be unique to individual 
patient.  Among these, Strains 8 and 9 displayed similar genetic profile as both strains 
were isolated from the same patient (Figure 4.12).  In an earlier study by Hua et al. (1999) 
which the in vitro interaction of 2 H. pylori strains in a mixed growth was assessed. In 
their study, they observed the growth of a predominant strain. Consequently, our data 
suggests that each patient was infected with a genetically predominant strain of H. pylori.   
 To further confirm that a single strain predominates in the gastric antrum of an 
individual, 5 strains were randomly selected for the clonal study.  From each of these 5 
selected strains, a total of 5 colonies were randomly chosen as clonal representatives for 
DNA fingerprinting. The genetic profiles from the 5 clones of a single isolate were 
indistinguishable.  A similar observation of a homogenous population of H. pylori was 
also noted by Marshall et al. (1995). 
 134
 5.2.2 H. pylori genotypes in children with epigastric pain 
H. pylori infection is one of the commonest chronic bacterial infections in human.  
However, only approximately 15-20% of H. pylori infected individuals will develop 
gastroduodenal disease (Suerbaum & Michetti, 2002). Presently, even with the 
phenomenal progress in research on H. pylori, the pathophysiological role of this human 
gastric pathogen remains to be resolved, particularly in the younger population.  Despite 
the high degree of genetic heterogeneity among H. pylori isolates (Akopyanz et al., 1992; 
Mukhopadhyay et al., 2000), several studies have reported that specific genotypes of       
H. pylori increased the risk of a clinically significant outcome (Blaser et al., 1995; 
Atherton et al., 1997; van Doorn et al., 1998). 
At present, several virulence associated genes have been identified in genome of 
H. pylori: cagA, cagE, vacA, iceA and babA2 (van Doorn et al., 1998; Gerhard et al., 
1999; Fukuta et al., 2002).  Among these, cagA gene is a widely studied virulence factor.  
The cagA gene is located at the most downstream of the cag pathogenicity island (PAI) 
and encodes for a highly immunogenic outer membrane protein, CagA (Covaci et al, 
1993).  In several studies, cagA gene/CagA protein is shown to be associated with a more 
severe clinical outcome in both adult and children (Blaser et al., 1995; Queiroz et al., 
2000; Yahav et al., 2000).  However, this observation is inconsistent as geographical 
differences have shown to be otherwise.  Nearly all East Asian strains are cagA positive, 
independent of clinical manifestations (Pan et al., 1997; Maeda et al., 1998, Zheng et al., 
2000).  In a recent study by Day et al. (2000), another gene in the cag PAI, cagE was 
shown to be associated with duodenal ulceration in children.  In current study, the 15 
clinical isolates from children with epigastric pain were examined for the prevalence of 
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 both cagA and cagE status.  Results showed that all the 15 isolates were positive for both 
genes.  The finding is in accordance with earlier studies by our research team, which also 
reported a high prevalence of cagA in the local adult population (Hua et al., 2000b; Zheng 
et al., 2000).  Hence, present study supports that cagA is not a useful virulence marker for 
peptic ulcer disease (Park et al., 1998; Perng et al., 2003; Qiao et al., 2003), at least in the 
Asian population.  Similarly, the prevalence of cagE is also high in our region irrespective 
of clinical status.  Fukuta and colleagues (2002) provided added data that cagE will not 
serve as an invariable marker for peptic ulcer disease as their study has failed to show an 
association between cagE gene and duodenal ulcer in 2 areas in Japan.   
Another important virulence determinant is VacA, which induces the formation of 
intracellular vacuoles in eukaryotic cells in vitro (Cover, 1996; Harris et al., 1996). The 
vacA gene contains 2 distinct regions: the signal region (s) and the middle region (m).  The 
signal and middle sequences could be designated s1 (subtypes s1a, s1b and s1c) or s2 and 
m1 or m2, for s and m regions, respectively (Yamaoka et al., 1999).  The s1 and m1 
subtypes have been linked to more severe clinical manifestations (Basso et al., 1998; De 
Gusmao, 2000).  In a study with Taiwanese patients, Wang and colleagues (1998) typed 
the H. pylori isolates with the different vacA genotypes using primers adopted from 
Atherton et al. (1997) and their modified primers for m1T and m1Tm2 types.  
Interestingly, the results suggested that s1a/m1T strains were associated with higher ulcer 
prevalence.  In the present study, we examined the distribution of the vacA genotypes in 
15 H. pylori paediatric isolates and identified 6 different genotypes (Table 4.9).  In this 
study, the commonly observed genotype is the s1c/m2.  This genotype is also reported in 
the study by Yamaoka et al. (1999), which showed that this genotype was predominant in 
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 Japan and Korea.  The s1c allele, which is the predominant vacA genotype in Japan and 
East Asia (Wong et al., 2001) was also observed in high incidence in the present study.  In 
contrast, vacA s1b and s2 were rare.  This observation is contrary to the Brazillian study 
(De Gusmao, 2000) which reported the association of s1 allele with duodenal ulcer in 
children and most of the s1 strains (97.5%) had the s1b allele.  However, s1b allele was 
not present in our local isolates. 
 A novel gene, iceA (induced by contact with epithelium) has 2 allelic variants, 
namely iceA1 and iceA2.  The function of this gene is not defined but there is significant 
homology to a type II restriction endonuclease.  The present study demonstrated iceA1 
allele to be the predominant subtype in local isolates.  This is not surprising since high 
incidence of the iceA1 allele has been reported as the predominant subtype in East Asia 
while iceA2 is the predominant allele in the USA and Columbia (Yamaoka et al., 1999).     
 Besides examining the prevalence of several important virulence factors, the 15 
strains were also typed for babA2.  This gene encodes the complete adhesin which has 
been shown to mediate adherence of the bacteria to human Leb blood group antigens on 
gastric epithelial cells (Ilver et al., 1998).  Studies based on Western population suggested 
an association between babA2 positive status with duodenal ulcer as well as gastric 
carcinoma (Gerhard et al., 1999; Oliveira et al., 2003).  In contrast, several studies have 
shown that the circulating H. pylori strains in the Asian countries are babA2 positive, 
regardless whether they were isolated from asymptomatic or diseased patients (Kim et al., 
2001; Mizushima et al., 2001; Lai et al., 2002).  Our findings from current study showed 
that 80% of the local paediatric isolates studied possessed the babA2 gene and this is in 
agreement with those studies from the Asian countries. 
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  Taken together, the results from this paediatric population study and an earlier 
adult population study (Zheng et al., 2000), neither babA2 nor combination of cagA, vacA 
and iceA would be useful markers to identify patients who are at higher risk for specific         
H. pylori-related diseases in this geographic region.  Furthermore, present study adds to 
the evidence that demonstrates H. pylori genotypes in Western and Asian countries are 
distinctly different.   
 The current study also demonstrates that co-infection with multiple H. pylori 
strains is uncommon in Singapore because the 5 individual clones selected from each of 
the 5 different strains showed similar RAPD profiles representing a single genotype.  This 
finding is unlike several reports that described multiple-strain infection (Yakoob et al., 
2001; Ashour et al., 2002).  One of the studies was by Morales-Espinosa and colleagues 
(1999) which detected 2 or more different vacA genotypes in 17/20 patients.  However, 




5.2.3 Antibiotic resistant H. pylori in paediatric patients 
The National Institutes of Health Consensus Development Conference has 
recommended the addition of antimicrobial agents to anti-secretory drugs for the treatment 
of patients with H. pylori associated peptic ulcer disease (NIH, 1994).  Hence, the first-
line therapy regimen widely used today is the combination therapy with 2 antibiotics and 
bismuth or an acid pump inhibitor (Fraser et al., 1999; Gold et al., 2000; Bazzoli et al., 
2002).  The antimicrobial agents frequently used in the treatment regimens include 
amoxicillin, tetracycline, clarithromycin and metronidazole (Unge, 1998).  
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 Primary resistance to nitroimidazoles and macrolides in H. pylori has been 
described in numerous studies and resistance of the bacterium to these antibiotics has been 
a major cause for therapeutic failure (Adamek et al., 1999; Pilloto et al., 2000; Perez et 
al., 2002).  As a result, the resistance of H. pylori to the available antibiotic treatment 
regimens has been a growing problem.  In developed countries, metronidazole resistance 
is observed to range 10 to 50% in adults infected with H. pylori (Graham, 1998; Adamek 
et al., 1999).  On the other hand, the rates of clarithromycin resistance are relatively low 
but rate has been increasing in recent years (Crone et al., 2003; Loffeld & Fijen, 2003).  
As in local context, our research team has documented earlier, a 4 years period of 
investigation on H. pylori resistance to metronidazole and clarithromycin in the adult 
population (Hua et al., 2000a).  In the study, the rate of metronidazole resistance increased 
over the 4 years from 20% in 1995 to 47% in 1998 and was believed to have reached a 
platform of ~50%.  However, clarithromycin resistance was observed to be comparatively 
low (6%) in the study population (Table 5.2).   
The incidence of antimicrobial resistance to H. pylori in the local young children 
with H. pylori infection has yet to be investigated. Hence, this study provides a 
preliminary data regarding resistance rates of H. pylori isolates from local symptomatic 
children.  The antibiotic sensitivity tests showed a high rate of resistance of H. pylori to 
metronidazole (53.3%) and moderate resistance to clarithromycin (13.3%) but no 
resistance to amoxicillin or tetracycline has been detected. These results are in agreement 
with a recent study by Rerksuppaphol et al. (2003) which reported the resistance rate to 
metronidazole and clarithromycin to be 43.5% and 8.7%, respectively. Likewise in their 
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 study, all the strains were sensitive to amoxicillin and tetracycline.  Table 5.2 depicts the 








Adult population1     
(Resistance 
isolates/total isolates )  
Children population2     
(Resistance 
isolates/total isolates )   p value 
Clarithromycin resistance 18/282 (6.4%) 2/15 (13.3%) 1.1 
Metronidazole resistance 130/282 (46.1%) 8/15 (53.3%) 0.3 
 
1 Hua et al., 2000 
2 Data from present study 
 
 
The high resistance of H. pylori to metronidazole could have been linked to the 
usage of this drug in the community. Metronidazole is used for treatment of parasitic 
infections, dental and gynaecological infections.  The idea that the resistance of H. pylori 
to metronidazole for treatment of unrelated infection such as gynaecological infections is 
not valid for children.  However, the history of using metronidazole in treating infectious 
disease other than H. pylori probably exposed the children to sublethal concentrations of 
the drug and may select for resistant strains or augment the development of resistance in 
previous sensitive strains.  This hypothesis is enhanced when a recent publication by Lui 
et al., 2003 has demonstrated that in the local adult population, the rate of metronidazole 
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 resistance was found to be more prevalent in non-ulcer dyspepsia than in peptic ulcer 
patients. 
There is a need for constant surveillance of both prevalence and evolution of 
antibiotic resistant H. pylori in children because of the association of the infection with 
prolonged or even lifelong risks of gastroduodenal diseases during adulthood. As the 
number of isolates obtained in this study is small, current study serves only as a 
preliminary documentation of antibiotic resistance in H. pylori isolates from children with 
epigastric pain per se.  In order to arrive at a significant conclusion regarding the rate of 
antibiotic resistance in our local paediatric population, a substantial number of H. pylori 
isolates is needed.  Subsequently, the collated findings can contribute to the enhancement 
of the eradication of H. pylori by providing guidelines for therapeutic recommendations.   
 
 
5.2.4 Lewis antigens expression in clinical H. pylori isolates 
H. pylori has been reported to express fucosyl-transferases which enable the 
bacteria to synthesize Lewis (Le) antigens (Appelmelk et al., 1996).  Serotyping of 
clinical strains of H. pylori based on the occurrence of Le epitopes was evaluated in the 
study by Simoons–Smit et al (1996) and had shown differentiation between strains.  It has 
been documented that the type II carbohydrate antigens, LeX and Ley were expressed by     
> 80% of H. pylori isolates from symptomatic patients (Simoons–Smit et al., 1996; Wirth 
et al., 1997).  Hence, in this study, the H. pylori strains isolated from children with 
epigastric pain were characterized by their Le antigens expression. 
  By ELISA, it was demonstrated that LeX and Ley were frequently expressed by 
local H. pylori isolates from children having epigastric pain.  This observation also holds 
 141
 true for the isolates from local adult patients as reported in the study by Zheng and 
colleagues (2000).   
LeX was shown to play a role in colonization via a Lewis antigen mediated 
adherence process as demonstrated in a series of studies (Edwards et al., 2000; Heneghan 
et al., 2000).  Edwards and colleagues showed that in contrast to the parental strain (LeX 
positive strain), 2 mutant strains which were unable to produce LeX did not adhere to the 
epithelial cells of gastric pits of human antral tissue sections.  A recent study by Munoz et 
al. (2001) which compared the expression of LeX and LeY in H. pylori isolated from 
children and adults showed that LeX expression was significantly higher in clones from 
children than in clones from adults.  They further commented that by expressing LeX 
during early phase of the colonization, H. pylori might have escaped the immune response 
that otherwise would have eliminated the infection.  This postulation was put forward 
because LeX found on the surface of the eggs of parasitic worm Schistosoma mansonii 
were able to down-regulate the T lymphocytes responses during an infection (Velupillai et 
al., 1994). Therefore, there is a likelihood that H. pylori LeX may shift the immunity from 
cell-mediated to that of antibody-mediated which as in H. pylori is ineffective in 
eliminating the infection of the bacteria by the host.  A high frequency of LeX expression 
in all 15 H. pylori isolates from infected children was observed in the present study, 
agreeing with the report by Munoz et al (2001) which also demonstrated a high LeX 
expression in children.  Moreover, the study by Zheng et al. (2000) with the local adult 
population showed that there was no significant difference between non-ulcer dyspepsia 
and peptic ulcer patients for LeX expression.  Hence, the findings might infer that LeX may 
possibly play a part in the early stage of infection possibly by assisting colonization.        
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 Some H. pylori strains expressed the type I Lewis antigens, Lea and Leb.  Current 
study showed that 6.7% (1/15) and 20% (3/15) of the isolates tested expressed Lea and 
Leb, respectively.  This frequency is noted to be higher than the study by Rasko et al. 
(2001) which showed that only 4.8% of the isolates from symptomatic patients expressed 
the type I Lewis antigens.  The difference in the frequency of expression could be due to 
the populations studied.  It is interesting to note that Chinese patients expressed Lea and 
Leb more frequently as compared to strains isolated in the western population (Zheng et 
al., 2000) while Chinese expresses the Le(a+b+) phenotype more often as compared to the 
caucasians (Broadberry & Lin-Chu, 1991). This observation holds as 3 out of the 4 




5.3 LEWIS ANTIGENS EXPRESSION OF H. pylori DURING 
MORPHOLOGICAL CONVERSION  
 
The ability of many H. pylori strains expressing Le antigens (Lea, Leb, LeX, Ley) 
similar to those of the host is considered by many to be a major factor in the ability of this 
gastric organism to cause chronic gastroduodenal diseases (Applemelk et al., 1996; Moran 
et al., 1996; Zheng et al., 2000).  In view of this characteristic of the bacteria and with the 
results obtained earlier regarding coccoid form being a probable infectious form (Section 
4.3), it was decided to examine the Le antigens expression during H. pylori morphological 
conversion from the spiral to coccoid form.   
Results from the present study show that H. pylori retained Le antigen expression 
even after prolonged incubation (Figure 4.17).  Additionally, a general trend was observed 
when assessing the level of Le antigens expression at various time points of the 2 strains 
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 (RH 54 & NCTC 11637) is that both strains exhibited peak expression at 5th & 30th day of 
growth.  As illustrated in Figure 4.17, the Le antigens expression increases substantially 
from day 3 to day 5 of growth.  This phenomenon could be attributed to the actively 
dividing bacteria cells (spiral form) at this phase of growth and hence an increased in Le 
expression.  Mimicry of human Le antigens by H. pylori has been suggested to be a 
mechanism of camouflage to escape elimination by host immune system (Wirth et al., 
1997) or to facilitate adherence of the bacteria to the gastric mucosa (Edwards et al., 2000; 
Moran et al., 2000).  If the postulation was valid, then an increase in the amount of Le 
antigens expressed as seen in this in vitro study would probably provide an added 
advantage to the bacteria in the initial infection.   
 Following the peak at 5th day of culture, Le antigens expression started to decline 
until 15th day of incubation.  After which, the expression was seen to increase again.  The 
period of 5th to 15th day of culture is probably the period of morphological conversion 
where coccoid forms became predominant (Benaissa et al., 1996).  Previous studies have 
demonstrated that the membrane of the H. pylori cells changed upon entry into the coccoid 
state (Benaissa et al., 1996; Sorberg et al., 1996).  It may mean that the decrease in the Le 
antigens expression is related to these membrane alterations, thus resulting in a loss of 
membrane integrity.  The study by Rasko et al (2001) further supports the relationship of 
declining Le expression with membrane modifications as Le antigens were observed to 
shed into the supernatant during the stationary growth phase of H. pylori.  This observation 
could imply that in the in vivo scenario, shedding of the Le antigens may function as an 
immunological decoy, thus preventing the coccoid form from eliminated by the host 
response.   
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  It is indeed interesting to note the registering of another peak of Le antigen 
expression after a prolonged incubation for 30 days.  One would assume that at this time 
point, all the cells would have converted to the coccoid form.  This observation suggests 
that the coccoid form is capable of expressing Le antigens and probably not likely to be the 
degenerate form as reported by Kusters et al. (1997).  This then raises the question if the 
coccoid form is the most infectious at this time point (30 days old culture). Further 
assessment of the Le antigens expression beyond 30 days of incubation and in vivo study 
with the 30 days old coccoid form may contribute to our understanding of the variation of 




5.4 IMMUNOELECTRON MICROSCOPY & FLOW CYTOMETRIC  
ANALYSIS 
The immunoelectron micrograph (Figure 4.18) shows that the AGE antigens of  
H. pylori used for the serology in this study consisted of surface bound proteins.  This is 
apparent as clusters of gold particles were observed to localize on the surface of the whole 
bacteria.  The 3 day old cells were subjected to both the spiral and coccoid antibodies 
which were raised against the spiral and coccoid H. pylori cells, respectively.  If the spiral 
form of H. pylori expressed spiral specific antigens and vice versa for the coccoid form of 
H. pylori, one would probably perceive a higher affinity of the spiral antibodies to the 
spiral cells as compared to the coccoid antibodies.  However, this phenomenon was not 
observed under the immunoelectron microscopy.  There is no apparent difference in the 
density of gold particles observed around the cells with either antibodies as illustrated in 
Figure 4.18A & B.  In view that the antigens used were basically localized on the surface 
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 of H. pylori (Figure 4.18), evaluation of the antigen-antibody interaction was carried out 
using flow cytometry.  This is a sensitive method that allows rapid mutliparametric 
analysis (Blom et al., 2001).  By using flow cytometry, it was shown that though the spiral 
and coccoid antigens shared many common antigens (overlapping area in Figure 4.19), it is 
still probable that the spiral/coccoid specific immunogenic proteins do exist.  
As seen in Figure 4.19A & B, the spiral antibodies showed preferred affinity for the 
3 day old H. pylori spiral cells.  Whilst, when the coccoid antibody was used, there was a 
shift of the fluorescence to, indicating the preference for the coccoid cells (30 and 184 day 
old)   (Figure 4.19).  These observations affirmed the use of the coccoid antigens in the 
earlier serology tests to detect patients who could have been infected with the coccoid form 
of H. pylori.   
 
 
5.5 GENOMIC STUDY OF AGING H. pylori CULTURES 
 
In order to understand the changes reflected during the morphological conversion, 
the integrity of the nucleic acids which contains the information for cellular multiplication 
(Moat & Foster, 1988) in both the morphological forms of H. pylori was examined.  It was 
shown that the RAPD profiles of different aged cultures displayed highly similar patterns 
(Figure 4.12).  Furthermore, the PCR assays detected the presence of the gene for a 26 kDa 
protein (tsaA), ureA and two important virulence genes (cagA & vacA). This was 
demonstrated even in cultures which were more than 6 months old (184/219 days).  These 
observations demonstrated no evidence of DNA fragmentation after prolonged incubation 
as judged by the RAPD profiling and PCR amplification of the H. pylori specific genes 
during conversion of the spiral to coccoid form.  In the study by Ren et al. (1999), they too 
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 observed genes coding for ureC, cagA, 26kDa and 16S rRNA that remained intact in both 
the helical and coccoid forms of H. pylori.  
 Besides demonstrating the integrity of the DNA, it was also observed that the aged 
culture maintained the expression of 26kDa and ureA genes (Figure 4.23) throughout the 
incubation period.  Several studies have also reported expression of virulence genes during 
conversion to the coccoid form.  One of these studies is a report from Sisto and co-workers 
(2000).  They showed that in some H. pylori strains, the ureA, cagA and vacA genes were 
still expressed after 31 days of prolonged incubation.  Similarly, in another study (Nilsson 
et al., 2002), the expression of mRNA for vacA, ureA and tsaA (26kDa) were detected in 
28 months old non-culturable cold-starved cells suspensions of H. pylori.  In addition, the 
cellular ATP was detectable for at least 25 days after the morphology conversion (Nilsson 
et al., 2002).     
 The role of coccoid form of H. pylori remains an open topic for debate.  The 
coccoid form of some organisms, such as Vibio vulnificus (Oliver et al., 1995) was able to 
recover from the VBNC state by a temperature upshift.  However, to date, resuscitation of 
VBNC cells of H. pylori has been futile. Some authors suggest that the coccoid 
morphology, which is generally non-culturable is merely dead cell (Kusters et al., 1997).  
Whilst others are in agreement that a small proportion of the coccoid cells are viable as 
they maintained the cellular functions such as DNA replication, transcription and 
translation (Mizoguchi et al,. 1999; Zheng et al., 1999; Nilsson et al., 2002).  Results from 
our study is in support of the notion that the coccoid form of H. pylori is viable as the 
chromosomal integrity was maintained and basic cell functions such as transcription and 
translation were also demonstrated.   
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 5.6 PROTEOMIC STUDY OF AGING H. pylori CULTURES 
 
5.6.1 Proteins identified from 1D-PAGE 
 
As discussed in the earlier sections, the present study shows that the coccoid form 
of H. pylori could be alive in the dormant state.  The final section of this study aims to 
examine the viability of the coccoid form by evaluating its protein synthesis.   
 The 1D PAGE protein profiles for the AGE preparations (Figure 4.24) and SDS-
PAGE for the time course experiments (Figure 4.25) show that the protein patterns of the 
coccoid populations are relatively similar to that of the spiral forms. However, as 
expectedly, the protein synthesis in the coccoids is relatively reduced. This is seen in 
Figure 4.24 & 4.25, which illustrate a reduction of the protein bands and also the band 
intensity.  Coccoid form being the dormant form of H. pylori probably may not be as 
metabolically active as the spiral form.  Nonetheless, this dormant form should be able to 
synthesize a minimum amount of proteins for its survival. 
 Several H. pylori proteins were identified after comparing the AGE preparations of 
the 2 forms (Table 4.24).  Proteins identified include iron superoxide dismutase, 26 kDa 
protein, Non-heme iron containing ferritin (Pfr), neutrophil activating protein (NapA), 
thioredoxin and a putative protein.  Results obtained from the database search showed that 
the putative protein is a conserved protein with no apparent known function.   
 The iron superoxide dismutase present in both spiral and coccoid form of H. pylori 
is a major defence mechanism against oxidative damage, catalyzes the breakdown of 
superoxide radicals to hydrogen peroxide and dioxygen. This enzyme acts to protect the 
pathogen from the lethal effects of toxic oxygen species.   
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  The amino acid sequences of the 26 kDa protein shows similarities with alkyl 
hydroperoxide reductases (Ahp C) in both prokaryotes and eukaryotes (Storz et al., 1989; 
Chae et al., 1994).  Alkyl hydroxide reductase belongs to the family of antioxidants known 
as the AhpC/TSA protein family.  This group of enzymes reduce the harmful alkyl 
hydroperoxides to their corresponding alcohol and these enzymes are also produced by 
many bacterial species (Storz et al., 1989).  It has been shown that this protein is an antigen 
produced in vivo as patients infected with H. pylori can mount an immune response against 
this protein (Mattsson et al., 1998).  The essential of this protein is demonstrated by the 
study of Lunstrom & Bolin (2000) which attempted to construct a mutant deficient for the 
gene in H. pylori was unsuccessful.  However, in a recent study by Olczak and colleagues 
(2002), ahpC mutant construct can be isolated if mutant selection is performed under low 
oxygen tension.  They demonstrated that the mutants were more sensitive than the parent 
strain to oxidative stress-related chemicals.  In the present comparative study, the 26kDa 
protein is observed in both forms.  It is interesting to note a slight increase in the intensity 
of that specific protein band is seen in the coccoid form (Figure 4.24).   
 Two of the proteins which were detected with comparative quantity (similar band 
intensity) in both morphology forms are the non-heme iron containing ferritin (Pfr) and the 
neutrophil activating protein (NapA).  The ferritin is a major iron storage protein of H. 
pylori. Waidner and colleagues (2002) have demonstrated that Pfr mediated iron storage is 
essential for survival of lethal iron starvation and protected the bacteria from acid 
amplified iron toxicity.  They had also shown that the functions of H. pylori Pfr in iron 
metabolism were essential for the survival of H. pylori in the gastric mucosa, as the pfr 
mutant was unable to colonize in the Mongolian gerbils.  This indicates that iron storage is 
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 a prerequisite for the successful colonization of H. pylori.  The protein identified as NapA, 
shared structure homology to the Dps family of proteins and Dps is implicated in the 
response of bacteria to oxidative stress (Tonello et al., 1999).  In addition, NapA has been 
shown to interact with DNA in vivo (Cooksley et al., 2003).  This interaction is postulated 
to protect against DNA damage.  The low molecular weight protein identified as 
thioredoxin has also been shown to play important role in aiding the survival of the 
bacteria under oxidative stress (Comtois et al., 2003).   
 Based on the proteins identified from current 1D-PAGE study, the coccoid form of 
H. pylori still exhibits proteins which probably play a part against the oxidative stress.  
Should the coccoid form be viable, these proteins may be undoubtedly important in its 
survival in the harsh aerobic environment outside the host. 
 
5.6.2 Proteins identified from 2D-PAGE 
The technique of 2D-PAGE is the heart of proteomic research. This technique 
separates proteins by molecular weight and pI of the proteins.  In the present study, besides 
the 1D-PAGE, this methodology was employed to display and identified the proteins 
expressed by H. pylori.  In accordance to that observed in 1D-PAGE (Figure 4.25), the 
number of proteins decreased at the various time course tested.  Analysis of the proteome 
maps showed a ~45% reduction of proteins during morphological conversion, with 676 
protein spots expressed in 3 day old culture to 374 spots expressed in 184 day old culture.  
The proteome maps show that majority of the proteins are presented near to the basic end 
(Figure 4.26).  On the basis of the genome of H. pylori, about 70% of the encoded proteins 
have pI >7 (Tomb et al., 1997).   
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 In addition, the proteome profiles presented numerous proteins which appeared as 
trains of spots. Amongst the several H. pylori proteins which presented in multiple 
isoforms, two proteins were identified; Urease B and 26kDa (tsaA) (Figure 4.26).  Lock et 
al. (2001) identified 12 protein spots for the gene coding tsaA and 5 proteins for ureB.  The 
multiplicity of protein isoforms may be the consequence of post-translation modifications 
such as phosphorylation (Lock et al., 2002).  In another study by Lock et al. (2002), they 
showed that clusters of Urease B proteins were immunoreactive to both IgG and IgA.  
They also commented that though the importance of protein isoforms in vivo remains to be 
explored, the protein isoforms may have some bearing on the use of the recombinant 
versions of the H. pylori proteins as vaccine antigens. 
The coccoid form of H. pylori maintains a level of the products of tsaA (Figure 
4.27B).  This protein is described earlier as having a role in the survival of H. pylori 
against oxidative stress environment.  On the contrary, the Urease B is observed to be 
reduced significantly in the 30 day old culture. Nilsson et al. (2000) demonstrated a decline 
in Urease B in 12 day cell extracts as compared to an 8 day cell extracts.   This observation 
is in agreement with that described by Zheng et al. (1999), the urease activity became 
weakly positive by day 28.   
 Several other proteins (Table 4.12) whose activities may maintain the viability of 
the bacteria are expressed in the aged culture. The results from the present differential 





 5.6.3 DIGE 
DIGE is the use of pre-electrophoretic labelling with fluorescent dyes. The 
advantage of this method over the conventional 2D PAGE is the reduction of gel-to-gel 
variation as the samples are run together on the same gel.  This methodology has been 
employed for normal proteomic analysis (Yan et al., 2002) as well as for comparative 
differential study (Zhou et al., 2001).  However, the use of DIGE in the study of             
H. pylori has yet to be reported. 
In the current study, we evaluate this new emerging technology by comparing the 
proteins expression in the spiral and coccoid H. pylori cells (Figure 4.29). The protein 
profiles are highly similar to that performed by the 2D-PAGE.  One of the proteins was 
identified as the TagD protein (this protein was also identified in the silvered stained gel 
PAGE).  From DIGE profile, 1 protein spot (adhesin-thiol peroxidase tagD) was              
up-regulated in the coccoid form. However, it is not clearly detected as up-regulated 
protein in coccoid cells by the 2D-PAGE.  Hence, this methodology provided yet another 
feasible and useful proteomic technique which enables the differences between samples to 





In the attempt to answer if the coccoid form of H. pylori plays a role in infection 
and transmission, the present study began with the familial clustering study. The results 
demonstrated clustering of H. pylori infection amongst family members using antibody 
profiling.  The study presents the possibility of a vertical transmission.  However, the mode 
of transmission remains elusive though it was postulated that the coccoid form which can 
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 survive in extragastric environment may hold the key to the understanding of the 
transmission cycle. Thus, it leads one to postulate that children as the link in the 
transmission of H. pylori infection.    
Earlier studies (Malaty et al., 2002; Perez-Perez et al., 2003) have pointed to the 
direction of H. pylori infection being acquired during childhood.  In the current study, the 
immune responses of children having epigastric pain was evaluated using spiral as well as 
coccoid form as antigens in our in-house ELISA.  The serological results showed a 2-fold 
increase in immune response against the spiral antigen in the symptomatic children as 
compared to the control group (asymptomatic school children of comparable age). Thus, 
inferring an association of H. pylori infection in children having epigastric pain. An 
interesting observation from the serology study is that a 4 fold increase in IgG level against 
the coccoid antigen in the children with epigastric pain was observed.  This finding voiced 
a concerned question: Is there an under-reporting on the presence of H. pylori infection in 
this group of symptomatic young population? 
The finding on the increase in immune response against the coccoid form of          
H. pylori in the symptomatic children and the many reports showing childhood as the 
period of acquisition of H. pylori infection, lead to the postulation that: could the infection 
have begun with the coccoid form. Thus, to be able to cause an infection, the coccoid 
forms would have to maintain its viability.  Hence, we probed further by examining the 
coccoid form of H. pylori at the genomic and proteomics aspects. 
The conversion of the spiral to coccoid form was observed over a time course. In 
this study, it was observed that the coccoid form exhibited fingerprinting profile highly 
similar to the spiral form. In addition, several putative determinants were conserved in the 
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 coccoid form.  The expression of the 26kDa and ureA was also observed throughout the 
time course.  Furthermore, the coccoid form was able to maintain the expression of the Le 
antigens as 2 peaks (at 5th & 30th day of culture) were noted in the time course study. 
Proteomic study was carried out with 1D and 2D PAGE.  Though the amount of 
proteins decreased during the morphological conversion, the protein profiles of the coccoid 
form was observed to be similar to the spiral form. Proteins from 1D and 2D PAGE 
identified by mass spectrometry showed that the coccoid form has retained the “essential” 
proteins (EF-TU, 26kDa, non-heme containing ferritin) as well as expressing proteins 
involved in combating oxidative stress.  This will be an advantage if the coccoid form is to 
survive in the extragastric environment.  
The innate response to the invading bacterial pathogen has shown a significant 
increasing IgG against the coccoid antigen. And yet, the coccoid form could not be 
resuscitated.  Could it be that no suitable medium has been identified because no suitable 
culture medium has been identified as the knowledge or the understanding of the “inducer” 
that could awake or resuscitate the coccoid form to the spiral form in in vitro condition is 
not available.  Nonetheless, this “inducer” could be readily available in in vivo condition.  
Is the coccoid form a survival strategy that the bacterium adapts to survive in the 
extragastric environment? In the present study, comparative results from epidemiological 
and proteomics studies have lend support to the viability of the coccoid form of H. pylori 
and also suggesting that this form could play a key role in the transmission cycle of           
H. pylori.  
Answering one or more of the questions regarding the coccoid form will help to 
shed light on the controversial point if the coccoid form is a degenerating form or VBNC 
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 or viable entity of H. pylori. This will in turn provide impetus into the management of           
H. pylori infection and the probable role of coccoid form in transmission of H. pylori 
infection.  One should therefore not overlook the close relationship of H. pylori infection in 
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 APPENDIX 1 
 
A1.1 Brain Heart Infusion (BHI) broth 
 For a 300 ml preparation, 
 Brain heart infusion (Gibco) 11.4 g 
 Yeast extract (Oxoid)     1.2 g 
 Distilled water      270 ml 
 Horse serum (10%) (Gibco)    30 ml  
 
• Horse serum was added after the mixture of Brain heart infusion and yeast extract was  




A1.2 Chocolate Blood agar (Non-selective)  
 For a 500 ml preparation,  
 Blood agar base No.2 (Oxoid)    20.0 g   
 Defibrinated horse blood (5%) (Gibco)  25 ml  
 Distilled water      475 ml  
 
• Blood agar base No.2 was mixed with 475 ml distilled water.  
• Mixture was autoclaved at 121°C for 15 minutes. 
• The agar was cooled to 50°C before addition of 25 ml (5%) of horse blood. 
• Mixture was swirled in a 80°C water bath for about 10 minutes to lyse the blood. 
• Mixture was cooled before pouring into the sterile petri dishes. 
 
 I
 A1.3 Chocolate Blood agar (selective)  
 Antibiotic Stock Solution 
     Final concentration  Stock concentration 
 Vancomycin (Sigma) 3 µg/ml   3 mg/ml  
 Trimethoprim (Sigma) 5 µg/ml   5 mg/ml 
 Nalidixic acid (Sigma)   10 µg/ml    10 mg/ml 
 Amphotericin B (Sigma) 2 µg/ml               2 mg/ml 
 
• Vancomycin and Nalidixic acid were prepared by dissolving the antibiotic powder in  
 distilled water. 
 
• Amphotericin B was dissolved in distilled water and adjusted to pH 11.0. 
• Trimethoprim was dissolved in 70% ethanol and adjusted to the appropriate concentration  
   with distilled water. 
 
• The antibiotics were filtered using a sterile 0.22 µm filter and filtrate was aliquoted into  
 eppendoff  tubes. 
 
• Aliquots were stored at -20°C until use. 
 
Chocolate blood agar supplemented with antibiotics 
 For a 500 ml preparation, 
 Chocolate blood agar (Section A1.2) 489 ml  
 Vancomycin stock solution   0.5 ml (Final concentration: 3 µg/ml) 
 Trimethoprim stock solution  0.5 ml (Final concentration: 5 µg/ml) 
 
 II
  Nalidixic acid stock solution   0.5 ml (Final concentration: 10 µg/ml) 
 Amphotericin B stock solution 0.5ml (Final concentration: 2 µg/ml) 
 
• Chocolate blood agar was prepared as described in Section A1.2 and cooled to 50 oC. 
 
• The antibiotic stock solutions were added to the cooled molten chocolate blood agar. 
   
• The well-mixed chocolate blood agar with antibiotics was poured into sterile petri  
dishes. 

































 APPENDIX 2 
 
A2.1 Urease Test Reagents 
For 50 ml preparation, 
 Urea (Sigma)   1g 
 Phenol red (0.5% w/v) 5 ml 
 Na2H2PO4. H2O  21.8 µg 
 Na2HPO4   51 µg 
 
• Urea and the inorganic salts were dissolved in 45 ml of distilled water. 
• The pH was adjusted to pH 6 before use. 
• Mixture was autoclaved at 121°C for 10 minutes. 













 APPENDIX 3  
 
Buffers and Reagents for ELISA 
A3.1 0.05 M Carbonate Buffer (pH 9.6) 
 Na2CO3    1.59 g 
 NaHCO3    2.93 g 
 Distilled water (qsp)   1L 
 
A3.2 10x Phosphate buffered saline (PBS), pH 7.4 
 For 1L preparation, 
 NaCl     80 g 
 Na2HPO4    14.4 g 
 KCl     2.8 g 
 KH2PO4    2.4 g 
 Distilled water  (qsp)   1L 
 
A3.3 Serum Diluent  
 PBS (1x)    1L 
 Tween 20 (Merck)  0.5 ml 
Thimerosal (Sigma)   0.2 g 
 Gelatin (Gibco)   1 g (dissolve by heating) 
 
A3.4 Wash Buffer I 
 PBS (1x)  1L 
 Tween 20  0.5 ml 
 Thimerosal  0.2 g  
 V
 A3.5 Conjugate Diluent 
 
PBS (1x)     1 L  
Thimerosal     0.2 g 
Gelatin     1g (dissolved by heating) 
Bovine serum albumin (BSA)(Sigma) 0.02 g 
 
A3.6 Wash Buffer II 
 PBS (1x)    1L 
  Thimerosal    0.2 g  
 
 
A3.7 Phosphate Citrate Buffer (Substrate Buffer), pH 5 
 
For 500 ml preparation, 
 
0.1 M Citric acid (Merck)  2.55 g 
 
0.2 M NaHPO4.2H2O   4.57 g 
 













 APPENDIX 4  
 
Buffers and Reagents for polyacrylamide gel electrophoresis 
 
A4.1 2X Treatment Buffer 
 
 4% SDS  4 ml from 10% SDS 
 0.5 M Tris-HCl (pH 6.8)  2.5 ml 
 ß-mecaptoethanol (BDH)  1.0 ml 
 Glycerol (Merck)  2.0 ml 
 Bromophenol Blue (Bio-Rad)  0.005 g 
 Distilled water    0.5 ml 
 
A4.2 Resolving gel Buffer (pH 8.8) 
 
 For 500 ml preparation,  
  1.5 M Tris    90.75 g  
  Distilled water (qsp)   500 ml 
  Adjust to pH 8.8 with HCl 
 
A4.3 Stacking gel Buffer (pH 6.8) 
 For 500 ml preparation, 
0.5 M Tris    30.17 g 
Distilled water (qsp)   500 ml 





 A4.4 10% SDS  
 
 SDS (Sigma)    10 g 
 
 Distilled water (qsp)   100 ml  
 
A4.5 10% Ammonium persulphate (APS) 
 
 APS (Bio-Rad)   1 g 
 
 Distilled water (qsp)   10 ml 
 
A4.6 10x Tank Buffer 
 
 Tris      30.28 g 
 Glycine (BDH)   144.13 g 
 SDS     10 g 
 Distilled water (qsp)   1L 
 
A4.7 Overlay Solution 
 Isopropanol or water saturated n-butanol 
 
A4.8 Resolving gel and stacking gel recipes 
 4% 12% 
Acrylamide-bis solution (30%) (Bio-Rad) 3.3 ml 40 ml 
Resolving gel buffer - 25 ml 
Stacking gel buffer 6.3 ml - 
10% SDS 250 µl 1.0 ml 
10% APS 125 µl 500 µl 
Temed (Bio-Rad) 25 µl 50 µl 
Distilled water 15 ml 33.45 ml 
Total Vol 25 ml 100 ml 
 VIII
 APPENDIX 5  
 
Buffers and Reagents for western blotting (Semi-dry electrophoretic transfer) 
A5.1 Transfer Buffer (pH 9.2) 
 
 48 mM Tris    5.82 g 
 39 mM glycine     2.93 g 
 1.3 mM SDS    3.75 ml from 10% SDS 
 20% Methanol   200 ml 
 Distilled water (qsp)   1L 
 
A5.2 Blocking Solution 
 
 Skim milk powder   5 g 
 PBS Tween-20   100 ml 
 
A5.3 Wash Buffer (PBS-Tween-20) 
 
 For 1L preparation, 
 PBS     1L 
 Tween 20     0.5 ml   
 
A5.4 Substrate Solution  
 
  4-chloro-1-napthol (Sigma)  60 mg 
  Cold methanol   20 ml 
  PBS     100 ml 
• Substrate, 4-chloro-1-napthol was dissolved in methanol in the dark. 
• 100 ml of PBS was added to the substrate and 60 µl of 30% hydrogen peroxide was added 
immediately before use. 
 IX
 APPENDIX 6 
 
Buffers and Reagents for DNA extraction and PCR 
DNA extraction 
A6.1 TE Buffer  
 1 M Tris (pH 8)   1 ml (Final conc: 10 mM) 
 0.5 M EDTA (pH 8)(Sigma)    0.2 ml (Final conc: 1mM)  
 Distilled water    98.8 ml 
 
PCR reaction  
A6.2 50X TAE BUFFER 
 Tris     242 g 
 Glacial acetic acid   57.1 ml 
 EDTA     18.6 g 
 Distilled water  (qsp)   1L 
• Buffer was diluted to 1X before use. 
 
 
A6.3 Loading Buffer (5X) 
 
 Glycerol    3 ml 
 
  Bromophenol Blue   0.025 g 
  Xylene Cyanol   0.025 g 






 APPENDIX 7 
 
Buffers and Reagents for 2D PAGE 
A7.1 Lysis Buffer 
 
 9 M Urea    9.8 g 
 4% CHAPS (UBS)   0.8 g 
 40 mM Tris     533 µl 
 Complete, Mini protease inhibitor 1 tablet 
 Cocktail tablets (Roche) 
 Distilled water (qsp)   20 ml 
 
 
A7.2 Rehydration stock solution with IPG Buffer 
 8 M Urea     12 g 
 2% CHAPS (w/v)    0.5 g 
 0.5% IPG Buffer    125 µl 
 0.001% Bromophenol blue (Bio-Rad) 0.25 mg or a few grains 
 Distilled water (qsp)    25 ml 
 
• Aliquots of 1ml amount were kept at -20ºC. 







 A7.3 SDS Equilibration Buffer 
 50 mM Tris     6.7 ml from 1.5 M Tris (pH 8.8)   
 6 M Urea     72.07 g 
 30% Glycerol (87% v/v)   69 ml 
 2% SDS     4 g 
 0.001% Bromophenol blue (Bio-Rad) 0.002 g 
 Distilled water (qsp)    200 ml 
 
• Aliquots were stored in 10 ml amount at -20ºC until use. 
• 100 mg DTT or 250 mg Iodoacetamide were added to the 10 ml buffer prior to use. 
 
        
 
 


















 APPENDIX 8 
 
2D DIGE preparation 
 
A8.1. Cell wash buffer 
  10 mM Tris (pH 8)   12 mg 
  Distilled water  (qsp)   10 ml 
 
 
A8.2 Lysis Buffer  
 
 30 mM Tris    36 mg 
 7 M Urea     4.2 g 
 2 M Thiourea (Sigma)  1.52 g 
 4% CHAPS (USB)   0.4 g 
 Distilled water (qsp)   10 ml 
 
 
• pH was adjusted to pH 8 with diluted HCl.  Aliquots of 1ml amount were stored at -20ºC  
 until use.   
 
 
A8.3 2X Sample Buffer 
 
 8 M Urea    4.8 g 
 130 mM DTT (Bio-rad)  0.2 g  
 4% Chaps    0.4 g 
 2% (v/v) Pharmalyte TM 3-10  0.2 ml 
 Distilled water (qsp)   10 ml 
• Aliquots of 1ml amount were stored at -20ºC until use.   
 XIII
